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Abstract
Fetal alcohol spectrum disorders (FASD) refers to the neurological, developmental,
and behavioural abnormalities arising from in utero ethanol exposure. These abnormities
included attention deficit, anxiety, and learning and memory impairment persisting into
adulthood. The molecular mechanisms of such persistent behavioural changes remain
unknown and are an area of intense research. In this thesis, mice were exposed to ethanol
during the third trimester equivalent, the peak of synaptic development. Following this
exposure, genome-wide epigenetic and gene expression and changes in the hippocampus
were assessed in adult (70 day old) mice.
In the first experiment, genome-wide trimethylation of histone H3 at histone H3
lysine 4 (H3K4me3) and lysine 27 (H3K27me3) were assessed using chromatin
immunoprecipitation (ChIP) microarray (ChIP-chip). Cell-cell signalling genes were
enriched for changes in both methylations. It included the protocadherin (Pcdh) genes, which
confer neuronal identity and may be important for synaptic development. Changes in
methylation also occurred at imprinted genes and lipid-metabolism genes
The second experiment assessed DNA methylation using methylated DNA
immunoprecipitation (MeDIP) microarray (MeDIP-chip). The screen identified genes
involved in peroxisome biogenesis, which metabolize lipids and generate free-radicals. This
was also true when the histone and DNA methylation changes were considered together.
Combined analysis of affected genes from each experiment implicated free-radical
scavenging genes. Identification of this novel interplay between epigenetic and oxidative
stress genes may provide insight into diagnostic or therapeutic interventions. In general, the
results support a role of epigenetic mechanisms in long-term FASD phenotypes.
Finally, the third experiment examined gene expression and miRNA microarrays
identified 59 and 60 differentially expressed genes and miRNAs between ethanol-exposed
and control mice. These genes primarily affect free radical scavenging genes. Differential
expression of five genes in this pathway was confirmed with droplet digital PCR (ddPCR),
including the transcription factor Tcf7l2 and the apoptosis regulator Casp3. The affected
genes also included other oxidative stress proteins, olfactory receptors, and biosynthetic
enzymes that may contribute to FASD-related abnormalities.
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1

Introduction
Fetal Alcohol Spectrum Disorders (FASD)
1.1.1

A Limited Definition
Fetal alcohol spectrum disorders (FASD) is a non-diagnostic umbrella term

encompassing several conditions caused by prenatal alcohol exposure (PAE). It includes
fetal alcohol syndrome (FAS), partial FAS (pFAS), alcohol-related neurodevelopmental
disorder (ARND) and alcohol-related birth defects (ARBD) (Chudley et al., 2005). These
disorders are characterized by neurological, developmental and behavioural
abnormalities. Birth defects in children of alcoholic parents were first described in 1968
(Lemoine et al., 1968). The specific diagnostic criteria associated with the condition, and
the term FAS were described in 1973 (Jones et al., 1973). These include four
components: 1) characteristic facial dysmorphia (smooth philtrum, thin upper lip, almond
shaped eyes) 2) impaired prenatal and/or postnatal growth, 3) central nervous system
(CNS) or neurobehavioural disorders, 4) known exposure to alcohol (ethanol) in utero.
The term fetal alcohol effects (FAE) was soon created to encompass individuals who
presented only some FAS criteria, presumably from differing timing and dosage of
ethanol (Clarren and Smith, 1978). FAE was later delineated to specific conditions:
ARND and ARBD as well as segregating FAS from pFAS (Stratton et al., 1996). Each
requires confirmed maternal ethanol consumption. pFAS is defined by facial dysmorphia,
and one of the other FAS criteria. ARBD is defined by presence of congenital
malformations. ARND is defined by presence of either CNS or behavioural abnormalities
(Stratton et al., 1996).
The behavioural phenotypes associated with FASD are diverse, and highly
detrimental to those affected. A behavioural phenotype is defined as “a characteristic
pattern of motor, cognitive, linguistic and social observations that is consistently
associated with a biological disorder” (O’Brien and Yule, 1995). Attention deficit,
hyperactivity, impaired executive function, learning and memory, social skills, are
observed in children with FASD (Sokol et al., 2003). Not one of these features is unique
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to FASD, nor is any combination of them. Further, many of these features can be present
in FASD individuals, but not be the result of PAE. This makes differentiation of FASD
from other disorders very challenging. For example, FASD is often misdiagnosed as
attention deficit hyperactivity disorder (ADHD) (Peadon and Elliott, 2010). ADHD also
has high comorbidity with FASD adding further complexity (Rasmussen et al., 2010).
FASD is distinguished primarily by known maternal ethanol exposure. Stigma and shame
associated with drinking while pregnant makes these self-reported metrics unreliable
(Sokol et al., 2003). PAE is believed to impact brain development creating cognitive
deficits as “primary disabilities” leading to behavioral outcomes as “secondary
disabilities” (Streissguth et al., 2004).
While the definitions of the FASD component disorders allow for phenotypic
classification, they do not provide any mechanistic or etiological insight. It is unknown
what dosage or developmental timing of ethanol exposure lead to which FASD
conditions. It is clear that the behavioural aberrations are caused by ethanol, but the
intervening molecular and cellular mechanisms are unclear. As such, the central
questions in FASD research concern characterizing molecular and cellular changes.

1.1.2

Statistics
FASD is the most common cause of developmental disability in the Western

world (May et al., 2009). The general estimate of FAS prevalence across Canada is
approximately 1 per 1000 live births while the estimate for FASD is 10 per 1000 live
births (Public Health Agency of Canada., 2003). Incidence rates vary greatly, and are
highly community-specific. Certain First Nations communities for example are at
substantially elevated risk. FASD prevalence in an isolated First Nations community in
British Columbia was estimated at 190 per 1000 live births (Robinson et al., 1987). The
incidence of FAS in northeastern Manitoba was estimated at 7.2 per 1000 live births
(Williams et al., 1999). A study of another Manitoba First Nations community estimated
an incidence of FAS and pFAS of 55-101 per 1000 lives births (Square, 1997).
Despite societal efforts to raise awareness about the risks, many women still
consume alcohol during pregnancy. Approximately 14% of women among the general
Canadian population (McCourt and Public Health Agency of Canada., 2005) and as high
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as 50% and 60% in isolated northern communities consume alcohol regularly while
pregnant (Dow-Clarke et al., 1994; Muckle et al., 2011). In a study of drinking patterns
in Inuit women in Quebec, more 19% of women who drank during pregnancy engaged in
binge drinking, defined as drinking bringing the blood alcohol concentration (BAC) to
0.08 grams percent or above (Fortin et al., 2015).
The cost of FASD in Canada in 2013 was conservatively estimated to be between
$1.3 billion and $2.3 billion (Popova et al., 2015). The largest contributing factor was the
cost of productivity losses due to disability and premature mortality, accounting for 42%
of the total cost. Second at 30% was the cost of corrections, including all interactions
with the criminal justice system. Indeed, FASD individuals are at substantially elevated
risk involvement with the criminal justice system (Fast et al., 1999). Third was the cost of
health care at 10% (Popova et al., 2015). The authors of these studies point out that these
estimates include only individuals diagnosed with FASD conditions, and as such
undiagnosed or misdiagnosed individuals may be driving the costs much higher.

1.1.3

Ethanol Metabolism
In adults, ethanol is metabolised in the liver by alcohol dehydrogenase (ADH) to

acetaldehyde which is converted to acetate by aldehyde dehydrogenase (ALDH). The
mitochondrial form of ADH (ADH2) is responsible for most acetaldehyde oxidation in
the body (Licinio and Wong, 2002). The equilibrium constant of ADH actually strongly
favors reduction of acetaldehyde to ethanol. ALDH however irreversible converts
acetaldehyde to acetate, which is what drives ethanol oxidation (Bosron and Li, 1987).
This also means that acetaldehyde is normally found at very low levels, which is
important since it exerts many of the detrimental effects commonly attributed to ethanol
(Tong et al., 2011). Ethanol can also be metabolized to acetaldehyde by catalase found in
peroxisomes and CYP2E1 found in microsomes (Haorah et al., 2008). ADH is not
expressed in sufficient levels in fetal liver to break down ethanol. CYP2E1 and other
cytochromes metabolize ethanol at much slower rates (Hines and McCarver, 2002).
These enzymes produce oxygen free radicals as part of their enzymatic action which are
believed to contribute to ethanol teratogenicity (Haorah et al., 2008). Further, this means
that ethanol remains present in the fetus much longer than the maternal bloodstream.
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ALDH2 is produced by fetal liver, but not until late in gestation in mice (Sanchis and
Guerri, 1986). This means that acetaldehyde is not readily metabolized; due to its
instability this leads to free radical formation and cellular damage (Tong et al., 2011).
Since ethanol can cross the blood brain barrier, these effects all occur in the developing
fetal brain (Muralidharan et al., 2013).

1.1.4

Role of Genetic Variation
The diversity of phenotypic outcomes from similar ethanol exposures suggests

that genetic factors may modulate the teratogenic effects of ethanol. Siblings of children
with FAS have a higher risk of FAS, 170 per 1000 live births among older sibs and 771
per 1000 live births in younger sibs (Abel, 1988). Monozygotic twins have a higher
concordance rate for FAS diagnosis than dizygotic twins (Streissguth and Dehaene,
1993). Several studies have examined the role of polymorphisms in ethanol metabolism
enzymes. ADH2 has several non-synonymous, common polymorphisms that alter the rate
of ethanol oxidation. ADH2*3 has two amino acid changes (Arg47 and Cys369) leading
to a greatly increased ethanol turnover rate, 80 times other variants (Licinio and Wong,
2002). The ADH2*3 allele was shown to have a protective effect when the mother had at
least one copy (Jacobson et al., 2006). When present in the fetus, ADH2*3 was
associated with reduced risk of low birth weight (Arfsten et al., 2004). Another variant
with increased enzyme kinetics, ADH2*2, was associated with decreased FAS presence
(Viljoen et al., 2001). Genetic variation also appears to play a role in the drinking
behaviour of pregnant women. ADH2*2 was associated with reduced alcohol
consumption during pregnancy (Zuccolo et al., 2009). ALDH polymorphisms are known
to be important in alcohol preference in risk for alcoholism in adults (Quertemont, 2004);
however, no studies have implicated these variants in FASD risk. Variants of CYP2E1
have also not been assessed in FASD and very little in alcoholism risk either. While
genetic factors play a role in risk, the mechanisms of FASD etiology encompass many
more molecular pathways.
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Understanding FASD: Animal Models
It is difficult to assess the action of ethanol on a cellular level in humans. As such,
animal models of PAE have been developed to gain insight into the molecular actions of
ethanol. There are several key advantages to animal models. First, all animal models
provide access to all tissues at many timepoints. In FASD, access to brain tissue of
ethanol exposed fetuses during development is key (Patten et al., 2014). Further, given
the clear importance of genetic background, use of genetically inbred stains allows
researchers to control for genetic effects (Nestler and Hyman, 2010). Animal models
usually have sequenced genomes with genetic tools available to characterize genomic and
transcriptional changes. Many animals have well documented behavioural tests to assess
changes in disease-relevant behaviours. Animal models also allow for replication using
many animals to increase statistical power. Specific to FASD, the developmental timing
and dosage of ethanol can be precisely controlled.
The most logical choice for a model of FASD would seem to be non-human
primates. Primates are close evolutionary relatives of humans, have similar gestational
development, and have complex social behaviours which could be assessed for ethanol
responsiveness (Patten et al., 2014). In practice, there have been very few studies of
FASD done in primates. Primates have very long gestational times compared to other
model organisms, and are also much longer lived, making experiments time consuming
(Schneider et al., 2011). Ethical approval can also be challenging, and the number of
animals raised is usually quite low, limiting statistical power. Experiments in these
models report growth restriction as well as various behavioural aberrations including
learning and memory deficits and tactile aversion (Clarren and Astley, 1992; Clarren et
al., 1992; Schneider et al., 2001, 2008).
Rodents are the most popular model organism in FASD research, with rats and
mice being the most common. Rats and mice have a short gestation period (21 days),
large litters, and complex behaviour with a battery of tests available. Mice are the most
common animal model of human disease in general, due to ease of care, ease of genetic
manipulation, and similarity to human development and physiology (Patten et al., 2014).
Rats are larger, generally allowing easier study of physiology compared to mice and more
tissue for molecular analyses. Rats also have more sophisticated behaviour than mice,
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with more behavioural tests available. Both are used in genetic, biochemical,
physiological, and behavioural studies of FASD. In mice, the C57BL/6J (B6) inbred
laboratory strain has become the most common. B6 mice have a long history of use in
ethanol research, in part because they voluntarily consume more ethanol solution than all
other strains (Rodgers, 1966). In response to ethanol during development, they have a
high amount of fetal malformations compared to other strains (Boehm et al., 1997).
Some research has taken place in guinea pigs. Guinea pigs have an advantage
over other rodent models of FASD: their gestation is much more similar to humans. All
three trimester equivalents of brain development occur in utero for guinea pigs, whereas
in mice and rats the third trimester equivalent brain development occurs postnatally
(Dobbing and Sands, 1979; Dringenberg et al., 2001). Drawbacks of guinea pigs include
longer gestation time (three times that of mice and rats), smaller litter size, and nonexploratory behavioural tendencies that make behavioural tests difficult (Dringenberg et
al., 2001). PAE models in other model organisms have been developed, including
Caenorhabditis elegans (Davis et al., 2008), Drosophila (McClure et al., 2011), Xenapus
laevis (Nakatsuji, 1983), zebrafish (Marrs et al., 2010), chickens (Smith, 2008), and
sheep (Cudd et al., 2001) (for review see Patten et al., 2014). The diverse strengths of
these models allow for examinations of FASD etiology at various biological levels.
The creation of specific FASD models must balance dosage and timing of ethanol
exposure. Dosage/duration of ethanol exposure is key, as it determines which
developmental processes are be affected. CNS development begins at gestational day
(GD) 7 in mice, equivalent to the first trimester in humans (Rice and Barone, 2010).
Neurulation initiates CNS formation, after which neurons proliferate, migrate outward,
and differentiate into mature neurons during trimester two (Rice and Barone, 2010). After
differentiation, neurons undergo synaptogenesis and maturation in trimester three.
Ethanol will disrupt each of these processes if it is administered at that time. The dosage
of ethanol is related to the timing; usually either moderate over a longer time (mimicking
human BAC levels) or high and episodic to maximize effects. ethanol exposure time
point: early gestation, late gestation, or post-natal (in mice and rats). Ethanol exposure at
these various timepoints has markedly different molecular and behavioral outcomes
(Kleiber et al., 2014; Mantha, Kleiber, & Singh, 2013; Miller, 2006; Patten, Fontaine, &
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Christie, 2014; Wozniak et al., 2004). In addition to dosage and timing, the vehicle of
exposure is also variable. The primary methods used are gavage, injection, consumption
(drinking or food), and inhalation (Kelly et al., 2009). Finally, the endpoint will
determine what type of effects are studied: acute vs. long-term. Along these various
dimensions, FASD rodent models are created and adjusted quite often; however, several
specific models have been consistently employed. The Singh laboratory has developed
and employed the continuous preference drinking model, trimester 1- and 2- equivalent
injections, and postnatal trimester three-equivalent injections (Mantha et al., 2013).

1.2.1

Trimester Three Binge Model: Synaptogenesis
Post-natal day (PND) 7 is a particularly important developmental timepoint in

mice. It is the peak of a rapid brain growth period termed “the brain growth spurt” and
synaptogenesis (Dobbing and Sands, 1979). Synaptogenesis refers to the establishment
and maturation of synaptic connections in the brain (Rice and Barone, 2000). In humans,
it peaks near birth, and but continues at low levels into adulthood (Dobbing and Sands,
1979; Rice and Barone, 2000). In mice and rats, it occurs in the first two postnatal weeks.
Exposure of mice to a high dose of ethanol at this time can be considered a model of
binge drinking behaviour in humans. However, PND 7 binge model has been refined to
cause BAC levels peaking at 500 mg/dl, which is would induce unconsciousness in
humans (Ikonomidou et al., 2000). Injection of ethanol twice on PND 7 spaced 2 hours
apart has a maximal effect on maintaining BAC: over 200 mg/dl for 15 hours
(Ikonomidou et al., 2000). As such, this model is viewed as a tool clearly delineate the
effects of a high dose of ethanol at this key timepoint, and not necessarily accurately
model FASD in humans. Other laboratories have shown that injection of ethanol on PND
7 causes widespread apoptotic neurodegeneration in the hippocampus and prefrontal
cortex and learning and memory impairment (Goodlett and Johnson, 1997; Ikonomidou
et al., 2000; Olney et al., 2002; Zimmerberg et al., 1991). The Singh laboratory has
introduced a model wherein pups are exposed to ethanol on PND 4 and 7. PND 4,7
exposure is intended to affect both the initiation and peak of synaptogenesis.
PND 4,7 mice demonstrate consistent FASD-relevant phenotypes. These mice
show delayed development, hyperactivity, and impaired learning and memory. PND 4,7
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mice are generally morphologically normal, but show delayed developmental milestones
(Mantha et al., 2013). These mice show reduced time exploring an open field, which is
associated with increased anxiety-related behaviours (Carola et al., 2002; Kleiber et al.,
2013). They also display increased home cage activity, indicating hyperactivity (Mantha
et al., 2013). PND 4,7 mice have particularly strong impairment on the Barnes maze
memory task. The Barnes maze is a circular table with one escape hole and many block
holes around its periphery (Barnes, 1979). A mouse is place on the board in given four
attempts per day for one week to find the exit hole. Mice eventually learn the location of
the hole based on spatial cues; latency to the target hole decreases over the week. PND
4,7 mice show highly reduced latency to the target hole across multiple testing days
compared to controls. Further, the greater statistical differences were identified than that
of trimesters one, two, or binge models indicating particularly strong impairment
(Mantha et al., 2013). Further, after one week, the mice were tested again to assess
memory, and were delayed in finding the target hole compared to controls (Mantha et al.,
2013). The PND 4,7 model thus provides an effective system to model FASD learning
and memory impairment in mice, and should provide utility in studying molecular
changes underling such aberrations.

Actions of Ethanol During Trimester Three
Exposure of mice and rats to ethanol during the first postnatal week is associated
with dramatic changes in brain structure and function. Synaptogenesis is the formation
and maturation of synapses. Synapses are small gaps that function as junctions between
neurons. They facilitate neuron-to-neuron communication via neurotransmitters (CohenCory, 2002). Synapses permit and regulate neuronal communication throughout the brain,
and thus are critical in regulation of nearly all brain processes (Cohen-Cory, 2002).
During synaptogenesis, many more synaptic connections than are ultimately needed are
formed initially. Necessary connections are reinforced while unnecessary connections are
removed in a process known as synaptic pruning (D’Amelio et al., 2012). Similarly,
unnecessary neurons are removed during this time through apoptosis (programmed cell
death). Selection of these neurons is regulated by synaptic NMDA and GABAA receptors
(Olney, 2004). NMDA receptor activation promotes neuronal survival while GABAA
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receptors promote apoptosis. Ethanol acts as both an NMDA antagonist and GABAA
agonist, triggering widespread neuronal apoptosis during the synaptogenesis period
(D’Amelio et al., 2012; Ikonomidou et al., 2000; Olney et al., 2002). This process occurs
in nearly all brain regions, but is particularly prevalent in the hippocampus, prefrontal
cortex, and cerebellum (Ikonomidou et al., 2000; Olney et al., 2002; Wozniak et al.,
2004). Loss of neurons in these key brain regions is believed to account, in part, for the
behavioural phenotypes associated with FASD.
In addition to apoptosis, ethanol causes neurodegeneration via activating the
immune response in the brain. The immune system of the brain utilizes microglia:
macrophage cells that respond to and remove damaged neurons by phagocytosis.
Surveillant microglia are important for guiding neuronal development by regulating
glutamatergic receptors and maturation and synaptic transmission (Dheen et al., 2007).
Upon receiving environmental cues, these surveying microglia can transition to an
activated state, characterized by production of pro-inflammatory factors and reactive
oxygen species (ROS). These lead to neuronal death during development (Dheen et al.,
2007). Ethanol triggers microglia activation, resulting in neuron death during the first
postnatal week in mice (Drew and Kane, 2014). Ethanol also triggers ROS production as
a result of its metabolism, further precipitating microglia activation and neuronal death
(Brocardo et al., 2011). In addition, ethanol causes a loss of microglia, reducing their
ability to carry out their maintenance functions later in life (Dheen et al., 2007).

1.3.1

Role of Hippocampus

1.3.1.1

Structure and Function

The hippocampal complex refers to the hippocampus proper and dentate gyrus.
The hippocampal formation includes the hippocampal complex, subiculum,
presubiculum, parasubisculum, and entorhinal cortex (Canto et al., 2008; Schultz and
Engelhardt, 2014). Its structure is conserved across mammals, and has analogous regions
in other vertebrates (Insausti, 1993). The hippocampus proper is divided into the CA1,
CA2, and CA3 regions. The hippocampus is similar to other cortical regions in that it has
large, pyramid-shaped projection neurons and smaller interneurons (Schultz and
Engelhardt, 2014). It is unique in the brain due to the largely unidirectional passage of
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information through intra hippocampal circuits, highly distributed three-dimensional
organization of connections, and organization of neurons into layers (Amaral et al., 2007;
Schultz and Engelhardt, 2014). The hippocampus receives highly processed sensory
information from numerous other regions. Information travels from the entorhinal cortex
up through the subiculum into the hippocampus proper then out through the dentate
gyrus. The predominate hippocampal cell type is glutamatergic excitatory pyramidal
neurons. These neurons differ in morphology and transcriptional profiles through the
hippocampus, which is what differentiates the CA1, CA2, and CA3 regions (Schultz and
Engelhardt, 2014). The dentate gyrus contains dentate granule neurons which project out
of the hippocampus (Amaral et al., 2007). Granule neurons and pyramidal neurons are
highly laminated into distinct layers (Andersen et al., 1971). Hippocampal structure is
very similar between rodents and humans, but there are subtle differences. The
hippocampus occupies a much larger relative proportion of the mouse brain (Insausti,
1993). Hippocampus neurogenesis begins on GD15.5 in mice, and is one of two brain
regions that continues neurogenesis into adulthood (Insausti, 1993). At PND 7, the
hippocampus is undergoing neurogenesis and synaptogenesis, making it exceptionally
vulnerable to ethanol exposure.
The hippocampus plays a major role in the formation of new memories and
visual/spatial memory. In mice and humans, damage to the hippocampus results in
profound difficulties forming new memories (Cho et al., 1999; Morris et al., 1982;
Squire, 2009) and difficulties with spatial, but not other learning (Cho et al., 1999; Olton
et al., 1978). The unique neuronal architecture of the hippocampus is believed to play a
major role in processing of sensory information to form new memories. Long-term
potentiation (LTP) is a mechanism believed to mediate memory formation in the
hippocampus. LTP refers to an increase in strength of a synaptic connection following
neuronal activation, lasting for hours or days (Bliss and Lomo, 1973; Lynch, 2004). By
changing synaptic strength, neuronal pathways are believed to store information (i.e.
memories) (Lynch, 2004). The precise mechanisms by which this occurs remain an area
of intense research. LTP is known to be accomplished in part by changes in neuronal
gene expression. Chemical or genetic impairment of LTP results in impaired learning and
memory in mice (Muñoz et al., 2016; Subbanna and Basavarajappa, 2014)
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1.3.1.2

Vulnerability to Ethanol

The hippocampus is particularly vulnerable to the effects of ethanol exposure
during development. Ethanol-induced neuronal apoptosis during synaptogenesis occurs at
relatively high levels in the hippocampus (Ikonomidou, 2000). Mice exposed to ethanol
in the first postnatal week display reductions in neuronal number (Gil-Mohapel et al.,
2010), adult neurogenesis (Bonthius and West, 1991; Gil-Mohapel et al., 2010) synaptic
efficacy (Bellinger et al., 1999), and dendritic spine density (Abel et al., 1983) in
adolescence and into adulthood. Mice exposed to ethanol on PND 7 also show spatial
learning and memory impairment, similar to mice with hippocampal lesions (Cho et al.,
1999; Mantha et al., 2013). Children with FAS show similar spatial deficits (Hamilton et
al., 2003; Uecker and Nadel, 1996, 1998), even though differences in hippocampal
structure are inconsistent (Spadoni et al., 2007). Data on non-hippocampal memory such
as object and verbal memory are inconsistent between studies (Mattson et al., 1996;
Smith and Milner, 1989; Uecker and Nadel, 1998).

Actions of Ethanol at the Molecular Level
1.4.1

Gene Expression Studies
Many of the changes ethanol exerts on the brain may occur via changes in gene

expression. Gene expression changes are involved in ethanol-induced neuronal apoptosis.
The genes Bax and Casp3 are required for apoptosis, which are upregulated by ethanol
(Nowoslawski et al., 2005). Blockage of upregulation of these genes prevents ethanolinduced neurotoxicity and behavioural changes (Sadrian et al., 2012). Exposure of
embryos to ethanol early in gestation results in dysregulation of cell proliferation,
differentiation, and apoptosis related genes (Hard et al., 2005). Ethanol can also cause
changes in transcription in immune response and inflammation genes, which can be
blocked by drugs that alter gene expression (Drew et al., 2015). PAE mice with induced
inflammation show distinct expression profiles in the hippocampus, failing to activate
genes and regulators involved in the immune response (Lussier et al., 2015).
Previous work in our laboratory has examined gene expression changes in four
mouse models of FASD. In the PND 4,7 mice, within two hours of exposure, there was
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dysregulation of apoptosis, lipid metabolism, and neurogenesis genes (Kleiber et al.,
2014b). In adult mice, genes involved in glutamate signalling, neurological diseases, and
cell-cell signalling were differentially expressed (Mantha et al., 2013). For a complete
introduction to gene expression, FASD, and previous results see Chapter 2. The
mechanisms which maintain gene expression changes into adulthood in these mice
remain unknown; however, epigenetic mechanisms are a strong candidate.

1.4.2

Epigenetics
Modern epigenetics is typically defined as a heritable change in chromosome

conformation without a change in DNA sequence (Berger et al., 2009). Various chemical
modifications to chromatin structure can promote the condensation or relaxation of its
structure, leading to repression or activation of gene expression, respectively. Covalent
modifications of histone proteins and methylation of DNA cytosine residues are the two
most studied mechanisms. For a complete introduction to histone modification and DNA
methylation, see Chapters 3 and 4 respectively. There are dozens of histone modifications
which are associated with open or closed chromatin at various genomic locations (Barski
et al., 2007). DNA methylation is associated with chromatin condensation and stable
repression of gene expression (Medvedeva et al., 2014). Both modification types are
stable through cell division, allowing long-term control over gene expression. There is
complex cross-talk between histone modification and DNA methylation which cooperate
to coordinate complex transcriptional responses (Cedar and Bergman, 2009; Schultz et
al., 2002). Despite their longevity, epigenetic marks are also reversible, and highly
sensitive to environmental perturbation, including by ethanol exposure (Rosenfeld, 2010).
Ethanol may act though epigenetic mechanisms to affect gene expression changes.
Indeed, histone modification and DNA methylation are sensitive to ethanol (Chapters 3,
4; Kleiber et al., 2014a; Liu et al., 2009; Shukla et al., 2008). Despite interest in
epigenetics in FASD, few studies have examined multiple epigenetic marks
simultaneously. Given the coordination of DNA methylation and histone modification,
examining both may provide broader insights into the effects of ethanol.
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Hypothesis
Neonatal ethanol exposure promotes epigenetic and gene expression changes in the
hippocampus in a mouse model of FASD.

Objectives
1. To assess all mouse genes and their promoters in adult mouse hippocampus
exposed to ethanol on postnatal days 4 & 7 and identify changes in:
a. two histone modifications, H3K4me3 and H3K27me3, using chromatin
immunoprecipitation (ChIP) coupled to the Roche NimbleGen MM9 Meth
2.1M CpG plus Promoter array.
b. DNA cytosine methylation using methylated DNA immunoprecipitation
(MeDIP) coupled to the Roche NimbleGen MM9 Meth 2.1M CpG plus
Promoter array.
c. gene and miRNA expression and using the Affymetrix GeneChip® Mouse
Gene 1.0 ST array and Affymetrix miRNA 2.0 array, respectively.
2. To characterize genes and pathways affected by epigenetic and gene expression
changes.
3. To confirm changes at specific genes using:
a. ChIP-real-time PCR (ChIP-qPCR) for histone modification changes.
b. sodium bisulfite pyrosequencing for DNA methylation changes.
c. qPCR and droplet digital PCR (ddPCR) for gene expression changes.

Thesis Organization:
The results of this thesis are organized into three chapters. Chapter 2 describes
histone modification changes in response to early ethanol exposure. Chapter 3 describes
DNA methylation changes as well as their relationship to histone medication changes
from Chapter 2. Chapter 4 describes gene expression changes and their relationship to
results from Chapters 2 and 3.
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Effects of Neonatal Ethanol Exposure on
Hippocampal Histone Modification
Overview
Histone modifications have not been well researched in FASD. In this chapter,
histone H3 lysine 4 trimethylation (H3K4me3) and H3 lysine 27 trimethylation
(H3K27me3) were assessed using ChIP-chip in the hippocampus of 70 day-old mice
exposed to ethanol as neonates. The results identified regions of differential histone
methylation (RDHMs) and genes proximal to them. These genes were used in pathway
analysis to identify impacted biological processes. The top pathway for the genes having
both methylation changes was protocadherin-guided synaptic development. There was an
RDHM in the protocadherin gamma gene cluster which contains a putative CTCF motif.
There were also putative CTCF motifs in two regions of differential H3K27me3
methylation the imprinted Snrpn/Ube3a region. Finally, there was a substantial
occurrence of lipid metabolism pathways in H3K4me3 affected genes suggesting a novel
interaction of lipid metabolism and epigenetics. These results are the first assessment of
genome-wide changes in histone modification in FASD.

Introduction
2.2.1

Post-translational Histone Modifications
The role of histone modifications in transcription was inferred following the

crystal structure of the nucleosome (Luger et al., 1997). The crystal structure showed that
the highly basic N-terminal tails of the histones extend from the nucleosome. The authors
postulated modification to these tails that could alter the intra-histone interactions and
interaction of the octamer with the DNA. Indeed, it is now clear that histone
modifications affect nucleosome stability via several mechanisms. To view the role of
such histone modifications in cellular events was formally described in the histone code
hypothesis (Turner, 1993). The hypothesis postulates that each histone modification
codes for a specific chromatin conformation. The different modifications would then
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form a combinatorial pattern which could heritably affect gene expression (Turner,
2000). In recent years the rigidity of the histone code hypothesis has been relaxed. Some
view histone modifications as more of a “language” (Oliver and Denu, 2011). The same
modifications can have different meanings in the context of nearby modifications, and are
not strictly associated with any chromatin state. There are also multiple modifications on
the same histone tail creating combinatorial complexity which is difficult to assay and
evaluate. As such, correlation mapping of each modification on its own is problematic for
grasping the full complexity of chromatin.
At least twelve histone modifications have been reported to over 60 different
amino acid residues. These include methylation of lysines and arginines, phosphorylation
of serine and threonine, acetylation of lysine, ubiquitylation, sumoylation, ADPribosylation, propionylation, butyrylation and crotonylation as well as arginine
citrullination, proline isomerization, and N-terminal formylation (Kouzarides, 2007). The
tails of histone H3 and H4 undergo the most modifications. While all the histone tails are
required for higher order chromatin structure (Allan et al., 1982), the H3 and H4 tails are
individually sufficient for nucleosome oligomerization (Gordon et al., 2005). This
indicates that while the tails work cooperatively, there is a greater contribution of H3 and
H4 to chromatin structure. Because histones and especially histone modification vary
greatly between species, this section will focus on mammalian histones only. The
nomenclature used here is “histone-residue-modification-number” (if applicable), where
modifications are shortened from acetylation to ac, methylation to me, and
phosphorylation to ph, for example histone H3 lysine 4 trimethylation is H3K4me3.

2.2.2

Histone Methylation
Histone methylation occurs at lysine and arginine residues on histone tails. Like

acetylation, lysine methylation predominantly occurs on histone H3 and to a lesser degree
on H4. An additional layer of complexity exists for lysine methylation, as the ε-amino
group of lysine residues can be mono-, di-, or tri-methylated. Different methylation states
of the same lysine reside can show unique genomic localization and carry out differing
functional roles. Since histone methylation does not affect the nucleosome charge, it must
carry out its effects on chromatin structure indirectly via effector proteins (Taverna et al.,
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2007; Voigt and Reinberg, 2011). Many domains recognize histone lysine methylation
including chromo, PHD, tudor, WD40, and MBT domains among others (Yun et al.,
2011). Further, histone H3 lysine 4 tri-methylation (H3K4me3) enhances transcription
via recruitment of the PHD domain-containing TAF3 subunit of the TFIID complex
(Lauberth et al., 2013). TFIID is the first protein to bind to chromatin during RNA
polymerase II pre-initiation complex formation (Dynlacht et al., 1991). Many of these
domains are present in multi-protein complexes that can bind and modify other marks.
Specific histone methylations are linked to nearly every chromatin state and are
very consistent between mammalian cell types (Barski et al., 2007; Zhou et al., 2011b).
Two in particular—H3K4me3 and H3K27me3—are commonly assessed in the context of
gene expression. H3K4me3 is often concomitant with transcription at transcriptional
initiation sites (Santos-Rosa et al., 2002; Schneider et al., 2004). H3K4me3 is often
viewed as the on/off switch of transcription (Dong et al., 2012). However, the true roles
of chromatin marks are clearly much more complex as transcription can occur in the
absence of H3K4me3 (Hödl and Basler, 2012). Further, H3K4me3 can mark poised
genes together with H3K27me3 termed bivalent domains (Bernstein et al., 2006). These
domains are believed to keep developmental genes poised for rapid activation while
maintaining repression (Voigt, Tee, & Reinberg, 2013). In somatic cells, H3K27
methylations, are linked with facultatively and constitutively repressed genes (Barski et
al., 2007). H3K27me3 is linked more tightly with repressed TSSs, while the mono- and
di-methylated forms are more dispersed (Barski et al., 2007). H3K9 methylations are also
linked with repressed transcription; H3K9me3 is deposited over large genomic regions
facilitating heterochromatin formation (Lehnertz et al., 2003; Soufi et al., 2012). Given
this background, H3K4me3 and H3K27me3 were chosen for this study as they have the
clearest known relationship with gene expression, and therefore are more likely to
represent relevant changes.

2.2.3

Acquisition and Propagation of Histone Marks
Histone marks like most other epigenetic marks are mutable and responsive to the

environment. Indeed, many studies have linked changes in gene expression in response to
various stimuli to changes in DNA methylation and histone modification at promoters
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(Rosenfeld, 2010). Studies such as these provide evidence that histone processes may
mediate gene-environment interactions. However, with any change in epigenetic marks, it
is not easy to distinguish between correlation and causation. Irrespective of their function,
histone modifications often reflect the structure of chromatin and it remains an active
area of research.
For a histone modification to be passed on, it must be passed through cell
division. It appears that some modifications can be passed on and are epigenetic in the
classical sense, while others are not. As the DNA replication fork propagates producing
two nascent DNA strands, the parental histones are displaced and are evenly distributed
to the daughter strands (Alabert and Groth, 2012; Annunziato, 2005; Margueron and
Reinberg, 2010; Probst et al., 2009). Parental H3/H4 dimers tend to stay together as
tetramers, H2A/H2B are loaded as dimers (Jackson, 1988; Xu et al., 2010). New and
parental tetramers are evenly distributed on average. Importantly, this means that the
simplest conceptual model for histone modification propagation—copying of histone
modifications within the same nucleosome—is not possible for H3 and H4 as both copies
of each are either parental or new. The parental histones retain their post-translational
marks (Alabert et al., 2015); the mechanism by which the modifications are copied onto
new histones remains unclear. There are currently two models which apply to different
modifications. For most histone modifications, new histones acquire modifications to
become identical to the old ones. Before the next cell cycle, within 2-24 hours, the
modifications are written on the new histones until they become identical to the parental
histones (Alabert et al., 2015). Therefore, histone modification writing is not tightly
coupled to replication, and oscillates with the cell cycle.
The buffer model proposed by (Huang et al., 2013) applies to the repressive
heterochromatin marks H3K27me and H3K9me. The buffer model protects constitutively
silent genes from being activated by varying repressive mark levels after DNA
replication. In general, repressive marks are found across large regions and function by
recruiting effector proteins that shape the region to become inaccessible (Boyer et al.,
2006). As such, exact replication of each histone modification after cell division is not
necessary for gene repression. Huang et al. (2013) propose relatively few nucleosomes
(20-30%) must bear repressive modifications to repress transcriptional activity.
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Therefore, the system functions as a buffer, wherein the levels of repressive marks never
drop below the critical threshold and remain non-permissive to transcription. This model
is supported by experimental evidence, which shows that the repressive H3K27me3 and
H3K9me3 methylations are slowly written on new histones after replication. Further,
even old histones acquired more H3K27me3 and H3K9me3 to reach pre-mitosis levels
after replication (Alabert et al., 2015).

2.2.4

Methods to Study Histone Modification
Nearly all technologies to assess histone modification rely on chromatin

immunoprecipitation. First devised in the 1970s, chromatin Immunoprecipitation (ChIP)
relies on a specific antibody to pull down a protein of interest and its interacting genomic
DNA (Jackson, 1978). In the case of histone analyses, the antibody is specific to a histone
modification of interest. After the DNA is isolated and purified, it can be assessed using a
number of approaches. Techniques including PCR (ChIP-qPCR), microarray (ChIPchip), and sequencing (ChIP-seq) are the most popular (Collas, 2010). In each case, the
data are output in “peaks” of DNA enrichment (Wilbanks and Facciotti, 2010).
ChIP-seq and ChIP-chip are the most common methods used to assess wholegenome changes in histone modification, while ChIP-qPCR is popular for assessing
specific loci. ChIP-chip has the advantage of utilizing the diversity of commercially
available microarrays, allowing researchers control over experimental scale. In contrast,
ChIP-seq examines the entire genome with greater resolution, and reduced signal-tonoise ratio allowing identification of more subtle binding events (Massie and Mills,
2012). ChIP-chip is more economical than ChIP-seq; however as sequencing
technologies advance, the price differential is becoming less dramatic. Microarrays are
limited in resolution compared to sequencing (Park, 2009). This is important for
identifying protein binding sites, but is less crucial for identifying histone modification
domains. Pinpointing individual histone binding sites is difficult with microarrays
however.
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2.2.5

Histones and Fetal Alcohol Spectrum Disorders
Ethanol has long been known to be an epigenetic disruptor. Garro et al., (1991)

found for the first time that fetuses exposed to ethanol had inhibited DNA
methyltransferase 1 (DNMT1) activity. Further, this inhibition was attributed to the first
metabolite of ethanol, acetaldehyde (Garro et al., 1991). Since this study, ethanol has
been found to impact methylation pathways in other direct and indirect ways (Figure
2.1). Ethanol inhibits folate absorption in both the intestine and kidney in part by
downregulating the expression of its transporter reduced folate carrier 1 (RFC1) (Hamid
and Kaur, 2005, 2007a). Reduced folate absorption impairs pyrimidine synthesis and
therefore DNA synthesis (Figure 2.1). Further, acetaldehyde inhibits methionine
synthase which converts homocysteine to methionine. (Halsted et al., 2002). These
actions reduce the availability of s-adenosylmethionine (SAM) which is the primary
substrate of methyltransferases and source of methyl groups.
Ethanol also induces oxidative stress as a primary effect and through its
metabolism which can alter methylation pathways. Conversion of ethanol to acetaldehyde
and acetate produces reactive oxygen species (ROS) directly via CYP2E1 and via
increased NADH levels (Figure 2.2). Ethanol-induced mitochondrial damage produces
additional ROS (Hoek et al., 2002). Increased ROS has numerous damaging effects on
macromolecules including DNA. Specifically, the hydroxyl radical causes mutations
including base substitutions, deletions, single and DSBs (Hoek et al., 2002). Single
stranded DNA can signal de novo DNMTs causing hyper-methylation of these regions
(Christman et al., 1995). With respect to methylation enzymes, under oxidative
conditions, homocysteine is converted to the ROS scavenging glutathione, depleting
SAM and reducing methylation (Figure 2.2; Kerksick and Willoughby, 2005). Ethanol
also impacts acetylation pathways. The metabolism of ethanol produces acetaldehyde
followed by acetate then acetyl-CoA. Acetyl-CoA is the substrate HATs use as an acetyl
group source (Figure 2.2).

2.2.6

Effect of Ethanol on Histone Modification
The first studies on histone modification and alcohol were focused on the effects

of ethanol directly on liver cells. They provided several key insights into how histone
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Figure 2.1 Inhibitory actions of ethanol on one-carbon metabolism.
Dotted lines indicate indirect inhibitory actions. Ethanol indirectly inhibits the folate
cycle (left) by its first metabolite acetaldehyde inhibiting MTR (Kenyon et al., 1998) and
by blocking folate uptake via RFC1 by downregulating its expression (Hamid and Kaur,
2007b). Ethanol induced oxidative stress (Figure 2.2) irreversibly inactivates MAT I and
III in the liver (Seitz and Stickel, 2007). AHCY: adenosylhomocysteinase; DHF:
dihydrofolate; DHFR: dihydrofolate reductase; dTMP: deoxythymidine monophosphate;
dUMP: deoxyuridine monophosphate; G9a: also known as EHMT2: euchromatic histonelysine N-methyltransferase 2; MAT: methionine adenosyl transferase; 5-MTHF: 5methyltetrahydrofolate; 5,10-MTHF: 5,10-methylenetetrahydrofolate; MTHFR:
methylenetetrahydrofolate reductase; MTR: methionine synthase; RFC1: reduced folate
carrier 1; SAH: S-adenosylhomocysteine; SAM: S-adenosylmethionine; THF:
tetrahydrofolate; TS: thymidylate synthase. Reprinted from Chater-Diehl et al., (2017)
with permission from Elsevier (Appendix I).
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Figure 2.2 Effects of the ethanol metabolism on epigenetic modifications.
Slashed lines indicate reduction/impairment of that step. Dashed lines indicate simplified
mechanism. Ethanol is metabolized to acetaldehyde, the acetate, both of which produce
NADH which led to increased ROS production. Ethanol also induces mitochondrial
damage which leads to further ROS production (Hoek et al., 2002). Oxidative conditions
drive production of glutathione, deleting SAM and therefore reducing methyl-donors for
histone (and other) methylation. Increased acetyl-CoA as a result of ethanol metabolism
drives histone (and other protein) acetylation. Depletion of NAD+ by ethanol metabolism
reduces the activity of NAD+-dependent sirtins, which prevents histone de-acetylation.
Metabolism of ethanol to acetaldehyde by CYP2E1 is simplified, not shown is
intermediate production of gem-diol and water, which convert to acetaldehyde and an
oxygen radical (shown as ROS above). Conversion of homocysteine to glutathione is
greatly simplified. Conversion of SAM to homocysteine is simplified (Figure 2.1). ACS:
acetyl-CoA synthetase; ADH: alcohol dehydrogenases; ALDH: aldehyde dehydrogenase;
CYP2E1: cytochrome P450 2E1; HAT: histone acetyltransferase; ROS: reactive oxygen
species; SAM: S-adenosylmethionine. Reprinted from Chater-Diehl et al., (2017) with
permission from Elsevier (Appendix I).
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modifications respond to ethanol. These studies found that H3K9ac (and not other lysine
acetylations) was increased in a time- and dose-dependent manner in (Kim and Shukla,
2005; Park et al., 2003). In 2007, Pal-Bhadra et al. examined H3K9me2 and H3K4me2 in
cultured hepatocytes. There were site-specific histone modification changes correlated
with gene expression changes in response to ethanol (Pal-Bhadra et al., 2007). H3K9me2
reduction and H3K4me2 increase occurred in the upregulated genes. In the
downregulated genes, H3K9me2 increased with little H3K4me2 (Pal-Bhadra et al.,
2007). This study showed that changes in histone modification can be correlated with
changes in gene expression, implying that they do have functional relevance.
Since these early studies, 15 publications have examined histone modifications
specifically in response to fetal ethanol exposure (Chater-Diehl et al., 2017). The first
study of histone modifications in the brain in FASD used inhalation exposure of rat pups
to ethanol from P2-12 (Guo et al., 2011). This study found reduced acetylated histone H3
(AcH3) and H4 (AcH4) in cerebellum. In two studies, C57BL/6J mice were exposed to
ethanol using a PND 7 dual injection model. Expression and activity of the HMT G9a
mRNA, protein expression, and protein activity were increased after ethanol exposure in
both hippocampus in neocortex (Subbanna et al., 2013, 2014). G9a catalyzes H3K27me3
(facilitating conversion to H3K27me3) and is involved in early synaptic remodeling
(Schaefer et al., 2009; Shinkai and Tachibana, 2011; Tachibana, 2002). PND 7 ethanol
exposure was associated with increased H3K9me2 and H3K27me2 as well as apoptotic
neurodegeneration. Treatment with the G9a inhibitor Bix prior to ethanol exposure
prevented these effects (Subbanna et al., 2014; Subbanna et al., 2013).
Two papers from Rajesh Miranda and Michael Golding’s group have examined
the effects of gestational ethanol exposure on H3K4me3 and H3K27me3 changes at
specific genes in the brain. Using neurospheres from fetal mice cultured in ethanol, the
investigators found that Hox and other gene promoters had reduced H3K4me3 (Veazey,
Carnahan, Muller, Miranda, & Golding, 2013). This study also used ChIP-qPCR of
repetitive transposable element sequences—up to 45% of the human genome—as a proxy
for genome-wide H3K4me3 and H3K27me3 changes (Slotkin and Martienssen, 2007).
There was significant reduction of H3K27me3 for all investigated transposon types.
There was also a trend toward reduction in H3K4me3 though it was non-significant
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(Veazey et al., 2013). In a follow-up study, these authors examined how histone
modification at specific genes changed following recovery from ethanol, and compared
these changes to an in vivo mouse model. In general, after 3 days of ethanol exposure
there were modest H3K4me3 changes, more pronounced H3K27me3 H3K9ac changes
and large-scale H3K9me2 changes (Veazey et al., 2015). After a four day recovery
period, the closed-chromatin marks (H3K27me3 and H3K9me2) became greatly enriched
(Veazey et al., 2015). In an in vivo model, the histone modification profile of malformed
ethanol-exposed pups correlated with the cell culture data: there was a reduction of
H3K27me3 at more than half of the candidates, an enrichment of H3K9ac at some, and a
dramatic increase in H3K9me2 at most (Veazey et al., 2015). The robust closedchromatin mark changes are interesting as H3K9 and H3K27 methylations are stable and
heritable through development likely replicating through the buffer model, acting as true
epigenetic marks of repressed chromatin (Chater-Diehl et al., 2017; Huang et al., 2013).
They are thus are very strong candidates for the transmission of a lasting ethanol-induced
signature (Veazey et al., 2015).
These studies have investigated several histone methylations globally and at
specific genes very soon after ethanol exposure. Only two previous studies from the same
group have examined histone modifications in adult rats in response to PAE. After
exposure to ethanol from GD 7-21, the rats matured to PND 60-80 when cells from
POMC cells in the hypothalamus were collected. There were reduced numbers of
H3K4me2,3-positive POMC cells, increased H3K9me2-positive POMC cells, and a
reduced H3K9ac-positive POMC (Bekdash et al., 2013; Govorko et al., 2012). To date,
no other study has examined specific genome-wide changes in histone modifications in
response to fetal ethanol, and very few have explored changes in adult mice.

2.2.7

H3K4me3 and H3K27me3 Study Background
In this chapter, H3K4me3 and H3K27me3 are assessed for changes across all

promoters in the PND 70 mouse hippocampus in the PND 4,7 treatment model. Regions
of differential histone modification (RDHMs) were identified for H3K4me3 and
H3K27me3 as were genes proximal to these regions. Gene ontology and pathway
analysis were used to identify the functional categories of these genes and the potential
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biological impact of their differential methylation. Both the pathway analysis and
previous work from our laboratory focused the analysis of this chapter on CCCTCbinding factor (CTCF) and imprinted loci.
CTCF is a highly conserved, ubiquitous protein involved in diverse processes
such as transcriptional regulation and organization of chromatin architecture. CTCF
creates three dimensional chromatin domains in which it promotes specific regulatory
interactions that positively or negatively affect transcription (Ong and Corces, 2014).
CTCF creates DNA loops at the Pcdha and Pcdhg genes, likely to bring isoform
promoters into contact with enhancers and transcriptional machinery (Golan-Mashiach et
al., 2012). The interactions of CTCF are dependent on specific patterns of DNA
methylation within its binding motifs (Golan-Mashiach et al., 2012; Wang et al., 2012).
In this chapter, CTCF binding motifs in RDHMs are identified and characterized.
CTCF is critical for regulating genomic imprinting. Genomic imprinting refers to
the expression of genes in a parent-of-origin-specific manner (Bartolomei and Tilghman,
1997). The regulation of gene expression is accomplished with methylation and
repression of one parental copy of the locus (the imprinted allele) while the other is
demethylated and expressed (Morgan et al., 2005). These patterns are established early in
development and are critical for normal cellular function, with aberrations leading to a
host of genetic disorders (Butler, 2009). CTCF has numerous functions at imprinting loci,
including binding to methylated DNA and preventing enhancer-promoter interactions and
repressing gene expression (Holwerda and de Laat, 2013). In this chapter, the relationship
between histone methylation, CTCF, and imprinted loci are explored in the context of
FASD.

Objectives
1. To assess all mouse genes and their promoters in adult mouse hippocampus
exposed to ethanol on postnatal days 4 & 7 and identify changes in H3K4me3 and
H3K27me3
2. To identify genes and pathways proximal to changes in H3K4me3, H3K27me3,
and both.
3. To confirm specific changes with ChIP-qPCR
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Materials and Methods
2.3.1

Mouse Care
Protocols were approved by the Animal Use Subcommittee (AUS) at the

University of Western Ontario, London, Ontario, Canada (Appendix A). C57BL/6J (B6)
mice were originally obtained from Jackson Laboratories (Bar Harbor, MA) and a
population was subsequently maintained at the Animal Care Facility at the University of
Western Ontario. Mice were housed in standard shoe-box sized cages and given access to
water and food (Lab-Diet® 5P00 ProLab® RMH 3000 (St. Louis, MO)) ad libitum.
Environmental conditions were maintained at a temperature range of 19-22ºC, a humidity
range of 40%-60% and a 14/10-hour light/dark cycle. 25 female mice age 12-18 weeks
were separated into individual cages and mated with males of approximately the same
age. The male was removed once the female was visibly pregnant. The day of birth was
PND zero.
Sex and weight-matched littermate pups were divided into two groups: ethanoltreated and saline control. Pups were given two subcutaneous dorsal injections at 9 am
and 11 am on both PND 4 and PND 7 using 30 gauge BD PrecisionGlide™ needles.
Ethanol-treated mice were injected with 2.5 g/kg of ethanol in 0.15 M NaCl
(Ikonomidou, 2000). This protocol produces blood alcohol concentrations above the toxic
threshold of 200 mg/dl for over eight hours (Wozniak et al., 2004). Control mice were
injected with 0.15 M saline. Pups were weaned on PND 21 and housed in cages of two to
four same-sex littermates. Male mice were used for all subsequent analyses (n=18). Mice
were sacrificed on PND 70 via carbon dioxide asphyxiation followed by cervical
dislocation. The hippocampus was dissected out (Spijker, 2011), snap-frozen in liquid
nitrogen, and stored at -80°C. Mice were divided among gene expression, DNA
methylation, and histone modification experiments (Table 2.1). Treatment groups
(control vs. ethanol-exposed) always contained littermates for each microarray
comparison. Mice from the same litter were not repeated in the same microarray
experiment. The same litters were represented in each microarray experiment.
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Table 2.1 Allocation of mouse litters within and between microarray studies †.
Histone methylation
Array 1
Array 2
Array 3
E5.2
C5.4
E10.4
C10.6
E11.3
C11.4
E12.5
C12.1
E16.5
C16.4
E17.3
C17.4
E19.1
C19.2
E19.5
C19.6
E20.5
C20.6
Gene/miRNA expression and DNA methylation
Array 1
Array 2
Array 3
E5.1
C5.3
E10.3
C10.5
E11.1
C11.2
E12.4
C12.2
E16.3
C16.2
E17.1
C17.2
E19.4
C19.4
E19.7
C19.8
E20.3
C20.4
†Each alphanumeric code refers to a single mouse. The first letter refers to ethanolexposed (E) or control (C); the number after the letter refers to the litter number; the
number after the period refers to the individual mouse. Each for each individual array, the
three samples were pooled together. Mice used for the DNA methylation microarray
experiment are in italics, which were not pooled with any other samples.
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2.3.2

Chromatin Immunoprecipitation Microarray (ChIP-chip)

2.3.2.1

Chromatin Immunoprecipitation

Hippocampal tissue samples were thawed on ice then treated with 1%
formaldehyde for five minutes and sonicated with the truChIPTM Tissue Prep Kit for SDS
Chromatin Shearing (Covaris) and the Covaris® S2 Sonicator (Woburn, MA, USA)
according to the manufacturer’s protocol. The EpiQuik™ Tissue Chromatin
Immunoprecipitation Kit (Epigentek) was used to perform ChIP. After sonication,
samples were divided and immunoprecipitated with ChIP-grade polyclonal antibodies
anti-H3K4me3 (Epigentek cat # A-4033) and anti-H3K27me3 (Millipore cat #07-499).
Two microarray experiments were performed, one for each methylation state using the
same chromatin sample from the same mice for each. Immunoprecipitated samples were
sent to ArrayStar Inc. (Rockville, MD, USA). ArrayStar performed whole-genome
amplification, target preparation DNA labelling, array hybridization, scanning, and data
summarization.

2.3.2.2

Whole Genome Amplification (WGA) and DNA Labelling

The enriched DNA was amplified using a WGA kit from Sigma-Aldrich (the
GenomePlex® Complete Whole Genome Amplification (WGA2) kit). The amplified
DNA samples were then purified with QIAquick PCR purification kit (Qiagen). The
NimbleGen Dual-Color DNA Labeling Kit was used according to the manufacturer’s
NimbleGen ChIP-on-chip protocol (Nimblegen Systems, Inc., Madison, WI, USA). One
μg of DNA from each sample was incubated for 10 min at 98°C with 1 OD of Cy5-9mer
primer (IP sample) or Cy3-9mer primer (input sample). Then, 100 pmol of
deoxynucleoside triphosphates and 100U of the Klenow fragment (New England Biolabs,
USA) was added and incubated at 37°C for 2 hours. The reaction was stopped by adding
0.1 volume of 0.5 M EDTA. The labelled DNA was purified by isopropanol/ethanol
precipitation.

2.3.2.3

Microarray Hybridization

Microarrays were hybridized at 42°C for four hours with 4μg of Cy3/5 labelled
DNA in Nimblegen hybridization buffer/ hybridization component A in a hybridization
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chamber (Nimblegen Systems, Inc., Madison, WI, USA). Washing was performed after
hybridization using the Nimblegen Wash Buffer kit (Nimblegen Systems, Inc., Madison,
WI, USA). For array hybridization, Roche NimbleGen's Mouse ChIP-chip 2.1M Deluxe
Promoter Array was used. Samples were pooled in triplicate and hybridized to three
arrays for each treatment; i.e. 9 ethanol-treated mice on three arrays were compared to 9
litter-matched controls on three arrays. Scanning was performed with the Axon GenePix
4000B microarray scanner. Raw data were extracted as pair files by NimbleScan
software. The files were uploaded to GEO (Series record GSE61488).

2.3.2.4

Microarray analysis

The .pair files were analyzed utilizing the tiling workflow provided in Partek
Genomics Suite® version 6.6 (St. Louis, Missouri, USA). Nimblegen .pair files
(representing the 635 nm and 532 nm scans) for each sample were normalized using the
default methods of normalization in the tiling workflow in Partek. The default method
includes adjustments for probe sequence, background correction, quantile normalization,
and Log (base 2) transformation. In addition, to ensure quality, Principal Components
Analysis (PCA) was performed. Files were annotated against the mm9 mouse genome
build and enriched regions were detected using a one-way ANOVA to compare
enrichment between the ethanol-exposed and control groups: three ethanol-exposed
mouse arrays contrasted to the three matched control mouse arrays. The enriched regions
settings were set at a minimum p-value of 0.01 and the number of probes to call a region
was set at a minimum of five. The Model-based Analysis of Tiling-arrays (MAT)
algorithm was used to detect enriched regions [64]. The MAT algorithm is designed to
detect enriched regions in tiling ChIP-chip experiments, and provides a score for the
degree of enrichment between experimental samples or groups of samples. A list of
regions with MAT scores and corresponding p-values was the output. These regions with
differential histone methylation (RDHMs) were scored to overlap with RefSeq (2014-0103 version) genes when they were present in the gene body or within 5000 bp upstream
or 3000 bp downstream of the transcriptional start site. The list of gene names
overlapping RDHMs with a MAT p-value<0.001 were generated. A false discovery rate
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(FDR) q-value < 0.05 was used to assess multiple testing error. No RDHMs passed this
threshold.
The list of gene names from Partek were submitted as text files to Ingenuity
Pathway Analysis (Ingenuity Systems Inc, CA, USA), Partek Pathway (Fishers Exact
Test), and Enrichr to determine overrepresented genes using gene ontology (GO)
analysis. A cut-off of p<0.05 was used to determine significant pathways for all software
programs.

2.3.3

CTCF Motif Prediction
To determine putative CTCF sites in the identified RDHMs, the online CTCFBS

database was used (Zentner and Henikoff, 2013). RDHM sequences were extracted from
the UCSC genome browser. Five additional nucleotides were extracted at the 5’ and 3’
ends of the RDHM to capture for CTCF sequences that may only partially overlap in the
RDHM. The sequences were submitted to CTCFBS’s prediction tool. The position
weight matrices (PWM) score associated with each predicted CTCF site was used to
identify significant predictions; a cut-off of PWM > 3 was used to identify matches as
recommended by the CTCFBSDB creators.

2.3.4

ChIP-qPCR
ChIP was performed on independent biological samples. Mice were treated with

ethanol or saline and hippocampus was isolated as described above. Five ethanol-exposed
and five control mice were generated. ChIP was performed against H3K27me3 as
described above. Input DNA was compared against H3K27me3 enrichment and normal
mouse IgG (background control) enrichment using SYBR green-based real time PCR.
qPCR was performed using SsoAdvanced™ Universal SYBR® Green Supermix
(BioRad) according the manufacture’s protocol on the CFX Connect™ Real-Time PCR
Detection System (BioRad). Primer sequences were as follows: Snrpn forward
TCCACATCCTTGTCAGCATC, reverse TCAAAAATTCAGGTGACAGCA;
Snord 1 forward AGATTGCTTTTGGCCATCC, reverse
GCCTGAGAACTTTTCACCAGA; Snord 3 forward CCACCTTGTCATGAGATTGC,
reverse GAGATCAAAGCAGGGATGGA; Ipw forward
CCACCTTGTCATGAGATTGC reverse GAGATCAAAGCAGGGATGGA;
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PCDHb5/a9 forward TTTTCCCAAGTGGCAGAGAC, reverse
AACTCTGTCTCCCTTGAACTGC. The efficiency of each primer pair was calculated
using a standard curve. The Pcdhb5/a9 primers did not fall within the acceptable 90110% efficiency and were not pursued further. After amplification, the raw Ct values
were corrected based on reaction efficiency. Enrichment was calculated as % enrichment
= 100% x efficiency^(input Ct-K3K27me3 Ct) and reported as average percent
H3K27me3 enrichment ± standard error. Significant differences were assessed using a
Paired Samples t-Test.
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Results
2.4.1

Distribution of Histone Modification Changes
To define significant regions of differential histone modification (RDHMs), a

Model-based Analysis of Tiling-arrays (MAT) score p-value cut-off of p<0.001 was
used. At this significance level, there were 625 unique H3K4me3 RDHMs and 165
unique H3K27me3 RDHMs (Figure 2.3). For H3K4me3, 29% (181) of RDHMs had a
negative MAT score indicating increased methylation (Figure 2.4); for H3K27me3, 16%
(26) of RDHMs had a negative MAT score (Figure 2.4). Thirteen regions had a change
in both H3K4me3 and H3K27me3.
The RDHMs were unevenly distributed across chromosomes (Figure 2.5). For
H3K4me3, chromosomes 7 and 11 had the most RDHMs. Most chromosomes mirrored
the positive MAT/negative MAT ratio of the genome overall i.e. they had more RDHMs
with more negative MAT scores than positive; however, chromosomes 11-15 did not.
Each of these had more positive MAT RDHMs, with chromosome 14 having all positive
MAT RDHMs (Figure 2.5). For H3K27me3, chromosomes 2, 7, and 11 had the most
RDHMs (Figure 2.5). Most chromosomes displayed the same positive MAT/negative
MAT ratio of the genome overall. i.e. they had more RDHMs with more positive MAT
scores than negative. An exception was chromosome 18 which had much more negative
than positive (Figure 2.5).
Since the experiment employed a promoter microarray, chromosomes with more
genes were interrogated more often. The RDMHs per chromosome were therefore
corrected based on gene density (Figure 2.6). Chromosomes 7 and 11 are very genedense, and as such their enrichment was somewhat normalized. Nevertheless,
chromosome 11 along with 15 and 18 had the most H3K4me3 RDHMs per gene.
Chromosome 15 also had the most H3K27me3 RDHMs per gene (Figure 2.6).
Chromosome 3 and the X chromosome were depleted of RDHMs of both methylations. A
linear regression of the number of genes per chromosome vs. the number of RDHMs
found R2 values of 0.51 for H3K4me3 and 0.30 for H3K27me3 (Appendix C). These
values indicate a modest correlation between these two variables, suggesting other factors
account for a substantial portion of the variation in RDHM distribution.
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Figure 2.3 Genomic overview of regions of differential H3K4me3 and H3K27me3.
Negative MAT score (red) indicates increased methylation, positive (blue) indicates
decreased methylation. Track A shows H3K4me3 regions of differential histone
modification (RDHMs) p<0.001; track B shows H3K27me3 RDHMs p<0.001.
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Figure 2.4 H3K4me3 and H3K27me3 regions with differential histone methylation
(RDHMs) and proximal genes.
Venn diagrams show numbers of unique A) RDHMs and B) genes identified at MAT
score p-value cut-off of p<0.001 (two-way ANOVA).
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Figure 2.5 Distribution of regions with differential histone methylation (RDHMs)
across chromosomes.
Bars show the number of RDHMs present on each chromosome at MAT p<0.001. Black
denotes RDHMs with a positive MAT score indicating depleted methylation, while white
denotes RDHMs with a negative MAT score indicating enriched methylation.
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Figure 2.6 Distribution of regions with differential histone methylation (RDHMs)
across chromosomes corrected for gene density.
The number of RDHMs on each chromosome was divided by the total number of genes
(from build mm10) on each chromosome.
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2.4.2

Ontology of Genes Proximal to Histone Modification
Changes
A list of genes potentially affected by RDHMs was next assembled. Genes were

included in the list if their promoter (defined as -5000 to 0 bp relative to the
transcriptional start site), or gene body contained at least one RDHM. For H3K4me3,
61% of RDHMs lay in gene promoters while 39% lay in gene bodies (including introns).
For H3K27me3, 68% of RDHMs lay in gene promoters, while 32% lay in gene bodies.
There were 797 genes proximal to H3K4me3 RDHMs, 227 genes proximal to
H3K27me3 RDHMs, and 33 genes proximal to both (Figure 2.4).
To identify genetic systems affected by H3K4me3 changes in the PND 4,7 FASD
model, gene ontology (GO) analysis was performed. The list of 797 genes proximal to a
H3K4me3 RDHM was used for GO analysis using Enrichr (Chen et al., 2013) (Table
2.2). Enricher determined biological processes, cellular components, molecular functions
overrepresented in the gene list. The top affected biological processes for this gene set
was “Cell-cell adhesion via plasma-membrane adhesion molecules”. The penultimate
affected biological process was also related to cell-cell adhesion (Table 2.2). Three of the
top ten biological processes were also related to the nervous system, and two were related
to kinase signaling (Table 2.2). The top affected cellular component was “Ionotropic
glutamate receptor complex”, with five other entries related to neurons, three of which
were synapse-specific (Table 2.2). Other components included cytosolic and
cytoskeleton proteins. The top affected molecular function was “Calcium ion binding”.
Nine of the top ten entries were related to substrate binding, including phosphoprotein,
phosphorylated amino acid, Ras GTPase, Rab GTPase binding. The other was “Receptor
signaling complex scaffold activity” (Table 2.2). In summary, the GO analysis implicates
synaptic, cell adhesion, and signal transduction genes as affected by H3K4me3 changes.
The list of 227 genes proximal to a H3K27me3 RDHM was used for GO analysis
using Enrichr (Chen et al., 2013) (Table 2.3). Similar to the H3K4me3 genes, the top
affected biological process was “Homophilic cell adhesion via plasma membrane
adhesion molecules”, and the second and third processes were also cell-cell
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Table 2.2 Gene ontology (GO) analysis of genes with regions of differential
H3K4me3 in their promoter†.
GO biological process
GO term
p-value
Cell-cell adhesion via plasma-membrane adhesion molecules
1.49E-09
(GO:0098742)
Cell-cell adhesion (GO:0098609)
1.66E-09
Nervous system development (GO:0007399)
0.003
Negative regulation of growth (GO:0045926)
0.0033
Regulation of neuron differentiation (GO:0045664)
0.0036
Sympathetic nervous system development (GO:0048485)
0.0042
Regulation of stress-activated MAPK cascade (GO:0032872)
0.0042
Cellular response to organonitrogen compound (GO:0071417)
0.0043
Regulation of stress-activated protein kinase signaling cascade
0.0044
(GO:0070302)
GO cellular component
Ionotropic glutamate receptor complex (GO:0008328)
0.002
Spectrin-associated cytoskeleton (GO:0014731)
0.0045
Synaptic membrane (GO:0097060)
0.0056
Postsynaptic membrane (GO:0045211)
0.0078
Transcription factor complex (GO:0005667)
0.011
Cell body (GO:0044297)
0.012
Neuronal cell body (GO:0043025)
0.023
Axon (GO:0030424)
0.023
Cytosol (GO:0005829)
0.027
Synapse part (GO:0044456)
0.028
GO molecular function
Calcium ion binding (GO:0005509)
0.00012
Phosphoprotein binding (GO:0051219)
0.00091
Receptor signaling complex scaffold activity (GO:0030159)
0.007
Protein phosphorylated amino acid binding (GO:0045309)
0.0081
Vinculin binding (GO:0017166)
0.011
Ras GTPase binding (GO:0017016)
0.011
SH3 domain binding (GO:0017124)
0.013
Rab GTPase binding (GO:0017137)
0.013
Gamma-catenin binding (GO:0045295)
0.013
GTPase binding (GO:0051020)
0.015
†
The top ten GO terms are shown where the number of entries exceeds ten. GO
identification numbers are shown for each term. p-values for each entry are shown
(Fisher’s exact test).
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Table 2.3 Gene ontology (GO) analysis of genes with regions of differential
H3K27me3 in their promoter†.
GO biological process
GO term
p-value
Homophilic cell adhesion via plasma membrane adhesion molecules
9.48E-10
(GO:0007156)
Cell-cell adhesion via plasma-membrane adhesion molecules
2.52E-08
(GO:0098742)
Cell-cell adhesion (GO:0098609)
2.67E-08
Mammary gland development (GO:0030879)
6.15E-05
Neuron fate specification (GO:0048665)
0.0015
Proximal/distal pattern formation (GO:0009954)
0.0018
Negative regulation of cell aging (GO:0090344)
0.0056
Insulin-like growth factor receptor signaling pathway (GO:0048009)
0.0084
Fibril organization (GO:0097435)
0.0084
Mitochondrial calcium ion homeostasis (GO:0051560)
0.0095
GO cellular component
Microfibril (GO:0001527)
0.0032
Fibril (GO:0043205)
0.006
Intermediate filament cytoskeleton (GO:0045111)
0.011
Integral component of mitochondrial membrane (GO:0032592)
0.038
Golgi apparatus (GO:0005794)
0.043
GO molecular function
Calcium ion binding (GO:0005509)
0.00011
Pre-mRNA binding (GO:0036002)
0.0071
Ankyrin binding (GO:0030506)
0.016
Extracellular matrix structural constituent (GO:0005201)
0.023
Core promoter sequence-specific DNA binding (GO:0001046)
0.025
Galactosyltransferase activity (GO:0008378)
0.038
Oxygen binding (GO:0019825)
0.044
†
Top 10 GO processes are shown where number of entries exceeds 10. GO identification
numbers are shown for each term. p-values for each entry are shown (Fisher’s exact test).
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adhesion related (Table 2.3). FASD-relevant biological processes include “Neuron fate
specification” and “Insulin-like growth factor receptor signaling pathway”. The top two
affected cellular components were “Microfibril” and “Fibril” with several other structural
components implicated (Table 2.3). The affected biological functions did not show any
trends, several binding activies were implicated including “Calcium ion binding”, “premRNA binding”, and “Oxygen binding” (Table 2.3).

2.4.3

Pathways Affected by Histone Methylation Changes
The set of enriched H3K4me3 genes was also submitted to three separate pathway

suites: Ingenuity Pathway Analysis (IPA), Partek Pathway, and Enrichr. The most
common process identified by each software suite was fatty acid metabolism, with 10
pathways identified across the three software platforms (Table 2.4). The top lipid-related
IPA network identified was “Endocrine System Development and Function, Lipid
Metabolism, Small Molecule Biochemistry” (Figure 2.7). IPA canonical pathways
identified include “Fatty acid β-oxidation”, “Sphingomyelin metabolism”, and “Fatty
acid metabolism” (Table 2.4). Patek pathway and Enrichr also identified “Sphingolipid
metabolism”. The individual genes present in the H3K4me3 list driving the identification
of these pathways include β-oxidation enzymes (Acsl4, Acsl6), lipases (Pnpla2, Lipe),
sialidases (Neu1, Neu2), sphingomyelinases (Smpd4, Smpd3), pre-angiotensinogens (Agt)
and oxidoreductases (Ecsit). Importantly, there is little redundancy in the genes identified
between these pathways, indicating diversity of affected lipid genes that cannot be
captured by one software alone. Other pathways identified include cell morphology,
development, and survival IPA networks, and cancer signaling pathways identified by
both IPA and Partek pathway (Table 2.4).
Unlike H3K4me3, the alterations in H3K27me3 methylation following ethanol
exposure appear to affect relatively few networks (Table 2.5). Predominantly, they affect
processes such as endocrine system development and function, molecular transport and
protein synthesis. The canonical pathways identified by IPA are enriched for
biosynthetic processes including eumelanin, myo-inositol, and proline biosynthesis.
Partek pathway analysis also identified two pathways, “Tyrosine metabolism” and
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Table 2.4 Pathways identified from each software suite in the genes in proximity to
H3K4me3 changes†.
Pathway name
IPA network/pathway
Carbohydrate Metabolism, Molecular Transport, Small Molecule
Biochemistry
Hematological System Development and Function, Tissue Morphology,
Cell Death and Survival
Humoral Immune Response, Protein Synthesis, Cellular Function and
Maintenance
Endocrine System Disorders, Gastrointestinal Disease, Immunological
Disease
Endocrine System Development and Function, Lipid Metabolism, Small
Molecule Biochemistry
Cellular Development, Cellular Growth and Proliferation, Cancer
Cell Morphology, Connective Tissue Development and Function, Cellular
Development
Energy Production, Lipid Metabolism, Small Molecule Biochemistry
Endocrine System Development and Function, Carbohydrate Metabolism,
Molecular Transport
Cellular Growth and Proliferation, Cell Morphology, Cellular Assembly
and Organization
Embryonic Development, Organismal Development, Gene Expression
Cellular Movement, Immune Cell Trafficking, Hematological System
Development and Function
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry
IPA canonical
Regulation of cellular mechanics by calpain protease
Fatty acid β-oxidation
Amyotrophic lateral sclerosis signaling
Bladder cancer signaling
Thyroid cancer signaling
Giloma invasiveness signaling
Non-small cell lung cancer signalling
Sphingomyelin metabolism
Estrogen biosynthesis
Spliceosomal cycle
FGF signaling
TREM1 signaling
FAK signaling
Partek Pathway
Pathways in cancer
Fatty acid metabolism
Sphingolipid metabolism

p-value
10E-63
10E-49
10E-31
10E-25
10E-24
10E-24
10E-23
10E-22
10E-20
10E-20
10E-18
10E-17
10E-14
0.0039
0.0044
0.0088
0.013
0.014
0.016
0.029
0.032
0.035
0.038
0.040
0.045
0.048
0.034
0.035
0.040
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Enrichr KEGG
MAPK Signaling pathway
0.041
Sphingolipid metabolism
0.046
†
p-values provided for each pathway are shown (Fishers exact test). Lists of genes present
in each pathway are found in Appendix D.
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Figure 2.7 Top lipid-related Ingenuity Pathway Analysis (IPA) network from
H3K4me3 affected genes.
The pathway is termed “Energy production, lipid metabolism, small molecule
biochemistry”. Nodes in red indicate increased H3K4me3 while nodes in green indicate
decreased H3K3me3 in ethanol exposed mice. Score determined in IPA was 23
corresponding to p=10E-23 (right-tailed Fisher’s Exact Test). See Appendix B for
symbol legend.
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Table 2.5 Pathways identified from each software suite in the genes in proximity to
H3K27me3 changes†.
Pathway name
IPA network/pathway
Endocrine System
Development and
Function, Molecular
Transport, Protein
Synthesis
Cancer, Skeletal and
Muscular Disorders,
Tissue Morphology

Genes in pathway and list
Myadml2, Nphs1, Igf1, Kif5a, Ublcp1, Appl2,
Mfap4, App, Tinagl1, Rbm39, Lingo1, Zbtb20,
Abcg2, Tmem40, Slc39a14, Tsc2, Sh2b2,
Sult1e1, Mif, Ccdc109b, Plec, Smad1, Retnlb,
Eif5b, Dnm1, Itm2b, Pou3f1, Sox9
Hoxd9, Hoxd10, Hoxb9, Cst12, Bcl6b, Hoxb3,
Hoxc10, Grik3, Lhx5, Epha3, Disp2, Rgs19,
Mb, Rpl10a, Rasa2, Phf1, Cd300e, Ccl6,
B3gnt3, Scnn1b, Muc4, Tmbim1, S1pr2
Mir195, Mir497b, Mir376c, H2-DMa, Tbx4,
Mir196a-2, Mir375, Pycr1, Rassf1, Tusc2,
Calb2, Icosl, Atp2b3, Fzr1, Gtf2h4, Apol6,
Nthl1, Psg28, Slc8a1, Cabin1, Zfhx3, Lrch1

Cellular Function and
Maintenance,
Inflammatory Response,
Hematological System
Development
Organismal Survival,
Hoxa7, Mir337, Mir543, Mir667, Sall3, Asap1,
Gene Expression,
Prdx4, Csnk1a1, Naf1, Dnajc6, Prh1, Rhof,
Endocrine System
Snrk, Dmrta2, Casz1, Macf1, Astn2, Dnal4,
Development and
Ap1b1, Matk, Flii, Ctnnd2
Function
IPA canonical
Eumelanin Biosynthesis
Mif
Myo-inositol
Impa1
Biosynthesis
Proline Biosynthesis I
Pycr1
Partek Pathway
Tyrosine Metabolism
Mettl2, Mif
Aldosterone-regulated
Igf1, Scnn1b
sodium reabsorption
Enrichr KEGG
MTOR signalling
Igf1, Tsc2, Eif5b, Ulk4
pathway
†
p-values for each pathway are shown (Fisher’s exact test).

p-value
10E-39

10E-30

10E-28

10E-28

0.037
0.037
0.037
0.031
0.036

0.033
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“Aldosterone-regulated sodium reabsorption” while Enrichr KEGG identified only
“MTOR signaling” (Table 2.5).

2.4.4

Genes and Pathways Affected by Both H3K4me3 and
H3K27me3 Changes
Genes affected by changes in both H3K4me3 and H3K27me3 following alcohol

exposure were next examined. This list constituted 33 genes (p<0.001; Appendix E). Six
of these regions had reciprocal changes in H3K4me3 and H3K27me3, meaning the
changes were in opposite directions. Similar to both of the individual H3K4me3 and
H3K27me3 gene lists, there was enrichment of cell-cell adhesion ontologies, representing
the top three biological processes (Table 2.6). Implicated cellular components included
many dendrite and synapse-related categories such as “Dendrite cytoplasm”, “Cell
projection cytoplasm” and “Presynaptic membrane” (Table 2.6). The top molecular
function was “Calcium ion binding”, with “Oxidoreductase activity” and “Glutamate
receptor” also implicated (Table 2.6).
Many of the Partek and IPA canonical pathways identified included very few
genes, often only one (Table 2.7). However, the top IPA network contained 12 genes,
termed “Cell-to-cell signaling and interaction, cellular assembly and organization,
nervous system development and function” (Figure 2.8). This pathway represents the
proteins that interact to organize synaptic networks during brain development. This gene
network contains at least five “hub genes” MYC, TP53, TNF, Rad21 and CTCF which are
transcription factors. Of special interest to these results is the CTCF (CCCTC-binding
factor) gene involved in the regulation of protocadherins. CTCF is a master
transcriptional regulator involved in establishing and maintaining specific chromatin
environments (Ong and Corces, 2014). Fourteen of the 33 genes in the shared
H3K4me3/H3K27me3 list were Pcdh genes (Appendix C). There are 11 RDHMs that
affect these 14 Pcdh genes, five of these have changes in both H3K4me3 and H3K27.
One particular RDHM overlaps with all 14 affected genes (Figure 2.9). Confirmation this
RDHM with ChIP-qPCR was attempted; however, suitably efficient primers could not be
designed to target the region. All RDHMs had a negative MAT score, indicating
increased trimethylation in these regions at both H3K4me3 and H3K27me3.
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Table 2.6 Gene ontology (GO) analysis of genes with both H3K4me3 and H3K27me3
RDHMs in their promoter.
GO biological process
GO term
Homophilic cell adhesion via plasma membrane adhesion molecules
(GO:0007156)
Cell-cell adhesion via plasma-membrane adhesion molecules
(GO:0098742)
Cell-cell adhesion (GO:0098609)
Regulation of mitochondrial membrane potential (GO:0051881)
Regulation of membrane potential (GO:0042391)
Proline biosynthetic process (GO:0006561)
Positive regulation of mitochondrial fission (GO:0090141)
Positive regulation of protein homooligomerization (GO:0032464)
Negative regulation of interleukin-17 production (GO:0032700)
Killing of cells in other organism involved in symbiotic interaction
(GO:0051883)
GO cellular component
Dendrite cytoplasm (GO:0032839)
Cell projection cytoplasm (GO:0032838)
Terminal bouton (GO:0043195)
Presynaptic membrane (GO:0042734)
Perikaryon (GO:0043204)
Intermediate filament cytoskeleton (GO:0045111)
Ionotropic glutamate receptor complex (GO:0008328)
GO molecular function
Calcium ion binding (GO:0005509)
Extracellular-glutamate-gated ion channel activity (GO:0005234)
FMN binding (GO:0010181)
Ionotropic glutamate receptor activity (GO:0004970)
Oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor
(GO:0016653)
Oxidoreductase activity, acting on the CH-NH group of donors, NAD or
NADP as acceptor (GO:0016646)
Glutamate receptor activity (GO:0008066)
Oxidoreductase activity, acting on the CH-NH group of donors
(GO:0016645)

p-value
1.80E-20
6.60E-19
7.04E-19
0.0013
0.0088
0.014
0.016
0.016
0.018
0.018

0.013
0.013
0.036
0.040
0.044
0.050
0.044
5.95E-12
0.031
0.026
0.032
0.021
0.032
0.045
0.047
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Table 2.7 Pathways identified from each software suite in the genes in proximity to
both H3K4me3 and H3K27me3 changes.
Pathway name
IPA
Cell-To-Cell Signaling and Interaction,
Cellular Assembly and Organization,
Nervous System Development and Function
Cell Death and Survival, Cancer, Infectious
Disease
Immunological Disease, Infectious Disease,
Cell Morphology
IPA canonical
Proline biosynthesis I
Partek
Asthma
Intestinal immune network for IgA
production
Bladder cancer
Inflammatory bowel disease (IBD)
Arginine and proline metabolism
Staphylococcus aureus infection
Graft-versus-host disease
Allograft rejection
Type I diabetes mellitus
Autoimmune thyroid disease
Non-small cell lung cancer
Biosynthesis of amino acids
KEGG
Bladder cancer
Arginine and proline metabolism
Non-small cell lung cancer
Biosynthesis of amino acids
Glutamatergic synapse

Genes in pathway and list

p-value

Fbxl16, Flii, Pebp4, Hoxa7,
Pycr1, Pcdhga4, Pcdhgb5,
Pcdhga7, Pcdhgb2, Pcdhga9,
Pcdhgb1, Rassf1
Tusc2

10E-23

0.013

H2-DMa

0.04

Pycr1

0.02

Rassf, Pycr1, H2-DMa
Rassf

0.017
0.030

Rassf1
Rassf1
Pycr1
Rassf1
Rassf1
Rassf1
Pycr1
H2-DMa
Rassf1
Pycr1

0.031
0.032
0.033
0.033
0.033
0.034
0.039
0.039
0.039
0.041

Rassf1
Pycr1
Rassf1
Pycr1
Rassf1

0.018
0.021
0.025
0.031
0.048
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Figure 2.8 Top Ingenuity Pathway Analysis (IPA) network for genes sharing both
H3K4me3 and H3K27me3 RDHMs.
The pathway is termed “Cell-To-Cell Signaling and Interaction, Cellular Assembly and
Organization, Nervous System Development and Function”. Nodes outlined in blue
represent proteins whose genes bear both H3K4me3 and H3K27me3 changes; functional
relationships with these proteins are highlighted in light blue. Red circle highlights CTCF
regulation of Pcdh genes.IPA pathway score 23 corresponding to p=10E-23 (right-tailed
Fisher Exact Test). See Appendix B for symbol legend.
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Figure 2.9 Location of region of differential H3K4me3 & H3K27me3 containing
putative CTCF binding motif in the mouse Pcdhg gene cluster.
Total expanded DNA sequence shows the DMR, while the underlined region shows the
putative CTCF binding motif. This DMR was enriched for H3K4me3 and H3K27me3 in
ethanol-exposed mice (H3K4me3 MAT score = -11.2, p= 9.36E-5.; H3K27me3 MAT
score = -14.1, p= 4.8E-4, CTCF position weight matrices score = 3.31)

58

2.4.5

Protocadherin-Proximal CTCF Motifs Show Altered
H3K4me3 and H3K27me3
Due to the implication of Pcdh genes and CTCF in the shared

H3K4me4/H3K27me3 gene list, CTCF motif analysis was performed on the RDHM
sequences using the CTCF prediction tool on the CTCFBS database 2.0. There were 150
out of 625 (24%) H3K4me3 RDHMs which contained a putative CTCF binding motif.
For the H3K27me3 RDHMs, 46 out of 166 (28%) contained a putative CTCFbinding
motif. Further, CTCF was identified as a top upstream regulator for both the H3K4me3
and H3K27me3 genes by IPA and Enrichr, respectively.
The 11 specific RDHMs affecting the Pcdh genes were assessed for putative
CTCF sites. One of the RDHMs contained a putative CTCF site (H3K4me3 MAT score =
-11.2, p= 9.36E-5.; H3K27me3 MAT score = -14.1, p= 4.8E-4, CTCF PWM score =
3.31). This RDHM overlapped with the gene bodies of all 14 Pcdh genes identified, and
is situated just after the first exon of Pcdhgb5 (Figure 2.9). The TAAACTGCC sequence
contained within the 20 bp RDHM is a predicted M2 CTCF binding motif (Schmidt et al.,
2012). This particular sequence at this position is somewhat conserved in rat, and absent
in humans.

2.4.6

H3K27me3 Reduction at Snrpn/Ube3a CTCF Sites
CTCF also controls the expression of many imprinted genes. Given our

laboratory’s previous findings regarding CTCF binding sites in the Snrpn/Ube3a
imprinted region (Laufer et al., 2013), histone methylation changes in potential CTCF
binding motifs in this region were assessed. There were five RDHMs in the Snrpn/Ube3a
region, two of which had significant predicted CTCF binding motifs (Figure 2.10). One
was a reduction of H3K27me3 in ethanol-treated mice 2.5 kb upstream of the Snrpn
transcriptional start site (H3K27me3 MAT score=1.5, p=0.001, CTCF position weight
matrices score=3.23). The other was a reduction in H3K27me3 1.2 kb upstream of the
Snord116 first transcriptional start site (H3K27me3 MAT score=3.1, p=0.0004, CTCF
PWM score=7.6). These CTCF motifs were in the correct orientation with respect to their
gene promoters. One is a predicted M2 motif upstream of the Snrpn gene, the other is a
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Figure 2.10 Location of region of differential H3K27me3 in mouse Snrpn/Ube3a
locus.
RDHMs are shown as vertical black lines. RDHMs containing a putative CTCF binding
site are expanded to sequence view, with the CTCF motif underlined. The RDHM
upstream of Snrpn was depleted of H3K27me3 in ethanol-exposed mice (MAT score =
1.5, p = 0.002, CTCF position weight matrices score = 3.23). The RDHM upstream of
Snord116 was also depleted of H3K27me3 in ethanol-exposed mice (MAT score = 3.1, p
= 0.0004, CTCF position weight matrices score = 7.6).
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predicted LM7 motif (Xie et al., 2007) upstream of the Snord116 promoter. There were
no H3K4me3 changes in the region.
Confirmation of all the RDHMs in Figure 2.10 were attempted with ChIP-qPCR
(Figure 2.11). The Snrpn RDHM showed 2.55 ± 0.69 fold H3K27me3 enrichment in
ethanol-exposed mice vs. 2.88 ± 1.13 in control mice (p=0.42, Paired Samples t-Test).
The more 5’ region upstream of Snord116 showed 3.18 ± 1.26 fold H3K27me3
enrichment in ethanol-exposed mice vs 3.90 ± 0.85 in control mice (p=0.34, Paired
Samples t-Test). The region more proximal to Snord116 showed 3.03 ± 0.92 fold
H3K27me3 enrichment in ethanol-exposed mice vs. 4.18 ± 1.93 in control mice (p=0.32,
Paired Samples t-Test). The RDHM upstream of IPW showed 2.53 ± 0.35 fold
H3K27me3 enrichment in ethanol-exposed mice vs. 4.30 ± 0.22 in control mice (p=0.26,
Paired Samples t-test). Primers could not be designed to target the RDHM upstream of
Ube3a.
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Figure 2.11 Attempted chromatin immunoprecipitation-real-time PCR
confirmations of H3K27me3 RDHMs in the Snrpn/Ube3a locus.
ChIP against each region was performed in independent biological samples (n=5 ethanol,
n=5 control) i.e. different mice than the ChIP-chip array. Enrichment for each sample was
assessed using qPCR and compared to its IgG control using % enrichment = 100% ×
efficiency^(input Ct - H3K27me3 Ct). Data shown are average percent H3K27me3
enrichment ± standard error. Significance was assessed using a Paired Samples t-Test; no
region was significantly enriched between ethanol and control groups.
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Discussion
2.5.1

Gene Ontology Analysis Implicates Synaptic Development
Genes
GO analysis of each of the H3K4me3, H3K27me3, and shared

H3K4me3/H3K27me3 gene lists implicate synaptic development genes. The H3K4me3
gene list was enriched for cell-cell adhesion genes, nervous system development genes,
and synaptic genes (Table 2.2). Similarly, GO analysis of the H3K27me3 gene list
showed enrichment of cell-cell adhesion genes, and neuron development genes (Table
2.3). In the shared gene list, the top three GO biological processes were cell-cell adhesion
related (Table 2.6). The top implicated cellular components included many dendrite and
synapse-related categories.
Taken together, the GO analyses of each gene list suggest that nervous system
development and cell-cell adhesion genes are disproportionately proximal to H3K4me3
and H3K27me3 changes in this model. The development of synapses during the neonatal
period in mice is guided by communication via cell-cell adhesion molecules, including
protocadherins (Cohen-Cory, 2002); the presence of these genes in each list likely drive
the implication of synaptic GO categories (Discussed in section 2.5.3 below). Disruption
of synaptogenesis by ethanol can lead to improper synapse formation, interfering with
synaptic transmission, potentiation, and plasticity in adulthood (Mameli et al., 2005;
Olney et al., 2002; Puglia and Valenzuela, 2010). Dysregulation in the expression of cellcell communication and synaptic development GO categories at PND 70 was reported
previously in our laboratory in this model (Kleiber et al., 2013). In this previous work and
this thesis, these alterations to synaptic development genes persist long after exposure to
ethanol. Such changes may represent the presence of a different pool of cells in the brain
following PND 4,7 ethanol-induced apoptosis, differential expression/methylation of
genes in remaining cell, or a combination of both (Kleiber et al., 2014). In any case, these
changes may represent a residual footprint of ethanol exposure.

2.5.2

H3K4me3 Changes Affect Lipid Pathways
The most striking feature of the pathways affected in the H3K4me3 genes is the

abundance of lipid metabolism pathways (Table 2.4). There were 10 pathways involving
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lipids identified across the three software platforms. Figure 2.7 shows the top lipidrelated pathway. The hub of this network is leptin, a peptide hormone that is the master
regulator of hunger and adipocyte function. Failure of leptin to cross the blood-brain
implicates leptin in neurological disorders such as Alzheimer’s (Lee, 2011). Other
important hub genes are the β-oxidation enzymes ACOX1 and BDNF, implicated in a
host of neurodevelopmental and processes and pathologies. There were several individual
genes identified as having proximal H3K4me3 driving lipid pathway identification.
These include the genes encoding the β-oxidation enzymes Acsl4 and Acsl6, lipases
Pnpla2 and Lipe, sialidases Neu1 and Neu2, sphingomyelinases Smpd4 and Smpd3, preangiotensinogen Agt and oxidoreductase Ecsit (Table 2.4). Acsl6 was upregulated in an
embryonic model of FASD (Zhou et al., 2011a). Pnpla2 expression was reduced in adult
mice exposed to fetal ethanol (Christensen et al., 2015).
Alteration of lipid metabolism is a feature of FASD. Prenatal ethanol exposure
causes changes in cholesterol in the adult mouse brain (Barcelo-Coblijn et al., 2013).
Prenatal ethanol exposure also causes changes to the entire phospholipid profile in the
hippocampus (Wen and Kim, 2004). Neonatal ethanol exposure during the third trimester
equivalent is characterized by widespread apoptosis involving Bax and caspase-3
activation. β-oxidation of fatty acids also produces reactive oxygen species (ROS). The
ACOX enzyme (present in the top network shown in Figure 2.7) catalyzes the first step
of β-oxidation in the brain and is a major source of ROS (Trompier et al., 2014). Fetal
alcohol exposure causes lipid peroxidation in the brain after ethanol exposure which can
persist to adulthood (Brocardo et al., 2016; Petkov et al., 1992; Smith et al., 2005).
Supplementation with omega-3 fatty acids can prevent oxidative damage and
hippocampal synaptic changes caused by prenatal ethanol exposure (Patten et al., 2013a,
2013b). This thesis is the first report of an interaction of histone modification and lipid
metabolism in ethanol-exposed hippocampus, the region implicated in learning and
memory deficits.
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2.5.3

Enrichment of Protocadherin Genes for H3K4me3 &
H3K27me3 Changes
The simultaneous changes in H3K4me3 and H3K27me3 are proximal to genes in

the network “Cell-to-cell signaling and interaction, cellular assembly and organization,
nervous system development and function” (Figure 2.8). This is the gene network
responsible for shaping cell-to-cell communication in the brain—synaptogenesis—during
development. The peak of synaptogenesis occurs on PND 7 in mice (Dobbing and Sands,
1979). Several RDHM-proximal genes in the top pathway were protocadherin (Pcdh)
genes which are crucial for synaptogenesis. Pcdh genes are clusters of related genes that
are believed to be responsible for establishing specific connections between neurons in
vertebrate brain development by generating single-neuron diversity (Thu et al., 2014).
The Pcdhg genes are necessary for neurite self-avoidance (Lefebvre et al., 2012). PCDH
proteins allow neurons to determine if they are self-synapsing, or synapsing with another
neuron. Neurites can then use this diversity to form the complex web of synaptic
connections during trimester three. Most Pcdh genes are organized into three genomic
clusters which are conserved across species. The Pcdha, Pcdhb and Pcdhg gene clusters
are located in tandem on human chromosome 5, and mouse chromosome 18. Pcdha and
Pcdhg have alternative first exons and are regulated by complex hierarchical chromatin
looping (Tasic et al., 2002; Wang et al., 2002). This leads to proteins with differing
extracellular domains, and constant cytoplasmic domains generating neuronal
individuality and guiding synaptic interactions.
The Pcdh genes are regulated in part by CCCTC-binding factor (CTCF). CTCF
creates three dimensional chromatin domains, and promotes specific regulatory
interactions that positively or negatively affect transcription (Ong and Corces, 2014). The
relationship of CTCF with histone modification is complex, and differs based on the
genomic context. Little is known about the relationship between H3K4me3 and CTCF.
H3K27me3 is enriched at CTCF binding sites, and may play a functional role in its
binding at some loci (Handoko et al., 2011). CTCF can also recruit the PRC2 complex
which trimethylates H3K27me3 (Li et al., 2012). CTCF acts as an insulator to the
repressive H3K27me3 mark and thereby promotes gene expression. Loss of CTCF can
thus lead to inappropriate gene silencing at such loci (Witcher and Emerson, 2009). All of
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the H3K4me3 and H3K27me3 RDHMs in the Pcdh loci identified here were increases in
methylation (Appendix E). These gains of H3K27me3 may be correlated with enhanced
CTCF binding, disrupting regulation of the region. Increased histone methylation and
enhanced CTCF binding in response to early ethanol exposure is consistent with DNA
methylation data.
Two recent studies—one from our laboratory—associate increased DNA
methylation at Pcdh loci with FASD in humans. Laufer et al., (2015) found that there was
increased DNA methylation in the Pcdhg cluster in children with FAS. A similar study
design with a larger sample size found again increases in DNA methylation in the Pcdhb
and Pcdhg cluster in children with FASD (Portales-Casamar et al., 2016). These two
studies point to Pcdh loci as candidate epigenetic biomarkers of FASD. Together with the
data presented in this thesis, a clear picture emerges suggesting protocadherin genes as
strong candidates for FASD etiology.

2.5.4

H3K27me3 Changes Affect Imprinted Loci
Previous work from our laboratory implicated DNA methylation changes at

CTCF sites in imprinted loci. Therefore, such sites were assessed for histone methylation
changes. The Snrpn-Ube3a locus expresses a neuron-specific polycistronic transcript that
includes two clusters of snoRNAs (Le Meur et al., 2005). The function of this transcript
is not clear; however its timing and dosage are critical, with alterations leading to
neurodevelopmental disorders (Leung et al., 2009). There were putative CTCF sites at
two of five H3K27me3 RDHMs in the Snrpn/Ube3a imprinted region. One site was
upstream of Snrpn and the other is upstream of Snord116 (Figure 2.10). A reduction of
methylation in H3K27me3 at CTCF sites could have a number of explanations. It is
likely that the H3K27me3 change itself was a result of altered one-carbon metabolism by
ethanol, which would then affect CTCF binding. It is also possible that ethanol-induced
changes in CTCF binding occurred, which precipitated H3K27me3 reduction, but a
mechanism for this is not clear. As described in the previous section, H3K27me3 may be
involved in the formation of CTCF DNA loops. Therefore, the reduction of H3K27me3
at CTCF motifs found at the Snrpn/Ube3a locus here may correlate with reduced CTCF
binding and a loss of looping and gene expression. It is known that a loss of CTCF at
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imprinted loci is associated with loss of insulator function, and thus deregulation of
imprinted genes (Kanduri et al., 2002; Szabo et al., 2004).
Confirmation of each of the RDHMs in the region was attempted (Figure 2.11).
The differences in enrichment between the ethanol-exposed and control groups were not
statistically significant. Each of the regions did trend toward the expected difference, that
is a decrease in H3K27me3 enrichment in ethanol-exposed mice. It is possible that
increased sample size would bring these regions toward significance. It should also be
noted that these confirmation ChIP-qPCR experiments were done in independent
biological samples, i.e. different mice that the ChIP-Chip assessment. Replication
between biological groups can be a challenge in ethanol research due to the
heterogeneous nature of the effects of ethanol.
The results of this section are supported by previous work from our laboratory
which found several ethanol-induced DNA methylation changes at imprinted regions
including CTCF sites. There was an increase in DNA methylation at CTCF sites in the
imprinting control region (ICR) of H19 and Igf2 (H19/Igf2) in response to fetal ethanol
exposure (Laufer et al., 2013). Others have also found changes in this particular CTCF
site in FASD including differential DNA methylation in FASD placental tissue (Haycock,
2009) and in sperm of alcohol-consuming fathers (Knezovich and Ramsay, 2012). At the
Snrpn/Ube3a locus specifically, our laboratory has shown increased expression of
ncRNA in FASD individuals (Laufer et al., 2015). Other research has found methylation
changes in the Ube3a gene in a model of FASD (Liu et al., 2009).

2.5.5

Conclusion
In this chapter, genes and pathways affected by histone methylation changes in

response to early ethanol exposure are described. Lipid metabolism genes were
predominantly proximal to H3K4me3 changes, which is consistent this results from the
gene expression and DNA methylation chapters of this thesis. A putative CTCF motif in
one of the Pcdhg promoters was found to have increased levels of H3K4me3 and
H3K27me3. Confirmation this change by ChIP-qPCR was attempted; however efficient
primers could not be designed for the region. Alteration of the epigenetic state of this
motif could affect the regulation of the entire region given that loss of CTCF is associated
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with reduced Pcdh expression dendritic arborisation (Hirayama et al., 2012). The
methylation changes may be remnants of earlier dysregulation, perhaps from the
synaptogenesis period. This observation may relate to learning and memory deficits in
FASD since these processes are dependent on synaptic structure and plasticity in the
hippocampus (Bliss and Collingridge, 1993; Whitlock et al., 2006). Indeed, our
laboratory has previously shown that this mouse model has impaired learning and
memory into adulthood (Mantha et al., 2014) and that many CTCF sites show altered
DNA methylation in whole-brain tissue (Laufer et al., 2013). The potential for epigenetic
deregulation of Pcdh genes to underlie this phenotype is also evident in changes in gene
expression and DNA methylation (Laufer et al., 2013). Such long lasting effects are
viewed as stable; they may account for cellular changes underling learning and memory
deficits in FASD. Finally, reduction in H3K27me3 across the Snrpn/Ube3A locus was
identified. These changes were not confirmed, but trended towards a reduction. Again,
this loss of methylation may represent footprint of earlier ethanol exposure.
The results of this section represent a timepoint in a small portion of the
hippocampal epigenome in response to ethanol. Based on the known effects of ethanol on
lipid metabolism, oxidative stress, methylation pathways, etc. hypotheses can be
generated regarding the origins of these histone methylation changes. The results of this
chapter suggest that altered one-carbon metabolism affects H3K4me3 and H3K27me3
soon after ethanol exposure which are maintained to PND 70. Further work
characterizing the histone methylation of the identified regions and their expression is
needed at earlier timepoints.
Footnote
A modified version of this chapter has been published (Chater-Diehl et al., 2017).
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Effects of Neonatal Ethanol Exposure on
Hippocampal DNA Methylation
Outline
Ethanol impairs one-carbon metabolic pathways from which methyl groups are
derived. Ethanol-induced changes in gene expression may lead to altered brain function
and behaviour. Previous work has implicated DNA methylation changes in models of
FASD, but none have examined long-term changes in the hippocampus. In this chapter,
hundreds of changes in DNA methylation were identified using methylated DNA
immunoprecipitation microarray in PND 70 mice exposed to ethanol as neonates.
Changes occurred in genes related to lysosomes, peroxisomes, and cell structure.
Differential methylation in the peroxisome gene Acaa1 was confirmed with sodium
bisulfite pyrosequencing. Also in this chapter, the DNA methylation results and histone
modification results are analyzed together. The combined analysis strengthened the
implication of peroxisome genes, and also implicated novel processes not found in
individual analyses including cardiovascular pathways and notch signalling. These data
suggest a novel interplay between oxidative stress and epigenetic methylation in the
ethanol exposed hippocampus.

Introduction
3.2.1

DNA Cytosine Methylation
Methylation of cytosine nucleotides in DNA is a well characterized modification

regulating chromatin structure and gene expression through development. 5-methylcytosine (5mC) was first described in 1948, with its chemical makeup inferred from its
chromatography separation pattern from cytosine (Hotchkiss, 1948). It was several
decades until the function of 5mC (often referred to as simply DNA methylation) was
determined. Studies in the late 70’s and early 80’s found that DNA methylation was
involved with local gene expression at developmental genes and regulating cell
differentiation (Compere and Palmiter, 1981; Holliday and Pugh, 1975). After intensive
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investigation, it has become clear that DNA methylation is principally a negative
regulator of gene expression in mammals. DNA methylation in gene promoters is
associated local gene repression and is stable over cellular differentiation once
established (Medvedeva et al., 2014).
Cytosine methylation occurs predominately at CpG dinucleotides in mammals,
which are almost always methylated (Deaton and Bird, 2011). 5mC has a high mutagenic
potential, as it is easily deaminated to thymine (Coulondre et al., 1978). As such, CpG
sites are evolutionarily constrained, and are depleted through the most eukaryotic
genomes (Bird, 1980). However, there are concentrations of CpG sites often found within
gene promoters which can be heavily demethylated called CpG islands (Bird et al., 1985).
CpG islands are routinely defined as a region at least 200 bp long with greater than 50%
GC content, and an observed-to-expected CpG ratio greater than 60% (Gardiner-Garden
and Frommer, 1987). Methylation of CpG islands is associated with the repression of
nearby (both up- and down-stream) genes (Deaton and Bird, 2011).

3.2.2

Regulation of DNA Methylation
DNA methylation patterns are established by complex protein interactions which

catalyze methylation at the appropriate time and genomic location. De novo CpG
methylation is established by the DNMT3A and DNMT3B enzymes which can methylate
unmodified CpG sites (Okano et al., 1998). CpG sites are a simple genetic palindrome,
the same 5’ to 3’ sequence on each strand. This structure is exploited by the maintenance
DNA methyltransferase DNMT1 to maintain DNA methylation after cell division. The
hemi-methylated CpG site in each daughter cell is recognized by DNMT1, which then
catalyzes the addition of a methyl group to the unmethylated strand. In this way,
methylation information is preserved through cell division. DNMT3A and DNMT3B are
highly active during embryonic development, during which time they establish patterns
which direct stem cell differentiation and ultimately provide somatic cell identity
(Seisenberger et al., 2012). DNA methylation is erased during gamete production
(Messerschmidt et al., 2014). During gametogenesis, there is an initial wave of
demethylation, followed by another after fertilization (Geiman and Muegge, 2009; Smith
and Meissner, 2013). This active demethylation is believed to be achieved by recently
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discovered DNA demethylases called TET proteins (Kohli and Zhang, 2013). De novo
methyltransferases and TET proteins are highly active during embryogenesis and early
development, but are then inactive in most adult tissues (Okano et al., 1999). DNMT1
remains active at low levels (Ratnam et al., 2002). In conjunction with DNA methylation
data, this suggest that DNA methylation is stable in most somatic tissues.
Once DNA methylation patterns are established, they must be translated into
signals to direct chromatin-based processes such as transcription. DNA methylation can
achieve repressive effects on transcription and promote condensed chromatin by either
promoting negative factor binding or blocking positive factor binding. There are several
classes of proteins that fill the former role. The MBD, SRA, Kaiso and Kaiso-like protein
domains are the major groups that bind to methyl-CpG sites (Defossez and Stancheva,
2011). These domains are components of proteins which form large multi-protein
complexes containing other domains that affect chromatin structure and/or transcription.
For example, the H3K9 methylase SETDB1 contains an MBD domain suggesting that
DNA methylation can drive the deposition of H3K9me (Schultz et al., 2002). H3K9me
directs chromatin condensation, prohibiting gene expression (Audergon et al., 2015).
Similarly, histone deacetylation is observed at 5mC-containing promoters, suggesting
DNA methylation carries out gene repression in part through blocking open-chromatin
marks (Cedar and Bergman, 2009). There are many such examples suggesting complex
crosstalk between DNA methylation and other chromatin modifications. The presence of
DNA methylation in specific DNA motifs may also occlude the binding of positive
transcription factors, repressing transcription (Spruijt and Vermeulen, 2014). Initially,
this was imagined to be the primary mechanism by which DNA methylation modulated
gene expression. Recent data suggest that it is rare however, restricted to specific
examples at particular genes (Medvedeva et al., 2014).

3.2.3

Functions of DNA Methylation

3.2.3.1

Unique Role in the Adult Brain

DNA methylation is relatively stable once established, supported by the
downregulation of de novo DNA methyltransferases in most adult tissues. In the brain
however, this pattern does not hold true. De novo DNMTs are expressed in post-mitotic
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neurons in the mammalian brain (Feng et al., 2005; Goto et al., 1994). Pharmacological
inhibition or deletion of DNMT3A and DNMT3B in the hippocampus results in impaired
synaptic plasticity and long-term potentiation (LTP) (Muñoz et al., 2016). These
processes are key to many brain functions including learning and memory. Specific
studies indicate that methylation is increased at some genes and decreased at others in
response to neuronal activation (Lubin et al., 2008; Miller and Sweatt, 2007; Miller et al.,
2010). This suggests that the blockage of DNMT3A and DNMT3B in neurons impairs
synaptic plasticity via disrupting the balance between the memory activating and
repressing genes (Zovkic et al., 2013).
The DNA demethylating TET enzymes are believed to play an important role in
maintaining a 5mC balance in the brain. The TET enzymes produce several intermediate
modifications of cytosine during demethylation: 5-hydroxymethylcytosine, 5formylcytosine, and 5-carboxylcytosine (Ito et al., 2011). 5-hydroxymethylcytosine
(5hmC) is enriched in the brain, specifically at genes involved in synaptic function
(Khare et al., 2012). Whether it is functioning as a unique epigenetic mark or is simply a
step in demethylation remains unclear. Some researchers hypothesize that 5hmC blocks
repressive 5mC-binding proteins and thus promotes transcription (Branco et al., 2011).
Some believe that during evolution the mammalian brain co-opted epigenetic
mechanisms which evolved to govern development, and tweaked them to accomplish
complex neurological functions.
Non-CpG cytosine methylation is also enriched in the brain. CpH (H=A, C, or
T) methylation is enriched in regions of low CpG density, reduced at protein binding
sites, and is negatively correlated with gene expression (Guo et al., 2014). CpH
methylation can be recognized by the same reader proteins as CpG methylation, such as
the MBD-containing MeCP2 implying that it may also repress gene expression (Guo et
al., 2014). CpH methylation is established by de novo methyltransferases in mature
neurons, suggesting it is involved in higher neuronal functions (Guo et al., 2014). More
research is needed to understand the role of this methylation subtype.
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3.2.3.2

Control of Gene Expression

CpGs islands are one of the organizational paradigms by which DNA methylation
regulates gene expression. CpG islands are a vertebrate-specific phenomenon where in
CpG sites are concentrated near a gene or genes. They are at least 200 bp long, but 1000
bp on average. Approximately 70% of genes are associated with a CpG island,
(Illingworth et al., 2010; Saxonov et al., 2006). CpG islands are sites of transcriptional
initiation, with about half localized over TSSs (Macleod et al., 1998). Interestingly, many
CpG islands are not associated with known gene TSSs; however, many such sites have
proved to be previously unknown genes (Macleod et al., 1998). Indeed, many CpG
islands not associated with genes have been shown to overlap with non-coding RNA
TSSs (Guttman et al., 2009). H3K4me3 is a hallmark of CpG islands and is necessary but
not sufficient for transcription to occur, as it is present even at inactive genes (Guenther
et al., 2007). CpG density alone correlates with H3K4me3 levels (Thomson et al., 2010).
Methylated CpG islands are associated with local gene repression; however, DNA
methylation often occurs after repression via histone modifications (Okamoto and Heard,
2009). Therefore, methylation of CpG islands may act to stably lock genes in a repressed
state. Examples from specific genes show that methylation of non-CpG-island promoters
cause similar changes to histones and repress gene expression (Han et al., 2011).
DNA methylation at enhancers is more complex. Enhancers tend to be CpG poor,
and incompletely methylated (Jones, 2012). Since TET proteins are also present at
enhancers during embryonic development, active DNA demethylation in may occur at
these loci (Lu et al., 2014). Indeed, whole-genome 5hmC analyses have shown that TETmediated demethylation occurs mainly at enhancers during development (Lu et al., 2014)
and is also prevalent in the adult brain (Tognini et al., 2015). Current research in this field
is testing the hypothesis that DNA demethylation and 5hmC at enhancers controls gene
expression in response to neuronal stimulation, long-term potentiation, and learning
(Tognini et al., 2015).

3.2.3.3

Genomic Imprinting

A key function of DNA methylation is regulating genomic imprinting. Genomic
imprinting refers to the expression of genes in a parent-of-origin-specific manner (Smith
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and Meissner, 2013). Depending on the locus, the maternal or paternal allele can be
imprinted. The imprinted allele is methylated and not expressed, while the other is
unmethylated and expressed. Often, differential methylation occurs at imprinting control
regions (ICRs) which direct the expression of several proximal imprinted genes
(Bartolomei and Tilghman, 1997). These patterns are established during germline
development and are maintained through epigenomic reprograming that occurs during
fertilization (Bartolomei and Tilghman, 1997). Only a small number of genes are
imprinted; the total number is estimated to be a few hundred in mice and humans (Ishida
and Moore, 2013). Imprinting is specific to eutherian mammals, and has evolved
independently in flowering plants (Scott and Spielman, 2006). Mutations and other
molecular aberrations at imprinted loci cause many genetic diseases in humans (Butler,
2009). The non-disease functions of genomic imprinting are not clear. It seems
disadvantageous to only express one copy of any gene in a diploid organism. The most
widely accepted theory of imprinting function is the kinship theory (Moore and Haig,
1991). It postulates that the paternal expressed genes promote maximal fetal growth, with
no regard for maternal health. The maternal expressed genes promote optimal fetal
growth, balanced with maternal health (Moore and Haig, 1991). DNA methylation is a
key mechanism by which this parent-of-origin expression is achieved.

3.2.4

DNA Methylation Analysis Methods
There are many methods to assess DNA methylation, and most fall into two

categories: enrichment-based or bisulfite-based. Enrichment-based techniques rely on a
protein to pull down methylated genomic DNA. The methylated DNA can then be
characterized by gene-specific methods such as qPCR, or genome-wide methods such as
microarrays and sequencing. Global analysis methods are also possible, in which the
amount of DNA enrichment between samples is simply compared. Global methods are
inexpensive and quick, by provide no genomic location information. Methylated DNA
immunoprecipitation (MeDIP) and MBD capture are specific enrichment methods.
MeDIP uses an antibody against 5mC (Jacinto et al., 2008), while MBD capture uses
beads coated with MBD to pull down 5mC. MBD capture is more sensitive to regions
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with high CpG density while MeDIP is more sensitive to regions with low CpG density
(Nair et al., 2011).
Bisulfite-based techniques use sodium bisulfite to chemically modify all
unmethylated cytosines to uracils. Following PCR amplification, these uracils are read as
thymines, but the methylated cytosine remain cytosines. The converted DNA can then be
sequenced using any region-specific or whole-genome technology. Comparison to the
reference genome can thus identify C-to-T transitions as unmethylated sites. Microarrays
which are specific to the converted and uncovered sequences are also used (Li and
Tollefsbol, 2011). Enrichment approaches have the advantage of not damaging DNA as
bisulfite does. Further, 5hmC is also insensitive to bisulfite conversion, meaning bisulfite
sequencing is unable to distinguish 5mC from 5hmC. The resolution of bisulfite is much
greater than enrichment techniques, allowing identification of single-base methylation
differences (Li and Tollefsbol, 2011). Enrichment techniques also greatly reduce the total
DNA sample amount, requiring a whole-genome application step that can introduce
biases against CpG regions (Robinson et al., 2010). Whole-genome bisulfite sequencing
is also very expensive, and often provides more information than the experiment
necessitates. Enrichment of CpG dense regions using enzymatic digestion at CCGG sites
reduces the total DNA to be sequenced dramatically, reducing cost per sample by 10
times (Gu et al., 2011). The diversity of methods available allows researchers to tailor the
technique to their experimental question.

3.2.5

DNA Methylation and FASD
DNA methylation is believed to be a key component of numerous disease

etiologies, including FASD. Aberration of DNA methylation is associated with many
human diseases. In particular, diseases involving errors in cellular differentiation such as
cancers often involve altered DNA methylation (Robertson and Wolffe, 2000).
Imprinting disorders are also caused by genetic or epigenetic changes at imprinting loci.
Repeat expansion disorders involve DNA methylation, as the expanded region is often
methylated leading to silencing (Robertson and Wolffe, 2000). Given the important role
of DNA methylation in neurological function, it is unsurprising that numerous
neurodevelopmental and neurodegenerative disorders are associated with changes in
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DNA methylation (Lu et al., 2013). Identifying a causative role for DNA methylation in
these disorders is very difficult compared with growth disorders. Nevertheless, DNA
methylation at disease-relevant genes is associated with dozens of human neurological
disorders (Lu et al., 2013). As the interest in DNA methylation in neurological disorders
increased through the 1990s, research was initiated into the role of DNA methylation in
FASD.
DNA methylation was suspected to be particularly relevant in FASD due to the
molecular actions of ethanol. DNA methyltransferases rely on one-carbon metabolic
pathways to transfer a methyl group onto cytosine. Briefly, DNMTs transfer the methyl
group from the methyl donor SAM. The first metabolite ethanol, acetaldehyde, exerts
several inhibitory effects on SAM availability. Acetaldehyde prevents the uptake of
folate, a precursor of SAM (Hamid and Kaur, 2007). Acetaldehyde also directly inhibits
methionine adenosyl transferase and methionine synthase which produce SAM and its
precursor methionine respectively (Kenyon et al., 1998; Seitz and Stickel, 2007). Much
of this information emerged from studies of adult alcohol-induced liver disease, which
has since been associated with changes in DNA methylation (Shukla et al., 2008). These
effects have also been observed in in vivo FASD models. Garro et al. (1991) provided the
first implication of DNA methylation in FASD. Exposure of mouse fetuses to ethanol
from GD9-11 resulted in DNA hypomethylation. Nuclei from ethanol-exposed fetuses
had lower levels of DNMT activity even when exposed to excess SAM, suggesting
irreversible enzyme activation (Garro et al., 1991). Furthermore, DNA methylation
provides a molecular mechanism for gene-by-environment interactions: environmental
changes can potentially affect gene expression via DNA methylation which is dependent
on environmental sources of carbon (Baccarelli and Bollati, 2009). Combined with
emerging studies on the importance of DNA methylation in neurological disease, these
data provided the theoretical basis for exploration of the role of 5mC in FASD.
DNA methylation has become a popular research area in FASD. Interestingly,
histone modifications were initially more studied in FASD through the late 1990’s and
early 2000s. At this time this thesis was undertaken in 2011, there had been only three
studies of DNA methylation in FASD models. The first was the aforementioned study by
Garro et al. (1991) which found global DNA hypomethylation in mouse fetuses following
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acute exposure to a high dose of ethanol from GD 9-11. Haycock and Ramsay (2009)
assessed the H19 imprinted domain using bisulfite sequencing of mouse embryos
exposed to ethanol during preimplantation (GD 1.5-2.5). When assessed at GD 10.5, the
authors found no DNA methylation changes in the embryos (Haycock and Ramsay,
2009). There was a reduction in methylation at the paternal alleles in ethanol-exposed
placentae. The third study was the most comprehensive, and has driven much of the
interest in the role of DNA methylation in FASD. Using whole-embryo culture, Liu et al.
(2009) investigated the effects of ethanol exposure on DNA methylation and gene
expression during neurulation. Using MeDIP-chip, the authors compared DNA
methylation in embryos that developed or did not develop neural tube deficits in response
to ethanol exposure. There was a 10-fold increase in the number of genes with increased
methylation on chromosomes 7, 10, and X (Liu et al., 2009). DNA methylation changes
were enriched in imprinted genes and olfactory genes, with notable examples of
developmental and chromatin-regulating genes (Liu et al., 2009). There were 84 genes
differentially expressed and differentially methylated. The results from these studies
provide evidence that ethanol may exert its neurotoxic effects at least in part through
epigenetic changes in gene expression.
Since the initiation of this thesis, there have been numerous other studies
investigating DNA methylation following various exposure paradigms in various tissues.
Rat pups exposed to ethanol from PND 2-10 showed global hypomethylation in the
hippocampus and prefrontal cortex (Otero et al., 2012). In another study, the promoter of
Pomc (a gene involved in neuronal control of stress and metabolism) showed reduced
methylation at PND 60 following GD 7-21 ethanol exposure. Pomc expression was also
reduced (Govorko et al., 2012). Interestingly, this effect was passed to the F2 and F3
male offspring of ethanol exposed mice. This study provided the first evidence that
ethanol-induced epigenetic changes could be passed transgenerationally. In another
study, mice exposed to ethanol from GD 7-16 showed altered 5mC and 5hmC levels in
hippocampus at PND 7 which were correlated with delayed hippocampal development
(Chen et al., 2013). Other studies have attempted to understand the mechanisms of
ethanol-induced DNA methylation changes. Blockage of the apoptosis-inducing factor
Caspase 3 prevented ethanol-induced reduction in DNMT1 and DNMT3A proteins and
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DNA methylation in the hippocampus. This suggests that DNA methylation changes
occur downstream of apoptosis in response to ethanol.
Our laboratory has also assessed DNA methylation in other models of FASD.
Using the CPD model, we found that adult mice show genome-wide changes in DNA
methylation in the whole-brain. These changes were enriched at imprinted genes and
genes regulated by CTCF (Laufer et al., 2013). When these data were compared to
human children with FAS, we found that both the mouse brain and human buccal cells
had enrichment of DNA methylation changes at protocadherins, glutamatergic synapses,
and hippo signaling genes (Laufer et al., 2015). Another group also found decreased
methylation at protocadherins genes in children with FASD, suggesting this may serve as
a biomarker for FASD (Portales-Casamar et al., 2016).

3.2.6

DNA Methylation Study Design
Previous studies have not assessed genome-wide DNA methylation changes in

adult mice exposed to ethanol during development. Studies have focused on the
hippocampus, but most have examined short-term responses to ethanol exposure (Chen et
al., 2013; Liu et al., 2009; Otero et al., 2012). The effects of DNA methylation in the
adult brain have only been assessed by one other group, which only investigated a single
gene (Govorko et al., 2012). Given that FASD is associated with lifelong changes in
behaviour (Among and Women, 2010) our laboratory has focused on studying molecular
changes in the young adult brain. In terms of tissue of interest, our laboratory and others
have focused on the hippocampus. As reviewed in Chapter 1, the hippocampus is highly
vulnerable to ethanol-induced neurotoxicity (Gil-Mohapel et al., 2010), and is the brain
region associated with spatial learning and memory which are disrupted in FASD
(Among and Women, 2010). DNA methylation also plays a dynamic role in learning in
the hippocampus. For these reasons, the experiments of this thesis were designed to
assess DNA methylation in the hippocampus of adult mice exposed to ethanol during
PND4-7. Given the nature of the experimental question, MeDIP-chip was selected with
confirmations by a completely different technology, bisulfite pyrosequencing. MeDIP
was coupled to a promoter microarray to restrict analysis to only regions relevant to gene
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expression, and reduce costs. Given the crosstalk between DNA methylation and histone
modifications, the genes and pathways affected by both were also considered.

Objectives
1. To assess all mouse genes and their promoters in PND 70 mouse hippocampus
exposed to ethanol on postnatal days 4 & 7 and identify changes in DNA
methylation.
2. To identify genes proximal to changes in DNA methylation, and pathways
affected.
3. To confirm specific changes with ChIP-qPCR.
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Materials and Methods
3.3.1

Mouse Care
For full mouse care protocol, see Chapter 2, section 2.3.1. In brief, all protocols

were approved by the Animal Use Subcommittee (AUS) at the University of Western
Ontario, London, Ontario, Canada. The day of birth was termed post-natal day (PND)
zero. Sex and weight-matched littermate pups were divided into two groups: ethanoltreated and saline control mice. Pups were given two subcutaneous dorsal injections on
both PND 4 and PND 7. Ethanol-treated mice were injected with 2.5 g/kg of ethanol in
0.15 M NaCl (Ikonomidou et al., 2000). Control mice were injected with 0.15 M saline
only. Male mice were used for all subsequent analyses (n=18). Mice were sacrificed on
PD 70 via carbon dioxide asphyxiation. The hippocampus was dissected out (Spijker,
2011), snap-frozen in liquid nitrogen, and stored at -80°C for no longer than 30 days until
formaldehyde fixation. The mice used in this chapter were the same used for the RNA
analysis in Chapter 2 (Table 2.1) The experimental design of this Chapter differs, in that
three individual mice were used for three separate microarrays per treatment group, i.e.
three biological replicates were not pooled together as in Chapter 2. The biological
sample used for each microarray in this section was used on one of the microarrays from
Chapter 2 (Table 2.1).

3.3.2

MeDIP-Chip

3.3.2.1

Genomic DNA Fragmentation

Genomic DNA (gDNA) was quantified and quality assessed by NanoDrop ND1000. Genomic DNA of each sample was sonicated to ~200 – 1000 bp with a Bioruptor
sonicator (Diagenode) on “Low” mode for 10 cycles of 30 seconds “ON” & 30 seconds
“OFF”. The gDNA and each sheared DNA were analyzed with agarose gel
electrophoresis.

3.3.2.2

Methyl-Cytosine Immunoprecipitation

1 μg of sonicated genomic DNA was used for immunoprecipitation using a mouse
monoclonal anti-5-mC antibody (Diagenode). For this, DNA was heat-denatured at 94°C
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for 10 min, rapidly cooled on ice, and immunoprecipitated with 1 μL primary antibody
overnight at 4°C with rocking agitation in 400 μL immunoprecipitation buffer (0.5%
BSA in PBS). To recover the immunoprecipitated DNA fragments, 200 μL of anti-mouse
IgG magnetic beads was added and incubated for an additional 2 hours at 4°C with
agitation. After immunoprecipitation, five immunoprecipitation washes were performed
with ice-cold immunoprecipitation buffer. Washed beads were resuspended in TE buffer
with 0.25% SDS and 0.25 mg/mL proteinase K for 2 hours at 65°C and then allowed to
cool down to room temperature. MeDIP DNA were purified using Qiagen MinElute
columns (Qiagen).

3.3.2.3

Whole Genome Amplification (WGA)

The MeDIP-enriched DNA was amplified using a WGA kit from Sigma-Aldrich
(GenomePlex® Complete Whole Genome Amplification (WGA2) kit) following the
manufacturer’s protocol. The amplified DNA samples were then purified with QIAquick
PCR purification kit (Qiagen) following the manufacture’s protocol.

3.3.2.4

Real-time PCR Assessment of Fold-Enrichment

The purpose of the qPCR experiment is to verify that the MeDIP DNA has been
enriched for methylated fragments and depleted for unmethylated fragments (Butcher and
Beck, 2010). This experiment was performed by ArrayStar Inc. The primers for
specifically methylated regions (the positive control, Tsh2b promoter) and unmethylated
regions (the negative control, Gapdh promoter) were used to assess the enrichment level
of these two regions in both input (sonicated DNA) and MeDIP-enriched DNA (Butcher
and Beck, 2010). All six samples showed expected enrichment. An enrichment value for
two samples could not be calculated due to complete lack of amplification in the IgG
negative control. All samples can be considered quantitatively above the background
signal (noise) for both. The PCR primer sequences were: Tsh2b 101 bp
F:5’CTCTCCTTGCGGCATCTCT3’ R:5’GCGGTAAAGGGTGCTACTATT3’. Gapdh
161 bp F:5’GCCCTTGAGCTAGGACTGGATAA3’
R:5’CCTGGCACTGCACAAGAAGATG3’.
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3.3.2.5

DNA Labelling and Array Hybridization

The purified DNA was quantified using a NanoDrop ND-1000. For DNA
labelling, the NimbleGen Dual-Color DNA Labeling Kit was used according to the
manufacturer’s guideline detailed in the NimbleGen MeDIP-chip protocol (NimbleGen
Systems, Inc., Madison, WI, USA). 1 μg DNA of each sample was incubated for 10 min
at 98°C with 1 OD of Cy5-9mer primer (IP sample) or Cy3-9mer primer (Input sample).
Then, 100 pmol of deoxynucleoside triphosphates and 100U of the Klenow fragment
(New England Biolabs, USA) were added and the mix incubated at 37°C for 2 hours. The
reaction was stopped by adding 0.1 volume of 0.5 M EDTA, and the labeled DNA was
purified by isopropanol / ethanol precipitation. Microarrays were hybridized at 42°C
during 16 to 20h with Cy3/5 labelled DNA in NimbleGen hybridization buffer/
hybridization component A in a hybridization chamber (Hybridization System NimbleGen Systems, Inc., Madison, WI, USA). Following hybridization, washing was
performed using the NimbleGen Wash Buffer kit (NimbleGen Systems, Inc., Madison,
WI, USA). For array hybridization, Roche NimbleGen's MM9 Meth 2.1M CpG plus
Promoter array was used.

3.3.2.6

Data Extraction and Normalization

Raw data were extracted as pair files by NimbleScan software. ArrayStar
performed Median-centering, quantile normalization, and linear smoothing by
Bioconductor packages Ringo, limma, and MEDME. After normalization, a normalized
log2-ratio data (*_ratio.gff file) was created for each sample. From the normalized log2ratio data, a sliding-window peak-finding algorithm provided by NimbleScan v2.5
(Roche-NimbleGen) was applied to find the enriched peaks with specified parameters
(sliding window width: 750 bp; mini probes per peak: 2; p-value minimum cut-off: 2;
maximum spacing between nearby probes within peak: 500 bp). Raw and normalized
data files were uploaded to GEO.

3.3.2.7

MEDME Analysis

To accurately quantify CpG methylation levels, MEDME (modeling experimental
data with MeDIP enrichment) was used to improve the evaluation and interpretation of
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MeDIP derived DNA methylation estimates. MEDME relies on generating a fully
methylated gDNA sample for comparison. To generate the fully methylated profiles,
DNA from each sample was pooled and treated with CpG methyltransferase (M.SssI,
NEB) to add methyl-groups to all cytosine residues within CpG di-nucleotides, in order
to obtain fully methylated genomic DNA. Raw data for fully methylated sample and test
samples were median-centered and quantile normalized using Bioconductor packages
Ringo and limma. Then MEDME was performed to calculate probe AMS and RMS. In
the fully methylated DNA MeDIP experimental dataset, the weighted count of
methylated CpG di-nucleotides in the 1 kb window centered at each probe is calculable
by genomic CpG in the window, as every CpG is expected to be methylated.
The MEDME protocol utilizes the absolute methylation score (AMS) as the
indicator of DNA methylation, which is decided by the weighted count of methylated
CpG di-nucleotides in a 1 kb window centered at each probe. The AMS is verified to be a
more accurate and sensitive indicator of DNA methylation than log-Ratio. The MEDME
method also provides a relative methylation score (RMS) that normalizes AMS with
respect to the total number of CpGs represented by CpGw. Differentially methylated
probes between ethanol-exposed and control groups were identified using AMS by Paired
Samples t-Test. And probes with p-value<0.05 and ABS (AMS_dif)>8 were selected and
used to find AMS DMRs. The RMS is more useful when comparing regions with
different CpG densities. Since this study is only comparing the same region across
samples, AMS was used in characterization and analysis. After probe AMS and RMS
were obtained from analyzing the MeDIP-chip data by MEDME, a further analysis of
identification of DMRs (differentially methylated regions) was performed to identify
significantly differentially methylated regions. An FDR q-value < 0.05 was used to
determine multiple testing error; no DMRs survived this threshold.

3.3.2.8

Sodium Bisulfite Pyrosequencing

The same DNA samples used for MeDIP-chip were used for sodium bisulfite
pyrosequencing (n=3 control and n=3 ethanol). EpigenDx Inc. performed pyrosequencing on the PSQ96 HS System (Qiagen) following the manufacturer’s instructions,
using custom assays and a gradient of controls with known methylation levels. This
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allowed for the quantiﬁcation of the absolute percent methylation (Lim et al., 2014) of
each CpG at specific loci using QCpG software (Qiagen). The absolute percent
methylation at each assayed cytosine was averaged among ethanol-exposed (n=3) and
control (n=3) samples and compared using a Paired Samples t-Test. The custom primers
assayed CpGs at the following positions (mm10): Acaa1: chr9:119342321,
chr9:119342332, chr9:119342352, chr9:119342366, chr9:119342378, chr9:119342386;
Pxmp1: 110285970, chr5110285964, chr5110285959, chr5110285948, chr5110285944,
chr5110285940, chr5110285908, chr5110285878; Pex6: chr17:46706646,
chr17:46706654, chr17:46706661, chr17:46706672, chr17:46706678, chr17:46706691,
chr17:46706698, chr17:46706715; Mafg: chr11:120625270, chr11:120625264,
chr11:120625261, chr11:120625225, chr11:120625205, chr11:120625131; Tcf7l2:
chr19:55745017, chr19:55745023.

3.3.3

8-OHdG ELISA
To assess oxidative damage to hippocampal DNA in PND 70 mice, 8-hydroxy-2' -

deoxyguanosine (8-OHdG) levels were assessed. The Colorometric EpiQuik 8-OHdG
DNA Damage Quantification Direct Kit (Epigentek) was used according to the
manufacturer’s protocol. The same DNA samples from the six ethanol-exposed and six
control mice used for MeDIP-chip were used (Chapter 2, Table 2.1). Florescence levels
were quantified by the Epoch 2 Microplate Spectrophotometer (BioTek). A standard
curve was generated from provided 8-OHdG standards. Individual 8-OHdG values for
each sample were calculated using Equation 1. Once 8-OHdG (ng) was calculated,
technical replicates for each sample (3) were averaged, then compared to input DNA
levels to obtain the percentage of 8-OHdG for each sample.

8 − 𝑂𝐻𝑑𝐺 (𝑛𝑔) =
Equation 1. Quantity of 8-OHdG.

𝑆𝑎𝑚𝑝𝑙𝑒 𝑂𝐷 − 𝑁𝐶 𝑂𝐷
𝑠𝑙𝑜𝑝𝑒
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OD refers to optical density determined by the instrument, NC refers to negative control,
slope refers to the slope of the line obtained by plotting OD vs. 8-OHdG concentration
for each standard.
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Results
3.4.1

Distribution of Differentially Methylated Regions
MeDIP-chip identified thousands of differentially methylated regions (DMRs)

across the mouse genome in response to ethanol exposure. DMRs are genomic regions
containing several differentially methylated cytosines. Two algorithms were used to
generate DMRs, absolute methylation score (AMS) and relative methylation score
(RMS). AMS is derived by the weighted count of methylated CpG di-nucleotides in a 1
kb window centered at each probe. RMS is simply the AMS score that normalized with
respect to the total number of CpGs in the region. Each algorithm produced different
DMRs, though there was overlap (Table 3.1). The AMS produced mostly DMRs with
increased methylation in response to ethanol, the RMS DMRs were nearly equally
increases and decreases. These trends in direction of methylation change remained
constant as the significance level of the AMS was increased (Figure 3.1; Figure 3.2).
There were more AMS DMRs than RMS DMRs. AMS identified changes in CpG
islands, while RMS did not, likely due the high CpG density of the regions. RMS is
intended to compare the relative methylation of different regions within the same sample.
Since this experiment only compared the same genomic regions between different
samples, AMS score alone was used for the remainder of the analysis.
The AMS DMRs were distributed relatively evenly across the genome (Figure
3.3). Chromosomes 7 and 11 had the most DMRs, while 18 and 19 and Y had the fewest,
with none on the Y chromosome. All chromosomes showed a similar distribution of
increased and decreased AMS scores: each had more increases than decreases indicating
hypermethylation (Figure 3.3). Since the experiment employed a promoter microarray,
chromosomes with more genes were interrogated more often. The DMRs per
chromosome were therefore corrected based on gene density (Figure 3.4). Despite being
relatively gene dense, chromosome 11 had the highest number of DMRs per gene.
Chromosome 6 had the lowest DMRs per gene, but the distribution was relatively even
across chromosomes. Indeed, a linear regression of number of genes vs. number of
DMRs found an R2 value of 0.86 indicating a strong correlation (Appendix C). Thus,
most of the variation in DMRs across chromosomes is attributed the number of genes on
the chromosome.

95

Table 3.1 Characteristics of differentially methylated regions (DMRs) identified by
methylated DNA immunoprecipitation microarray (MeDIP-chip)†.

Location
Promoter

p-value cut
off
p<0.05

Promoter
Promoter

Number of DMRs (%
increased methylation)
AMS
RMS
7738 (55%)

p<0.01

10599
(82.2%)
4640 (82.3%)

p<0.001

733 (83.3%)

435 (47%)

2766 (52%)

Number of Identical
DMRs
3773 (43.6%↑↑,
8.4%↓↓, 47.8% differ)
582 (48.6%↑↑,
10.1%↓↓, 46.4 differ)
18 (27.7%↑↑, 5.6%↓↓,
66.7% differ)
N/A
N/A
N/A
3 (66.6%↑↑, 33.3%↓↓)

CpG island
p<0.05
1112 (91.7%) 0
CpG island
p<0.01
549 (93.2%)
0
CpG island
p<0.001
100 (92%)
0
miRNA
p<0.05
292 (66.1%)
238 (47.9%)
promoter
miRNA
p<0.01
126 (65.1%)
63 (52.3%)
0
promoter
miRNA
p<0.001
16 (87.5%)
3 (66.6%)
0
promoter
†
Lists of DMRs for each genomic location (as identified by Array-star analysis) were
generated for three p-values. The number of DMRs in these lists for both absolute

methylation score (AMS) and relative methylation score (RMS) algorithms are shown.
The number of identical DMRs, i.e. those having are the same start and end points, is
shown. The agreement of the direction of methylation change (up “↑” or down “↓”) for
the identical DMRs is shown.
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Figure 3.1 Differentially methylated regions (DMRs) identified by absolute
methylation score (AMS) at increasing stringency levels.
Track A shows genomic locations of DMRs with AMS p-value<0.05; Track B shows
genomic locations of DMRs with AMS p-value<0.01; Track C shows genomic locations
of DMRs with AMS p-value<0.001. Colours denote the direction and magnitude of the
AMS score of each DMR.
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Figure 3.2 Differentially methylated regions (DMRs) identified by relative
methylation score (RMS) at increasing stringency levels.
Track A shows genomic locations of DMRs with RMS p-value<0.05; Track B shows
genomic locations of DMRs with RMS p-value<0.01; Track C shows genomic locations
of DMRs with RMS p-value<0.001. Colours denote the direction and magnitude of the
RMS score of each DMR.

98

Figure 3.3 Distribution of differentially methylated regions (DMRs) across
chromosomes.
Bars show the number of DMRs present on each chromosome at an AMS p<0.001. Black
denotes positive AMS score, indicating increased methylation, while white denotes
negative AMS score indicating reduced methylation.
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Figure 3.4 Distribution of differentially methylated regions (DMRs) across
chromosomes corrected for gene density.
The number of DMRs on each chromosome was divided by the total number of genes
(from build mm10) on each chromosome.
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3.4.2

Ontology of Genes Proximal to DNA Methylation Changes
To identify genetic systems affected by DNA methylation changes in the PND 4,7

FASD model, gene ontology (GO) analysis was performed. A list of 689 genes in
proximity to the 733 DMRs (AMS p<0.001) was generated for gene ontology and
pathway analysis. The DMR was required to lay within 5000 bp upstream of the
transcriptional start site of the gene, or the gene body. Genes were also implicated if a
DMR occurred in a CpG island known to correlate with expression of the gene. These
genes were submitted to gene ontology software. The top two affected biological
processes were related to myeloid cell differentiation (Table 3.2). Several other processes
were related to cell growth and development. Three of the top ten biological processes
were related to hormone response (Table 3.2). Also notable were “Negative regulation of
lipid biosynthetic process” and “Regulation of neuron projection development”. The top
ten cellular components were all related to cellular structure or membrane components
(Table 3.2). The top affected component was “Basement membrane” with various other
membranes and components implicated (Table 3.2). The top three affected molecular
functions were hormone, estrogen, and growth factor binding (Table 3.2). Other
receptors were implicated including neuropeptide, nuclear hormone, and tumor necrosis
factor, and notch binding.

3.4.3

Pathways Affected by DNA Methylation Changes
The list of 689 genes proximal to DMRs was also submitted to three separate

pathway suites: Ingenuity Pathway Analysis (IPA), Partek Pathway, and Enrichr (Table
3.3). The top IPA pathway was “Cellular Movement, Cell Death and Survival, Cellular
Development” (Figure 3.5). In total five pathways were identified by IPA, each related to
cell growth and development, or cell death (Table 3.3). Partek pathway identified five
pathways, the top being “Hematopoietic cell lineage”. Enrichr identified two pathways,
which were the same as two identified by Partek pathway: “Peroxisome” and
“Lysosome”. Due to “Peroxisome” being identified by both software suites, and
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Table 3.2 Gene ontology (GO) analysis of genes with differentially methylated
regions (DMRs) in their promoter†.
GO term
GO biological processes
Myeloid leukocyte differentiation (GO:0002573)
Myeloid cell differentiation (GO:0030099)
Cellular response to thyroid hormone stimulus (GO:0097067)
Positive regulation of cell fate commitment (GO:0010455)
Negative regulation of lipid biosynthetic process (GO:0051055)
Granulocyte differentiation (GO:0030851)
Response to thyroid hormone (GO:0097066)
Positive regulation of developmental growth (GO:0048639)
Cellular response to hormone stimulus (GO:0032870)
Regulation of neuron projection development (GO:0010975)
GO cellular component
Basement membrane (GO:0005604)
Extracellular matrix part (GO:0044420)
Anchored component of membrane (GO:0031225)
Extrinsic component of cytoplasmic side of plasma membrane
(GO:0031234)
Extracellular matrix (GO:0031012)
Ruffle (GO:0001726)
Cortical cytoskeleton (GO:0030863)
Extrinsic component of plasma membrane (GO:0019897)
Cell surface (GO:0009986)
Exosome (RNase complex) (GO:0000178)
GO molecular function
Hormone receptor binding (GO:0051427)
Estrogen receptor binding (GO:0030331)
Growth factor activity (GO:0008083)
Glycosaminoglycan binding (GO:0005539)
S100 protein binding (GO:0044548)
Neuropeptide receptor binding (GO:0071855)
Sequence-specific DNA binding RNA polymerase II transcription factor
activity (GO:0000981)
Nuclear hormone receptor binding (GO:0035257)
Tumor necrosis factor receptor superfamily binding (GO:0032813)
Notch binding (GO:0005112)
†Top 10 GO processes are shown where number of entries exceeds 10.

p-value
0.0004
0.0004
0.0008
0.0013
0.0017
0.0020
0.0020
0.0022
0.0026
0.0027
0.0002
0.0008
0.0027
0.011
0.011
0.021
0.022
0.025
0.027
0.028
0.0020
0.0027
0.0060
0.0076
0.0074
0.011
0.013
0.013
0.013
0.015
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Table 3.3 Pathways significantly enriched with differentially methylated genes†.
Network name
p-value
IPA
Cellular Movement, Cell Death and Survival, Cellular Development
10E-130
Cell Cycle, Cellular Development, Cellular Growth and Proliferation
10E-50
Inflammatory Response, Cellular Movement, Immune Cell Trafficking
10E-50
Organismal Development, Tissue Development, Embryonic Development
10E-43
Cell Death and Survival, Cellular Development, Cellular Growth and
10E-35
Proliferation
Partek pathway
Hematopoietic cell lineage
0.0003
Peroxisome
0.0006
Jak-STAT signaling pathway
0.0006
Lysosome
0.003
Taurine and hypotaurine metabolism
0.009
Enrichr KEGG
Peroxisome
0.024
Lysosome
0.026
†p-values for each entry are shown (Fisher’s exact test). For list of genes in each pathway,
see Appendix G.
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Figure 3.5 Top affected IPA pathway for genes proximal to a differentially
methylated region (DMR).
Pathway is titled “Cellular Movement, Cell Death and Survival, Cellular Development”
(IPA score 130). Red indicates proteins which have increased DNA methylation proximal
to their encoding gene, green indicates decreased methylation. For full legend of symbols
used, see Appendix B.
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identified in the histone analysis, the Partek Peroxisome pathway was selected for further
analysis (Figure 3.6).

3.4.4

Combined DNA & Histone Methylation Analysis
To examine genes proximal to ether DNA methylation or histone modification

changes, a combined gene list of genes with either a DMR or an RDHM in their
promoter/gene body was created. There was minimal overlap between lists, and no single
gene contained a DMR, H3K4me3 RDHM, and H3K27me3 RDHM (Figure 3.7). The
direction of each change in ethanol-exposed mice was standardised between the marks by
listing genes with changes predicted to increase gene expression as +1 (i.e. loss of DNA
methylation, loss of H3K27me3, gain of H3K4me3) and changes predicted to decrease
gene expression as -1 (i.e. gain of DNA methylation, gain of H3K27me3, loss of
H3K4me3). Conflicting gains/losses were scored as 0 (22 genes total). The DMR/RDHM
p-value cut off was kept at p<0.001. The list comprised 1589 genes.

3.4.5

Combined Gene Ontology and Pathway Analyses
The combined list was submitted to GO and pathway analysis software. GO

analysis of the combined list identified some, but not all of the same processes as the
DNA methylation or histone modification lists alone. The top affected biological
processes were both cell-cell adhesion related (Table 3.4), which was also true for the
H3K4me3, H3K27me3, and shared histone methylation GO analyses (Chapter 2). The
next to top processes were “Regulation of neuron differentiation”—which was not
implicated in any of the individual GO analyses—and “Regulation of neuron projection
development”—which was only implicated in the DNA methylation GO analysis (Table
3.4; Table 3.2; Chapter 2). Also of note was “Nervous system development” which was
also implicated in H3K4me3 GO analysis (Table 3.4; Chapter 2). “Myeloid cell
differentiation” was also implicated; this was the top hit for the DNA methylation GO
analysis but was not implicated in the histone analyses (Table 3.4; Table 3.2). “CD4positive, alpha-beta T cell activation” was implicated, but was not in any of the individual
lists (Table 3.4).
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Figure 3.6 Top Partek pathway for genes proximal to differentially methylated
regions (DMRs).
Pathway is titled “Peroxisome biogenesis”. Proteins whose encoding genes are proximal
to an increase in methylation are shown in red, decreases are shown in green.
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Figure 3.7 Combined gene list characterization, genes proximal to either a DNA
methylation (5mC), H3K4me3, or H3K27me3 change.
The number of genes proximal to each methylation change are shown in each circle.
Genes proximal to multiple changes, regardless of the direction of those changes, are
shown in overlapping regions.
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Table 3.4 Gene ontology (GO) analysis of genes proximal to a differential
methylated region (DMR) or region of differential histone modification (RDHM)†.
GO term
GO biological processes
Cell-cell adhesion via plasma-membrane molecules (GO:0098742)
Cell-cell adhesion (GO:0098609)
Regulation of neuron differentiation (GO:0045664)
Regulation of neuron projection development (GO:0010975)
Myeloid cell differentiation (GO:0030099)
Regulation of cell projection organization (GO:0031344)
Erythrocyte differentiation (GO:0030218)
Nervous system development (GO:0007399)
CD4-positive, alpha-beta T cell activation (GO:0035710)
Mammary gland development (GO:0030879)
GO cellular component
Basement membrane (GO:0005604)
Extracellular matrix part (GO:0044420)
Transcription factor complex (GO:0005667)
Synapse (GO:0045202)
Extracellular matrix (GO:0031012)
Ionotropic glutamate receptor complex (GO:0008328)
Axon (GO:0030424)
STAGA complex (GO:0030914)
Synaptic membrane (GO:0097060)
Ruffle (GO:0001726)
GO molecular functions
Calcium ion binding (GO:0005509)
Estrogen receptor binding (GO:0030331)
Calmodulin binding (GO:0005516)
Growth factor activity (GO:0008083)
Integrin binding (GO:0005178)
Protein tyrosine kinase activity (GO:0004713)
S100 protein binding (GO:0044548)
Extracellular matrix structural constituent (GO:0005201)
Hormone receptor binding (GO:0051427)
Gamma-catenin binding (GO:0045295)
†Top 10 GO processes are shown for each.

p-value
5.26E-06
5.81E-06
5.63E-05
0.00012
0.00034
0.00047
0.00050
0.00051
0.00062
0.0011
0.0019
0.0026
0.0033
0.005
0.0092
0.011
0.012
0.02
0.021
0.027
0.00061
0.0021
0.0047
0.0058
0.01
0.011
0.015
0.015
0.016
0.019
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In general, the GO cellular components implicated a mix of structural components
and neuronal/synaptic components (Table 3.4). The top two components were “Basement
membrane” and “Extracellular matrix part”, which was also true for the DNA
methylation GO analysis (Table 3.4;Table 3.2). “Transcription factor complex”, “Axon”,
and synaptic components were implicated and were also present in the H3K4me3
analysis (Table 3.4; Chapter 2). “Ionotropic glutamate receptor complex” was implicated
and was also present in the H3K4me3 and shared lists (Table 3.4; Chapter 2). “STAGA
complex” was implicated, but was not in any of the individual analyses (Table 3.4). The
top molecular function was “Calcium ion binding” which was also true for all three
histone lists (Table 3.4; Chapter 2). “Estrogen receptor binding” as well as several other
receptor binding functions were implicated and also present in the DNA analysis (Table
3.4; Table 3.2). The third to top function was “Calmodulin binding” and the fifth was
“Integrin binding” neither of which were implicated in any of the other lists (Table 3.4).
The combined list was submitted to three pathway analysis software suites (Table
3.5). IPA implicated 22 total pathways; the top pathway was “Embryonic Development,
Organismal Development, Cellular Development” (Figure 3.8). This pathway was not
identified in any of the individual analyses. Four of the top six pathways were related to
hematological/cardiovascular development and function (Table 3.5). Six pathways
involved cell-to-cell signaling and interaction. Cell-to-cell signalling pathways were
implicated in the histone analyses (Chapter 2). Four pathways involved cell death and
survival; this term was also implicated in the DNA methylation analysis (Table 3.2;
Table 3.4). Four pathways involved nervous system development, which was also
identified in the H3K4me3 analysis. Three pathways involving lipid metabolism were
implicated. Three lipid metabolism pathways were also implicated in the H3K4me3
analysis (Chapter 2). Partek pathway identified four pathways enriched for genes in the
combined DNA methylation and histone modification list (Table 3.4). The top affected
pathway was “Peroxisome biogenesis” (Figure 3.9). The same pathway was implicated
in the DNA methylation analysis using Partek as well as the DNA methylation KEGG
analysis (Table 3.3). The KEGG analysis of the combined list did identify “Peroxisome”
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Table 3.5 Pathways significantly enriched with genes proximal to DNA methylation
or histone methylation changes†.
Pathway name
IPA
Embryonic Development, Organismal Development, Cellular Development
Cardiac Hypertrophy, Cardiovascular Disease, Developmental Disorder
Humoral Immune Response, Protein Synthesis, Hematological System
Development and Function
Cellular Development, Cellular Growth and Proliferation, Hematological
System Development and Function
Skeletal and Muscular Disorders, Developmental Disorder, Hereditary
Disorder
Hematological System Development and Function, Tissue Morphology,
Cell-To-Cell Signaling and Interaction
Endocrine System Development and Function, Molecular Transport, Protein
Synthesis
Cell Death and Survival, Antimicrobial Response, Inflammatory Response
Cell-To-Cell Signaling and Interaction, Hematological System Development
and Function, Immune Cell Trafficking
Embryonic Development, Organismal Development, Cell-To-Cell Signaling
and Interaction
Cell-To-Cell Signaling and Interaction, Reproductive System Development
and Function, Tissue Development
Cell Death and Survival, Lipid Metabolism, Small Molecule Biochemistry
Cell Cycle, DNA Replication, Recombination, and Repair, Cellular
Development
Embryonic Development, Organismal Development, Cell Morphology
Cell Death and Survival, Cancer, Cellular Development
Cell-To-Cell Signaling and Interaction, Nervous System Development and
Function, Behavior
Lipid Metabolism, Small Molecule Biochemistry, Molecular Transport
Cell Morphology, Cell Death and Survival, Nervous System Development
and Function
Cell-To-Cell Signaling and Interaction, Nervous System Development and
Function, Cellular Development
Lipid Metabolism, Small Molecule Biochemistry, Vitamin and Mineral
Metabolism
Tissue Morphology, Embryonic Development, Organismal Development
Nervous System Development and Function, Cellular Development, Tissue
Morphology
Partek Pathway
Peroxisome
Hematopoietic cell lineage
Notch signalling pathway

p-value
10E-64
10E-56
10E-49
10E-41
10E-30
10E-26
10E-24
10E-23
10E-21
10E-20
10E-20
10E-20
10E-19
10E-19
10E-19
10E-18
10E-18
10E-16
10E-16
10E-15
10E-15
10E-14

0.008
0.01
0.032
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ABC transporters
0.036
Enrichr KEGG
Notch signaling pathway
0.040
Bladder cancer
0.048
†
p-values for each entry are shown (Fishers exact test). For a list of genes in each
pathway, see Appendix H.
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Figure 3.8 Top affected Ingenuity Pathway Analysis (IPA) pathway for genes
proximal to either a DNA methylation or histone methylation change.
Pathway is titled “Embryonic Development, Organismal Development, Cellular
Development” (IPA score 64). Red indicates proteins whose encoding genes are proximal
to a DMR or RDHM which is associated with increased gene expression, green indicates
those predicted to decrease gene expression. For full legend of symbols used, see
Appendix B.
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Figure 3.9 Top Partek pathway for genes proximal to either a DNA methylation or
histone methylation change.
Pathway is titled “Peroxisome biogenesis”. Red indicates proteins whose encoding genes
are proximal to a DMR or RDHM which is associated with increased gene expression,
green indicates those predicted to decrease gene expression.
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as well, however; it a p-value of 0.070, and as this did no meet the cut-off it was not
shown. “Notch signalling pathway” was also implicated in both the Partek and KEGG
analyses of the combined list (Table 3.5). “Hematopoietic cell lineage” was the second
Partek pathway, which was also identified in the DNA methylation analysis (Table 3.3;
Table 3.5). Given the implication of peroxisomes in both analyses, oxidative damage to
hippocampal DNA was assessed. No difference in the DNA oxidative damage marker 8hydroxy-2' -deoxyguanosine (8-OHdG) was found (Figure 3.10).

3.4.5.1

DNA Methylation Confirmations

To confirm differential methylation of cytosines in the identified DMRs, sodium
bisulfite pyrosequencing was performed. Five DMRs were selected for confirmation
(Table 3.6). Two genes were selected which also showed differential expression on the
microarray: Tcf7l2 and Mafg. Three genes were selected from the “Peroxisome
biogenesis” Partek pathway: Acaa1, Pex6, and Pxmp2. Primers were designed to target as
many CpG cytosines in each DMR as possible (Table 3.6). There were three DMRs
proximal to Mafg, the DMR selected for analysis was upstream of the TSS and had a
reciprocal change in methylation relative to gene expression. One cytosine was confirmed
to have a decrease in methylation in the region proximal to Acaa1 (Figure 3.11). This
cytosine was located just outside of the DMR in intron 2 (Figure 3.12). There was also a
nominally significant change in the Pex6 DMR (Figure 3.11).
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1.4
1.2

8-OHdG (% total DNA)

1
0.8

0.6
0.4
0.2
0

Control

Ethanol

Figure 3.10 Quantification of oxidative damage to DNA in ethanol-exposed vs.
control mice.
Absolute 8-OHdG levels for each sample were normalized to input DNA amount to
obtain the 8-OHdG percentage in total DNA. Data are mean ± standard error. p=0.16
(Paired Samples t-Test)
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Table 3.6 Percentage methylation of CpG cytosines in gene of interest differentially
methylated regions (DMRs) as assessed by bisulfite pyrosequencing†.
Gene

Mafg

Acaa1

Pex6

Pxmp2

Tcf7l2
†

Location

From
TSS
(bp)

Mixing
control
R2

chr11:120625270

8331

0.90

Ethanol
methylation
(%)
5.55

Ethanol
SEM

Control
SEM

T-test
p-value

0.37

Control
methylation
(%)
6.12

0.69

0.44

chr11:120625261

8340

0.95

13.77

0.16

13.68

0.98

0.45

chr11:120625225

8376

0.95

3.46

0.52

4.23

0.35

0.37

chr11:120625205

8396

0.93

3.27

0.28

4.30

0.36

0.44

chr11:120625131

8470

0.95

2.30

0.09

1.41

0.72

0.13

chr9:119342321

1028

0.99

72.18

0.58

71.94

1.75

0.26

chr9:119342332

1039

0.99

68.07

1.59

68.32

1.74

0.29

chr9:119342352

1059

1.00

61.70

1.35

64.89

1.25

0.49

chr9:119342366

1073

1.00

74.24

1.10

75.49

1.10

0.10

chr9:119342378

1085

0.98

63.52

0.60

64.54

1.58

0.04

chr17:46706646

-4817

0.97

94.02

1.52

93.72

0.72

0.22

chr17:46706661

-4802

0.99

93.74

0.31

95.33

0.90

0.06

chr17:46706678

-4785

0.96

87.63

0.45

87.28

1.71

0.12

chr17:46706715

-4748

0.98

98.52

0.93

98.97

0.68

0.17

chr5:110285970

217

0.97

0.00

0.00

1.37

1.37

0.21

chr5:110285964

223

0.98

1.71

0.90

4.91

0.42

0.35

chr5:110285959

228

0.97

0.00

0.00

0.00

0.00

N/A

chr5:110285948

239

0.90

2.04

1.02

1.40

1.40

0.22

chr5:110285944

243

0.95

0.00

0.00

0.00

0.00

N/A

chr5:110285940

247

0.97

0.00

0.00

0.00

0.00

N/A

chr5:110285908

279

0.96

0.00

0.00

0.00

0.00

N/A

chr5:110285878

309

0.96

0.00

0.00

0.00

0.00

N/A

chr19:55745017

3208

0.92

46.89

1.26

50.40

0.94

0.40

chr19:55745023

3214

0.96

38.90

0.54

40.58

1.46

0.17

Genomic location and distance from nearest gene transcriptional start site (TSS) are

shown for each CpG cytosine. Mixing control R2 value is shown for each location. Mean
of n=3 samples and standard error of the mean (SEM) are shown for control and ethanolexposed mice. The p-value for a Paired Samples t-Test comparing these two groups is
shown for each cytosine.
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Acaa1 chr9:119342378

Pex6 Chr17:46706661

64.0

62.0

60.0

Control

Ethanol

Percent cytosine methylation

Percent cytosine methylation

*
66.0

96.0

94.0

92.0

90.0

Control

Ethanol

Figure 3.11 Confirmation of cytosine methylation changes in peroxisome genes.
Percentage cytosine methylation for each was assessed for n=3 samples per group using
pyrosequencing. Data shown are mean ± standard error. *p<0.05.
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Figure 3.12 Location of differentially methylated CpG position in of Acaa1 gene.
Bars denote Acaa1 exons, lines denote introns, grey bars denote untranslated regions, and
black bars denote coding sequence. Yellow bar shows location of DMR from microarray.
Red line shows location of 3.2% decrease in methylation at cytosine in CpG site in
ethanol-exposed mice (Paired Samples t-Test). Not pictured an additional DMR 3.7 kb
upstream, 1.2 kb in size.
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Discussion
There were hundreds of DNA methylation changes identified using MEDIP-chip.
Interestingly, the changes were predominantly increases in methylation. This finding
became more pronounced as the p-value cut-off of the DMR was increased and also
remained true regardless of the region: gene promoters, CpG islands, and miRNA
promoters (Table 3.1). The majority of FASD methylation studies have found global
hypomethylation after ethanol exposure, consistent with ethanol-impaired cellular
methylation processes. The findings presented in this chapter corroborate one of the few
studies of similar design, which found hypermethylation in the hippocampus following
neonatal ethanol exposure in a rat model of FASD (Otero et al., 2012). The effect of
ethanol on the methylome is not simple, with timing, dosage, and tissue/cell type offering
dramatically different results. However, the findings may be reproducible with similar
experimental designs. This hypermethylation may be explained be ethanol-induced
changes in oxidative stress pathways, which also impact methyl donor metabolism
(Wallace and Fan, 2010). It may be that this particular ethanol-exposure regime results in
specific cellular conditions leading to DNA hypermethylation.
The RMS algorithm, which was not used for analysis, indicated nearly equal
increases and decreases in methylation. RMS is simply the AMS normalized to the
number of CpG within the region. It is especially useful from comparing regions with
different CpG densities (Pelizzola et al., 2008). As such, it was not used in this study, in
which only the same regions are compared between treatment groups. The difference
between these two algorithms (i.e. hypermethylation in AMS) is likely due to many
increases in methylation occurring to relatively few CpGs in CpG dense regions. This is
an important consideration of the AMS dataset, as it indicates numerous regions have
increased methylation, but not all CpG cytosines in these regions are methylated.

3.5.1

Differential Methylation of Growth and Lysosomal Genes
Both the GO and pathway analyses of the DNA methylation data implicated

differential methylation at cell growth and development genes. GO analysis implicated
myeloid cell differentiation, as well as cell growth and development. Three of the top ten
biological processes were related to hormone response (Table 3.2). There was also one
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lipid and one neuron-related process. In line with the GO analysis, all five IPA pathways
related to cell growth and development or cell death. Despite these pathways having
similar names, they contain very different genes, with only seven genes occurring in
more than one pathway (Ddx5, Polr2a, Tmem97, Egr2, Numbl, Thpo, and Cdc25c).
Polr2a encodes the largest component of the RNA polymerase II complex. Ddx5 is
involved in mRNA splicing. Egr2, Thpo, and Cdc25c are involved in cell cycle and cell
growth regulation. Numbl is involved in embryonic neurogenesis.
“Peroxisome” and “Lysosome” were implicated by both Partek and KEGG
pathway analysis. Though these are both similar organelles in terms of general structure,
the genes implicating them were completely different (Table 3.3). Lysosomes are
organelles which contain hydrolytic enzymes and are responsible for breaking down
cellular waste. They are also involved in repair, cell signalling, and metabolism
(Settembre et al., 2013). In the developing brain, lysosomal autophagy is believed to be a
response to ethanol-induced neurotoxicity and oxidative stress (Chen et al., 2012).
Interestingly, peroxisomes, which modulate oxidative stress, were also implicated in
pathway analysis. Peroxisomes are discussed in conjunction with the combined
methylation results below. Ap1g2, Lamp2, Ap1s1, Tcirg1, Ctsd, and Ctsb

3.5.2

Combined Gene Ontology and Pathway Analysis
The DNA methylation changes discussed above do not occur in isolation in the

mouse hippocampus. The histone modification changes from Chapter 2 are present in the
same tissue at the same time. Biologically, DNA methylation and histone modification
cooperate and engage in complex cross-talk to regulation the chromatin environment
(Cedar and Bergman, 2009). Therefore, a combined list of the genes proximal to either
DNA methylation DMRs or histone modification RDHMs was created to give a more
complete picture of the impact ethanol. In general, the GO and pathway analyses of the
combined methylation genelist found a mix of the processes implicated by the individual
histone and DNA methylation analyses. There were instances of emergent hits not
present in the top ten processes of any component analysis. These processes indicate a
modest enrichment of these genes in each list, that become more significant when the
lists are considered cumulatively. Identifying hits such as these was the intended purpose
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of analyzing the combined lists. As the individual lists are discussed in their respective
chapters, this section will focus on the emergent processes and pathways.

3.5.2.1

GO Analysis

The penultimate GO biological process was “Regulation of neuron
differentiation” which was not implicated in any of the individual GO analyses. “CD4positive, alpha-beta T cell activation” was also implicated, but not in any of the
individual lists (Table 3.4). Differentially methylation of genes involved in neuron
differentiation has clear relevance to FASD in the brain. The relevance of T cell genes in
the brain is less clear, as T cells are normally prohibited from crossing the blood brain
barrier; however they can cross under numerous pathological conditions (Takeshita and
Ransohoff, 2012). Differential methylation of T-cell genes may also represent a more
general epigenomic response to inflammation, which is a key component of FASD
etiology (Drew et al., 2015).
In general, the cellular components were a mix of structural components
implicated from the DNA methylation gene list and cell-cell communication genes
implicated from the histone lists. An exception was “STAGA complex” which was not in
any of the individual analyses (Table 3.4). The STAGA complex is transcriptional coactivator protein complex responsible for histone acetylation during transcription, DNA
repair, and splicing (Martinez et al., 2001). STAGA genes are crucial for
neurodevelopment and their depletion is associated with numerous neurodegenerative
diseases (Wang and Dent, 2014). The top molecular function was “Calcium ion binding”
which was also true for all three histone lists (Table 3.4; Chapter 2). “Estrogen receptor
binding” as well as several other receptor binding functions were implicated and also
present in the DNA analysis (Table 3.4; Table 3.2). The third to top GO molecular
function was “Calmodulin binding”. Calmodulin is a calcium-binding messenger protein
involved in mediating Ca2+ signaling cascades. Calmodulin is critical for propagating
nerve impulses, and may also be involved in ethanol-induced neurotoxicity (Caillard et
al., 1999; Flentke et al., 2014). Differential methylation of calmodulin binding proteins
may represent an epigenomic response to early ethanol exposure.
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3.5.2.2

Pathway Analysis

IPA implicated 22 total pathways. The top pathway was “Embryonic
Development, Organismal Development, Cellular Development” (Figure 3.6). This
pathway was not identified in any of the individual analyses. A hub of this network is
proinsulin, which is regulated by Tcf7l2, which was differentially expressed (Chapter 4).
Proinsulin is the precursor of the peptide hormone insulin. Deregulation of insulin
signalling and insulin resistance in the CNS are a key feature of FASD (Dembele et al.,
2006a; de la Monte and Wands, 2010). Four of the top six pathways were related to
hematological/cardiovascular development and function (Table 3.3). There were very
few cardiovascular pathways implicated in the histone or DNA methylation analyses.
“Cellular Development, Cellular Growth and Proliferation, Hematological System
Development and Function” was identified in this analysis, and the exact same pathway
was identified in previous work by our laboratory in GD18 fetus (Mantha et al., 2014).
None of the same genes were identified however. Malformations in the heart and
cardiovascular system are a major component of FASD; congenital heart disease is
present in in 67% of individuals with FAS (Burd et al., 2007). Changes in epigenetic
regulation of heart genes may not be functional in the hippocampus, but if they also
occurred in the heart they may be involved with FASD-induced heart defects. The
implication of these pathways may arise from the presence of blood in the brain samples.
In order to flash freeze hippocampal tissue as fast as possible to preserve RNA quality,
the mice in this study were not perfused. This means that blood is still present in the
vasculature of the hippocampus. Thus, some of the blood epigenome is likely represented
in the epigenomic and transcriptomic data.
Only one pathway—“Endocrine System Development and Function, Molecular
Transport, Protein Synthesis Six” —was implicated in the H3K27me3 another analysis
(Chapter 2). Many pathways had similar terms however. There were cell-to-cell
signalling and nervous system development pathways which were also identified in the
H3K4me3 analysis (Chapter 2). Cell death and survival pathways were also prevalent in
the DNA methylation analysis (Table 3.3). Three pathways involving lipid metabolism
were implicated. Three lipid metabolism pathways were also implicated in the H3K4me3
analysis (Chapter 2). Interestingly, the top Partek pathway, “Peroxisome biogenesis” was
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also related to lipid metabolism (Figure 3.9). The same pathway was implicated in the
DNA methylation analysis using Partek as well as the DNA methylation KEGG analysis
(See below for discussion).
Notch signaling was implicated by both Partek pathway and KEGG analyses
(Table 3.5). The same genes made up both pathway lists. Notch signaling promotes
neurogenesis in both embryonic development and the adult brain (Imayoshi and
Kageyama, 2011). Notch proteins are expressed in the adult brain and appear to be
involved in learning and memory (Costa et al., 2003). There is also evidence that Notch
signaling is dysregulated in some early developmental models of FASD (Sarmah et al.,
2016). Changes in epigenetic marks at Notch signaling genes could represent a
maintained “footprint” of ethanol exposure (see Chapter 5).

3.5.3

Peroxisome Biogenesis Pathway
The top network from the Partek DNA methylation (Figure 3.6) and combined

methylation analysis (Figure 3.9) was “Peroxisome biogenesis”. Peroxisomes are
membrane bound organelles found in all eukaryotic cells. Their main functions are the βoxidation of very-long-chain fatty acids (VLCFAs) and synthesis of ether lipids such as
plasmalogens (Trompier et al., 2014). The β-oxidation genes Acaa1a (Acetyl-CoA
Acyltransferase 1A) and Peci were proximal to hypermethylated DMRs. Acaa1a also had
increased H3K4me3 levels. Importantly, peroxisomes are key to the redox balance of the
cell; both generating and scavenging free radicals (Trompier et al., 2014). The ROSgenerating Nitric Oxide Synthase, Nos2, gene was proximal to a hypermethyalted DMR
in this study. NOS2 is also involved in neurotransmission (Vincent, 2010). Peroxisome
production in response to oxidative stress is regulated by the Pex genes, which assemble
peroxisome structure and guide matrix proteins inside the organelle. The Pex26 and Pex6
genes were proximal to hypermethylated DMRs in this study. PEX26 is a peroxisome
biogenesis factor that anchors Pex1 and Pex6 to the peroxisomal membrane, and is likely
required for protein import (Tamura et al., 2014). Five genes (Acsl4, Acsl6, Agt, Mpv17,
and Mpv17l2) had only histone changes, being implicated in the combined analysis but
not the DNA methylation analysis (Table 3.4).

123

Due to the potential for oxidative damage to hippocampal cells, levels of 8hydroxy-2' -deoxyguanosine (8-OHdG) were assessed in the genomic DNA. 8-OHdG is
an excellent biomarker of oxidative DNA damage, as it is directly caused by free radicals.
Further, it has high potential for detrimental effects include G-to-T transversions, and
inappropriate binding of DNA methylation proteins such as MBD (Valavandis et al.,
2009). There was no change in 8-OHdG in the mice used for the MeDIP analysis (Figure
3.10). 8-OHdG is repaired by DNA repair enzymes, and thus may not have persisted to
PND 70 if it were induced (Valavandis et al., 2009). Other oxidative damage such as lipid
peroxidation is not repaired, and has been observed in long-term FASD models (Petkov
et al., 1992). Thus, examination 8-OHdG much earlier or other macromolecules at PND
70 may have identified changes in this experiment.
Oxidative stress is a well characterized component of FASD etiology. Ethanol
acts directly on mitochondria to produce superoxide, hydroxide, and nitric oxide radicals
(Wu and Cederbaum, 2003). Metabolism of ethanol by cytochrome CYP2E1 produces
oxidized products and ultimately hydroxide radial generation (Mansouri et al., 2001).
Catalase also produces acetaldehyde from alcohol in the brain, further increasing the
formation of ROS (Shaw, 1989). Oxidative damage can lead to blood-brain barrier
impairment, inflammation, and increased apoptosis (Haorah et al., 2008). Interestingly,
these are also key features of FASD etiology. Indeed, oxidative damage is observed in
many rodent models of FASD, including lipid peroxidation, protein oxidation, and DNA
damage (Brocardo et al., 2011). Lipid peroxidation is not often present in young animals,
but accumulates over time into adulthood (Dembele et al., 2006b). In a Drosophila model
of developmental ethanol exposure, changes in expression of antioxidant genes
contributed to oxidative stress in adult flies (Logan-Garbisch et al., 2014). Further, this
increased oxidative stress was a primary cause of developmental delay associated with
ethanol exposure (Logan-Garbisch et al., 2014).
Peroxisomes are being explored as a target for FASD therapies. A class of drugs
known as PPAR (Peroxisome proliferator-activated receptor) agonists were initially
developed to treat other disorders. PPARs are nuclear receptors that act as transcription
factors when activated by ligand binding. PPARα is important for lipid metabolism in the
liver; when activated by fatty acid ligands it transcribes hundreds of target genes. PPARγ
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is activated by prostaglandins and regulates fatty acid storage and glucose metabolism.
The PPARγ agonist pioglitazone was developed to treat diabetes (Bajaj et al., 2007).
Several researchers later noted that pioglitazone reduced inflammation, including
inhibition of microglia activation and cytokine production in the brain (Bernardo et al.,
2000; Petrova et al., 1999). Kane et al. (2011) found that co-administration of
pioglitazone with ethanol prevented cultured granule cells and microglia from the toxic
effects of ethanol (Kane et al., 2011). A subsequent in vivo study found that coadministration of pioglitazone and ethanol from PND4-9 prevented ethanol-induced
increases in cytokines interleukin-1β and tumor necrosis factors in the hippocampus
(Drew et al., 2015). These studies suggest that upregulation of peroxisome (and other)
gene expression may prevent inflammatory responses associated the brain’s response to
FASD-induced oxidative stress.

3.5.4

Pyrosequencing Confirmations
CpG cytosines in five DMRs were investigated using pyrosequencing. A 3.2%

decrease in the methylation of one CpG in the Acaa1 regulatory region was confirmed
(Figure 3.11). As stated above, this gene is critical for the peroxisomal β-oxidation. No
other statistically significant changes were identified, though one nominally significant
(p=0.057) decrease in methylation occurred at one cytosine in the Pex6 DMR (Figure
3.11). PEX6 is a membrane-associated protein which is necessary for import of
peroxisome proteins. Mutations in both Acaa1 and Pex6 cause peroxisome biogenesis
disorders in (Trompier et al., 2014). One possible reason for not confirming more
methylation changes by pyrosequencing was the use of anti-methylcytosine antibody for
the MeDIP-chip. This would allow any differences in cytosine methylation, not just CpG
cytosines, to be identified by MeDIP analysis. Due to the limitations of bisulfite
pyrosequencing assay design, only CpG cytosines could be assessed. Non-CpG
methylation is highly abundant in the brain, representing 25% of all cytosine methylation
in hippocampal dentate granule neurons (Guo et al., 2014). It is possible that the DMRs
implicated by MeDIP-chip included many CpH cytosines methylation changes, which
would not be assayed by pyrosequencing.
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3.5.5

Conclusion
This chapter describes genes and pathways affected by DNA methylation changes

in the hippocampus in response to early ethanol exposure. These changes provide insight
into the long-term effects of PAE on the epigenome. These genes and pathways were
distinct from those affected by histone methylation changes. Analysis of the DNA
methylation data with the histone data identified novel processes not found in any of the
individual analyses. Cardiovascular pathways and notch signalling emerged as affected
processes in the combined analysis. These processes are important to FASD etiology and
their differential methylation in the hippocampus may be relevant. Peroxisome biogenesis
was implicated in the DNA methylation analysis, and was the top affected pathway in the
combined methylation analyses. Peroxisomes are key regulators of oxidative stress and
lipid metabolism; upregulating their biogenesis is already being explored as a therapy for
FASD.
Footnote
A modified version of this chapter has been published (Chater-Diehl et al., 2016).
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Effects of Neonatal Ethanol Exposure on the
Hippocampal Transcriptome
Overview
Gene expression changes are thought to be an important part of FASD etiology.
PAE induces apoptosis, and numerous other changes at the cellular level; they are
hypothesized to be involved in altered expression of important genes in response to
ethanol. Further, small regulatory RNAs such as microRNAs (miRNAs) are believed to
regulate the expression many genes in response to ethanol. Pervious work has
investigated ethanol-responsive genes in various models of FASD. Prior to this thesis, no
study has investigated long-term gene expression changes in the hippocampus in
response to PAE. In this chapter, 59 genes and 60 miRNAs were found to be
differentially expressed in 70-day-old mouse hippocampus after neonatal ethanol
exposure. Gene ontology and pathway analysis found that the genes are enriched for
several functions including oxidative stress-response, biosynthetic, and olfaction. Six
genes from the top pathway “Free Radical Scavenging, Gene Expression, Dermatological
Diseases and Conditions” were confirmed using droplet digital PCR. Several miRNAs
identified have FASD-relevant regulatory functions, and many were implicated in
pervious work. Gene expression data were also compared with the epigenetic methylation
data from Chapters 2 and 3. Tcf7l2 was the only differentially expressed gene to have
changes in H3K4me3, H3K27me3, and DNA methylation. Tcf7l2 may thus be a strong
candidate gene for FASD given its role in oxidative stress amelioration, and the
implication of peroxisome genes in the methylation analysis.

Introduction
Assessment of the transcriptome allows for identification of genes which are
responsive to a given condition. Eukaryotic protein-coding genes are transcribed from
genomic DNA by RNA polymerase II (RNAPII) (Lee and Young, 2000). Transcription is
regulated by numerous transcription factors and enhancer proteins that bind specifically
to target genes (Lee and Young, 2000). The timing of these events coordinates expression
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of target genes to necessary developmental and regulatory timepoints. Dysregulation of
gene expression is associated with altered cellular function, and many disease conditions
(Emilsson et al., 2008). Beyond single genes, alteration of transcriptome-wide expression
patterns are observed in response to a variety of exposures and environmental factors
including ethanol (Jaluria et al., 2007). Such studies assess these changes involving the
whole transcriptome using microarrays.
Microarrays have become a common tool to assess the expression of a large
subset of genes in one experiment. Developed in the 1990’s, microarrays provide
enormous scale, allowing the entire transcriptome to be assessed simultaneously
(Hoheisel, 2006). Microarrays permit hypothesis-free experimental design. The
researcher does not need to have any preconceived knowledge of the experimental system
or prior candidate genes in mind. Another main advantage of microarray analyses is the
emergence of patterns in gene expression profiles (Khatri et al., 2012). The dysregulation
of several genes in the same pathway may represent a meaningful biological change.
Pathway analysis tools provide further insight into the biological impact of these groups
of gene expression changes.
It is often assumed that changes in mRNA expression translate into changes in
protein abundance, and thereby affect cellular processes. However, data show only partial
correlation between gene and protein expression levels. In mice, a study found a
coefficient of determination of R2=0.41 between mRNA and protein expression levels for
over 5000 genes, indicating only a moderate correlation between the two (Schwanhäusser
et al., 2011). Many factors between mRNA and protein expression may account for this
discrepancy. For instance, mRNAs are far less stable than proteins. Further, mRNAs are
translated at a rate of approximately 2 per hour, whereas dozens of copies of the
corresponding protein are produced (Schwanhäusser et al., 2011; Vogel and Marcotte,
2012). Such factors also vary greatly between genes. Regardless of their applicability to
protein levels, mRNA studies do make definitive statements on the available mRNA
pool, and remain a popular tool in molecular biology.
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4.2.1

Non-Protein-Coding RNAs
MicroRNAs (miRNAs) are short (~26 base pair), non-protein coding RNA

molecules that can regulate mRNAs. Like mRNAs, miRNAs are transcribed by RNAPII
and have several similarities in their promoter motifs (Zhou et al., 2007). They are
transcribed in stem-loop structures termed primary miRNAs (pri-miRNAs). These primiRNAs can be found in protein-coding gene 3’UTRs, and can also contain up to six
miRNA hairpin precursors (Lee et al., 2004). These are spliced out, and exported from
the nucleus. In the cytoplasm, the RNA-induced silencing complex (RISC) processes the
double-stranded hairpin precursor into a single-stranded mature miRNA (Rana, 2007).
The mature miRNA can then regulate complementary mRNA by two methods: targeting
the mRNA for degradation or preventing translation (Rana, 2007). Perfect pairing of the
miRNA and mRNA target promotes degradation of the mRNA via endonucleolytic
cleavage, whereas a mismatch promotes translational blockage mediated by the
Argonaute family of proteins (Gu and Kay, 2010; Valencia-Sanchez et al., 2006). The
latter is more common in mammalian cells. A single miRNA can target hundreds of
mRNAs, and a single mRNA can be targeted by dozens of miRNAs. There are
approximately 2200 miRNA genes in the in the mammalian genome, and about one third
of the human genome is estimated to be regulated by miRNAs (Urbich et al., 2008).
MiRNAs are important regulators of numerous development- and disease-relevant
processes. MiRNAs are a key regulator of cellular differentiation due to their ability to
influence expression of many genes simultaneously. Specific miRNA profiles have been
observed in numerous cancers (Naeini and Ardekani, 2009). Targeting miRNAs has been
suggested as a promising therapeutic strategy in cancer treatment (Cheng et al., 2014).
MiRNAs are also important in neurological development and disease. Mammalian brains
have a higher expression level of miRNAs than most other tissues (Babak et al., 2004).
Several miRNAs have key regulatory roles during neurodevelopment, with alteration in
their expression causing abnormal brain growth (Sun and Shi, 2015). They are also
involved in complex brain functions such as learning and memory. Expression levels of
specific miRNAs regulating signalling pathways during long-term potentiation (Wang et
al., 2012). Many neurological diseases impact neuroplasticity, and many do so via
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alteration in miRNA expression. Drug addiction, schizophrenia, and autism have well
characterized associations with miRNA expression changes (Wang et al., 2012).

4.2.2

Gene Expression Changes in FASD are Gene-Specific
Gene expression changes have been studied in several FASD models. Gene

expression changes are part of the mechanisms by which ethanol induces neuronal
apoptosis (Ikonomidou, 2000). Exposure of embryos to ethanol early in gestation results
in dysregulation of cell proliferation, differentiation, and apoptosis related genes (Hard et
al., 2005). Ethanol can also cause changes in immune response and inflammation that are
present at the transcript level. PAE mice with induced inflammation show distinct
expression profiles in the hippocampus, failing to activate genes and regulators involved
in the immune response (Lussier et al., 2015). Gene expression changes may also
underlie morphological abnormalities in FASD. Cell growth, apoptosis, and histone
variant genes were differentially expressed in a study of neural tube deficits following
ethanol exposure to embryos in culture (Zhou et al., 2011). Further, expression profiles
were specific to a neural tube phenotype, with closed and open tubes associated with
neurotrophic/growth factor and histone variant genes respectively (Zhou et al., 2011).
In addition to expression profiles, there have also been studies characterizing the
causal relationship between gene expression change and FASD phenotypes. A study
found downregulation of sonic hedgehog (Shh) in embryonic neural crest cells associated
with ethanol exposure in fetal chicks. Sonic hedgehog is responsible for cranio-facial
development, with mutations causing severe facial abnormalities (Nanni et al., 1999).
Addition of the SHH protein to ethanol-exposed chicks ablated cranio-facial deformities
(Ahlgren et al., 2002). In another study, exposure of Xenopus embryos to ethanol resulted
in malformation of the eye with associated changes in eye development genes (Peng et
al., 2004). Reduction of oxidative stress via upregulation of catalase and of cytosolic and
mitochondrial peroxiredoxin prevented the gene expression changes and malformations
(Peng et al., 2004). In a study using mouse whole-embryo culture, many developmental
morphology parameters (including hindbrain, midbrain, forebrain, and optic systems)
were reduced in size by ethanol exposure. Treatment with capsaicin ameliorated most of
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these morphogenic changes, likely via the increased antioxidant mRNA expression levels
(Kim et al., 2008).
MiRNA expression changes have also been associated with FASD. As in other
neurological disorders, miRNAs differentially expressed in FASD disproportionately
affect neurological development and function. Suppression of specific miRNAs in fetal
neural stem cells (NSCs) and neural progenitor cells (NPCs) accounted for their
resistance to apoptosis (Sathyan et al., 2007). Other studies have found miRNAs
associated with cranial abnormalities (Sathyan et al., 2007). From these studies, it is clear
that gene and miRNA expression changes can underlie the phenotypic effects of PAE.

4.2.3

Gene Expression Changes in FASD are Pathway- and
Network-Specific
Pathway and network analysis are key tools for understanding how groups of

affected genes may interact to affect a phenotype. Gene lists generated from microarray
and sequencing experiments provide candidate genes for the phenotype. However, these
lists do not provide mechanistic insight into the underlying biology. Reducing the gene
list to smaller sets based on pathways reduces complexity. These pathways often provide
more explanatory power than a single differentially expressed gene list (Khatri et al.,
2012). Many of these tools use over representation analysis (also known as enrichment
analysis). Hundreds of biological pathways are assessed for the percentage of their
component genes that are differentially expressed in the researcher experiment (Khatri et
al., 2012). Using a Fisher’s exact test, the software determines the statistical significance
of the overlap with each pathway. Partek pathway uses the well annotated list of Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways. Ingenuity pathway analysis
(IPA) uses a proprietary network database based on curated literature searches. Gene
ontology analysis uses the same principle to assess enrichment of gene functions.

4.2.4

Previous Results from the Singh Laboratory in FASD Models
Previously, the Singh laboratory characterized gene expression changes in several

FASD models. We have sought to identify genes responsive to PAE across various
exposure regimes, developmental endpoints, and after mitigating or exacerbating factors.
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Using the continuous preference drinking (CPD) model, significant gene networks were
cellular and tissue development, free radical scavenging, lipid metabolism, and nervous
system development in PND 70 mouse brain (Kleiber et al., 2012). This study identified
relatively few (less than 20) differentially expressed genes with greater than a 1.2 fold
change (p<0.05). In another study in this model, we assessed miRNA expression changes
in addition to gene expression changes. There was an enrichment of miRNAs with roles
in neuronal development and function, as well as an enrichment (20%) of miRNAs which
targeted imprinted regions (Laufer et al., 2013).
In the trimester one model of exposure, PND 60 mice showed dysregulation of
genes involved in apoptosis, cell-cell signalling, and neurological disease (Mantha et al.,
2013). In the trimester two exposure model, short- (GD 16) and long-term (PND 70) gene
expression changes in the whole-brain were assessed (Mantha et al., 2013). These genes
were enriched for apoptosis, free-radical scavenging, lipid metabolism, and neurological
functions (Mantha et al., 2014). There were also 20 miRNAs differentially expressed in
the PND 70 mice.
In the trimester three PND 4,7 injection model, short (PND 7) and long (PND 60)
gene expression changes in the whole-brain have been assessed. The short term mice
showed dysregulation of apoptosis, lipid metabolism, and neurogenesis genes (Kleiber et
al., 2014a). In adult mice, genes involved in glutamate signalling, neurological diseases,
and cell-cell signalling were differentially expressed (Mantha et al., 2013). There were
also 33 differentially expressed miRNAs at PND 60. Together, these previous wholebrain studies have consistently implicated free radical scavenging, lipid metabolism, and
brain development and function genes as well as several miRNAs.

4.2.5

Gene Expression Changes in the Hippocampus
The previous work from our laboratory used mouse whole-brain for gene

expression microarray analysis. Gene expression patterns differ within the brain;
approximately 50% of expressed genes are differently expressed between brain regions in
mice and humans (Strand et al., 2007). Pooling all brain regions together will lose this
heterogeneity. Changes in specific brain regions may also be washed out by expression in
other regions. Furthermore, individual brain regions are associated with specific FASD-
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relevant behaviours, while the whole-brain is not associated with any single behaviour.
For these reasons, this thesis examined a specific brain region, the hippocampus. The
hippocampus is particularly vulnerable to the pro-apoptotic effects of ethanol
(Ikonomidou, 2000). It is involved in the formation of new memories and visual/spatial
memory (Cho et al., 1999; Morris et al., 1982; Squire, 2009). Mice exposed to ethanol on
PND 7 also show spatial learning and memory impairment, similar to mice with
hippocampal lesions (Cho et al., 1999; Mantha et al., 2013). Children with FAS show
similar spatial deficits (Hamilton et al., 2003; Uecker and Nadel, 1996, 1998). Changes in
gene expression are associated with learning impairment in response to PAE (Subbanna
and Basavarajappa, 2014). In this chapter, gene and miRNA expression changes in the
hippocampus of PND 70 mice exposed to ethanol on PND 4 & 7 are assessed.

Objectives
1. To assess expression of all mouse protein coding genes and miRNAs in PND 70
mouse hippocampus exposed to ethanol on postnatal days 4 and 7.
2. To identify the ontology and pathway enrichment of differentially expressed
genes.
3. To confirm specific changes with qPCR/ddPCR.
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Materials and Methods
4.3.1

Mouse Care
For the full mouse care protocol, see Chapter 2 Materials and Methods. In brief,

all protocols were approved by the Animal Use Subcommittee (AUS) at the University of
Western Ontario, London, Ontario, Canada. The day of birth was termed PND zero. Sex
and weight-matched littermate pups were divided into two groups: ethanol-treated and
saline-injected control mice. Pups were given two subcutaneous dorsal injections on both
PND 4 and PND 7. Ethanol-treated mice were injected with 2.5 g/kg of ethanol in 0.15 M
NaCl (Ikonomidou et al., 2000). Control mice were injected with 0.15 M saline only.
Male mice were used for all subsequent analyses. The mice used in this chapter included
the same mice used for the DNA methylation analysis in Chapter 3 (n=9 control and n=9
ethanol-exposed mice; see Table 2.1). Mice were sacrificed on PND 70 via carbon
dioxide asphyxiation. The hippocampus was dissected out (Spijker, 2011), snap-frozen in
liquid nitrogen, and stored at -80°C for no longer than 30 days until formaldehyde
fixation.

4.3.2

DNA/RNA Isolation
DNA and RNA were isolated with AllPrep DNA/RNA Mini Kit (Qiagen,

Valencia, CA, USA) according to the manufacturer’s protocol. This kit allows DNA and
RNA to be isolated from the same hippocampal sample. DNA and RNA were stored at
-20°C and -80°C respectively.

4.3.3

Gene and miRNA Expression Microarray
Nine ethanol-exposed and nine control hippocampus samples were used for

expression analysis. RNA quality was assessed using the Agilent 2100 Bioanalyzer
(Agilent Technologies Inc., Palo Alto, CA) and the RNA 6000 Nano kit (Caliper Life
Sciences, Mountain View, CA). RNA from three non-littermate males was then pooled
for microarray analysis on three separate arrays per treatment group.
All sample labeling and GeneChip processing was performed at the London
Regional Genomics Centre (Robarts Research Institute, London, Ontario, Canada;
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http://www.lrgc.ca). RNA quality was assessed using the Agilent 2100 Bioanalyzer
(Agilent Technologies Inc., Palo Alto, CA) and the RNA 6000 Nano kit (Caliper Life
Sciences, Mountain View, CA). Single-stranded complimentary DNA (sscDNA) was
prepared from 200 ng of total RNA as per the Ambion WT Expression Kit for Affymetrix
GeneChip Whole Transcript WT Expression Arrays
(http://www.ambion.com/techlib/prot/fm_4411973.pdf, Applied Biosystems, Carlsbad,
CA) and the Affymetrix GeneChip WT Terminal Labeling kit and Hybridization User
Manual (http://media.affymetrix.com/support/downloads/manuals/wt_term_label_ambion
_user_manual.pdf, Affymetrix, Santa Clara, CA).
Total RNA was first converted to cDNA, followed by in vitro transcription to
make cRNA. 5.5 μg of single stranded cDNA was synthesized, end labeled and
hybridized, for 16 hours at 45°C, to Mouse Gene 1.0 ST arrays (Affymetrix, Santa Clara,
CA). One microgram of total RNA was labeled using the Flash Tag Biotin HSR kit from
Genisphere (http://www.genisphere.com/array_detection_flashtag_biotin.html). Samples
were then hybridized to Affymetrix miRNA 2.0 arrays for 16 hours at 48°C. All washing
steps were performed by a GeneChip Fluidics Station 450 and GeneChips were scanned
with the GeneChip Scanner 3000 7G (Affymetrix, Santa Clara, CA) using Command
Console v1.1.
Probe level (.CEL file) data was generated using Affymetrix Command Console
v1.1. Probes were summarized at the miRNA and gene level using RMA (Irizarry et al.,
2003). Partek was used to determine ANOVA p-values and fold changes for genes and
miRNAs. Species annotations were added and used to filter miRNAs. Partek Pathway
and Ingenuity pathway analysis (IPA) were used to determine and visualize significantly
enriched pathways (using a Fisher’s exact test). Gene list was also uploaded to Enrichr
(Chen et al., 2013) for Gene Ontology (GO) analysis. .CEL files and log2 normalized
files were uploaded to GEO. An FDR q-value < 0.05 was used to determine multiple
testing error; no transcripts survived this threshold.

4.3.4

Gene-Specific Confirmations
Purified RNA was converted to cDNA using the High-Capacity cDNA Reverse

Transcription Kit (Thermo-Fisher). cDNA was diluted 10-fold and stored at -20°C until
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use. Individual genes were investigated with TaqMan® assays (Applied Biosystems),
assays IDs: Vipr2: Mm01238618_g1; Synpo2: Mm03809162_m1; Tcf7l2:
Mm00501505_m1; Casp3: Mm01195085_m1, Krt8: Mm04209403_g1; L3mbtl4:
Mm00623914_m1, Stac; Mm00450338_m1, Mafg: Mm00521961_g1, Tmem79:
Mm00470361_m1, Defb4: Mm00731768_m1. For all assays, TATA binding protein
(TBP) was used as a reference gene: Mm01277042_m1. Individual (i.e. not pooled)
ethanol-exposed (n=7) and control (n=7) samples from the gene expression microarray
were used for these analyses. Four samples from the microarray experiment (E17.1,
C17.2, E19.7, C19.8) could not be included as they had insufficient RNA remaining for
cDNA synthesis.

4.3.4.1

Real-Time PCR

For each assay, the gene of interest and Tbp reference gene were run in multiplex
using FAM and VIC labeling respectively. Reactions were prepared using TaqMan®
Gene Expression Master Mix (Applied Biosystems). Each sample was run in three
technical replicates. The probe/primer pairs for each gene of interest were multiplexed
with TBP primer/probe; 10 μl reactions were used. Gene expression levels were
quantified using the comparative delta Ct, or delta delta Ct (ΔΔCt) method, where Ct
refers to critical threshold when the amplification signal rises above background levels.
ΔΔCt, relative quantity, and fold change were calculated by the StepOne software.
DataAssist software (Applied Biosystems) was used for statistical analysis, in which
average ΔΔCt values for each technical replicate were averaged (after removing any
outliers), and treatment groups were compared using a Paired Samples t-Test with
littermates paired.

4.3.4.2

Droplet Digital PCR

For each assay, the gene of interest and TBP reference gene were run in multiplex
using FAM and VIC labeling respectively. Reactions were prepared using ddPCR™
Supermix for Probes (BioRad), cDNA, and probes according to the manufacturer’s
protocol. Droplets were generated from the reactions using Droplet Generation Oil for
Probes (BioRad) on the QX100 Droplet Generator (BioRad) according to the
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manufacturer’s protocol. Droplets were cycled on the C1000 Touch Thermal Cycler
(BioRad) for 40 cycles, 60°C annealing temperature, 2°C/sec ramp speed. Droplets were
read using the QX100 Droplet Reader (BioRad). Data were analyzed in QuantaSoft
software (BioRad). All samples had between 17000-20000 droplets indicating highquality. The concertation of each RNA species and ratio of gene of interest/reference
gene concentration were calculated using QuantaSoft for each sample. Each DNA sample
was run in three technical replicates, the average ratio across technical replicates for each
sample was calculated manually. Each cDNA sample’s average ratio was used to
compare ethanol-exposed to control samples using a paired sample Paired Samples t-Test
with littermates paired. Averages were normalized to 1.00 relative expression level for
control group.
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Results
4.4.1

Differentially Expressed Genes
To describe which transcripts were significantly differentially expressed in the

PND 70 mouse hippocampus following PND 4,7 ethanol exposure, a fold-change cut-off
of >1.2 or <-1.2 as well as an ANOVA p-value<0.05 were used to determine statistical
significance. These cut-offs are relatively standard in PAE research in the Singh
laboratory and others; they are intended to be permissive enough to capture the subtle
effects of ethanol without excessive false positives. There were 317 transcripts meeting
these criteria, which were visualized using a heat map (Figure 4.1). The distance tree
shows that the control and ethanol-exposed groups cluster together. The relative
expression level for each transcript was quite consistent across the three biological
replicates, indicating a consistent effect of ethanol on the abundance of each (Figure 4.1).
Of these differentially expressed transcripts, there were 59 annotated genes differentially
expressed at a fold cut off>1.2 and p<0.05 (Table 4.1). Two thirds of these were
upregulated, and one third down-regulated in response to ethanol. The largest increase in
expression was 1.5 fold and the largest decrease was -1.39 fold.

4.4.2

Ontology of Differentially Expressed Genes
Known and predicted interactions between proteins encoded by differentially

expressed genes were assessed using GeneMania. The resulting network illustrates that
there were relatively few known functional relationships between these genes. The most
common relationships were co-expression or co-localization (Figure 4.2). Gene ontology
(GO) analysis was performed to categorize differentially expressed genes, and assess
their biological impact. The list of 59 differentially expressed genes (fold cut-off>1.5,
p<0.05) was used for GO analysis using Enrichr (Chen et al., 2013). The top affected
biological processes include various biosynthetic processes such as dicarboxylic acid,
kynurenine, and tryptophan metabolism (Table 4.2). “Intrinsic apoptotic signaling
pathway in response to oxidative stress” was also implicated, which is particularly
relevant to FASD. The top affected cellular components include various structural
components such as Z-disc, contractile fiber, and plasma membrane (Table 4.2). The top
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Figure 4.1 Heirarchical clustering of expression patterns from indiviual
mircoarrays.
Differentailly expressed transcripts with fold changes>1.2 and p<0.05 are shown.
Distance trees show similaries in expression patterns among genes and among
experimental groups. Consistencey of expression changes across biological repilcates is
evident for each gene by the consistencey of the fold (colour) change.
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Table 4.1 Differentailly expressed genes in response to neonatal ethanol exposure in
the adult mouse hippocampus†.
Gene Symbol p-value Fold
Tcf7l2
0.032 change
1.50
Synpo2
0.047
1.43
Vipr2
0.043
1.42
Cypt2
0.012
1.40
Defb5
0.002
1.39
Serpinb1b
0.027
1.35
Gm8994
0.021
1.32
Gm7168
0.016
1.31
Olfr119
0.007
1.30
Vmn2r15
0.049
1.29
Cfhr2
0.023
1.29
LOC10003842
0.025
1.28
2Nup210l
0.037
1.27
Kmo
0.024
1.27
Tmprss11a
0.049
1.26
BC094916
0.036
1.26
Krt8
0.013
1.25
Olfr539
0.035
1.25
Slitrk6
0.023
1.24
Cd209f
0.031
1.24
Krt39
0.008
1.23
Olfr121
0.026
1.23
Gm11362
0.041
1.23
Hcn4
0.048
1.23
Olfr1018
0.022
1.23
Cdnf
0.044
1.23
Casp3
0.021
1.23
4933416I08Rik
0.049
1.22
Vmn2r109
0.022
1.22
Stac
0.029
1.22
Vmn1r5
0.042
1.21
Dnm3os
0.050
1.21
Olfr648
0.003
1.21
Olfr1131
0.026
1.21
4930524N10Ri
0.006
1.21
k
Gm4801
0.011
1.21
Mrgprh
0.007
1.21
Gm11437
0.026
1.20
Apol7a
0.010
1.20
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C330022B21Ri
0.020
-1.20
k
1600015I10Rik
0.005
-1.20
Gm4776
0.024
-1.20
Olfr455
0.011
-1.20
Olfr979
0.007
-1.21
Mafg
0.036
-1.21
Olfr2
0.022
-1.21
Gm16551
0.006
-1.22
4930401B11Ri
0.047
-1.22
k
L3mbtl4
0.040
-1.22
D4Wsu53e
0.005
-1.22
Olfr281
0.013
-1.24
D730002M21R
0.045
-1.25
ik
BC055004
0.039
-1.25
Hdx
0.015
-1.25
Olfr1350
0.002
-1.26
Crygb
0.011
-1.27
Tmem79
0.027
-1.29
Zfa
0.023
-1.31
Dnahc7a
0.023
-1.39
†n=3 ethanol-exposed and n=3 control microarrays. p-values deterimed using a one-way
ANOVA, fold change in expression vs. control group deterimend using Partek RMA
alorithm. Genes presented passed a fold cut off >1.2 and p<0.05.
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Figure 4.2 Interaction network of published interactions between differentially
expressed genes.
Gene node increases with increased connections, line width decreases with number of
connections from its node. Co-expression indicates expression levels are similar across
conditions in a published gene expression study. Co-localization indicates genes
expressed in the same tissue, or proteins found in the same cellular location. Predicted
indicates a predicated functional relationship between genes, often protein interactions,
based on data from other organisms. Examples of Other include phenotype correlations
from Ensembl or disease information from OMIM. Protein domain indicates the same
protein domain in each gene.
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Table 4.2 Gene ontology (GO) analysis of differentially expressed genes†.
GO term
GO biological processes
Dicarboxylic acid biosynthetic process (GO:0043650)
Kynurenine metabolic process (GO:0070189)
Genitalia morphogenesis (GO:0035112)
Positive regulation of triglyceride biosynthetic process (GO:0010867)
Positive regulation of glycoprotein biosynthetic process (GO:0010560)
Positive regulation of gluconeogenesis (GO:0045722)
Response to auditory stimulus (GO:0010996)
Tryptophan metabolic process (GO:0006568)
Positive regulation of protein export from nucleus (GO:0046827)
Intrinsic apoptotic signaling pathway in response to oxidative stress
(GO:0008631)
GO cellular component
Z disc (GO:0030018)
Contractile fiber part (GO:0044449)
Dystrophin-associated glycoprotein complex (GO:0016010)
Intermediate filament (GO:0005882)
Costamere (GO:0043034)
Integral component of plasma membrane (GO:0005887)
Intrinsic component of plasma membrane (GO:0031226)
GO molecular function
Intracellular cAMP activated cation channel activity (GO:0005222)
Muscle alpha-actinin binding (GO:0051371)
armadillo repeat domain binding (GO:0070016)
Cyclic nucleotide-gated ion channel activity (GO:0043855)
Intracellular cyclic nucleotide activated cation channel activity
(GO:0005221)
Gamma-catenin binding (GO:0045295)
Cyclin-dependent protein serine/threonine kinase inhibitor activity
(GO:0004861)
Oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor
(GO:0050664)
14-3-3 protein binding (GO:0071889)
Structural constituent of eye lens (GO:0005212)
†Top 10 GO processes are shown where number of entries exceeds 20.

p-value
0.010
0.010
0.011
0.011
0.012
0.013
0.013
0.013
0.013
0.017

0.004
0.015
0.020
0.021
0.025
0.028
0.038
0.008
0.009
0.009
0.010
0.010
0.011
0.011
0.014
0.016
0.018
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affected cellular components included various nucleotide-gated ion channels, as well as
structural components and oxidoreductase activity (Table 4.2).

4.4.3

Pathways Affected by Differentially Expressed Genes.
The list of differentially expressed genes was also submitted to three separate

pathway suites: Ingenuity Pathway Analysis (IPA), Partek Pathway, and Enrichr (Table
4.3). The genes Casp3 and Tcf7l2 are responsible for implicating many of the genes in
these pathways; one or both are present in >90% of the identified pathways. Casp3
encodes Caspase-3 which is involved in apoptosis, Tcf7l2 encodes a transcription factor
involved in Wnt signalling (D’Amelio et al., 2012). These two genes were also
responsible for implicating pathways related to cancer and development across each
software platform (Table 4.3). The top IPA pathway was “Free radical scavenging, gene
expression, dermatological diseases and conditions” which also contained Tcf7l2 and
Casp3 (Figure 4.3). The top Partek pathway was “Olfactory transduction”, implicated by
10 olfactory receptor genes (Table 4.3).

4.4.4

Gene-Specific Confirmations
Five differentially expressed genes from the top IPA pathway (Figure 4.3) were

selected for confirmation via real-time polymerase chain reaction (qPCR). Casp3, Mafg,
Stac, Tcf7l2, and Vipr2 qPCR confirmations were attempted (Table 4.4). Though Vipr2
and Tcf7l2 approached statistical significance, none of these genes were confirmed to be
differentially expressed in ethanol-exposed mice. Since several genes approached
significance, droplet digital PCR (ddPCR) was employed for each gene using the same
cDNA samples. Casp3, Tcf7l2, and Vipr2 were confirmed using ddPCR (Table 4.4;
Figure 4.4). Mafg and Stac were non-significant (Table 4.4; Figure 4.4). Given this
success, ddPCR was employed for four more genes, two from the top IPA pathway
(Tmem79 and Krt8), one with a targeting miRNA (L3mbl4), and one with relevance to
brain function (Synpo2). Synpo2 and L3mbl4 were confirmed, while Tmem79 and Krt8
were not (Table 4.4).
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Table 4.3 Pathways significantly enriched with differentially expressed genes.
Pathway name
IPA network/pathway
Free Radical Scavenging, Gene
Expression, Dermatological Diseases
and Conditions
Cellular Development, Developmental
Disorder, Hereditary Disorder
Molecular Transport, RNA Trafficking,
Cell Death and Survival
Cell Cycle, Nervous System
Development and Function, Cell
Signaling
Cardiovascular System Development
and Function, Skeletal and Muscular
System Development and Function,
Cell-To-Cell Signaling and Interaction
Partek pathway
Olfactory Transduction

Colorectal Cancer
Amoebiasis
Enrichr KEGG
Colorectal cancer
cAMP signaling pathway
Thyroid cancer
Tryptophan metabolism
Pathways in cancer
Amyotrophic lateral sclerosis (ALS)
Endometrial cancer
Legionellosis
Basal cell carcinoma

Affected genes
Apol7a, Defb4, Dnah7, Hdx,
Ifi204, Kmo, Krt8, Mafg Tcf7l2,
Tmem79, Stac, Vipr2
Casp3, Tcf7l2

p-value
10E-31

0.001

Casp3, Kmo

0.001

Casp3, Tcf7l2

0.001

Casp3, Hcn4

0.01

Olfr2, Olfr121, Olfr281,
Olfr455, Olfr539, Olfr648,
Olfr979, Olfr1018, Olfr1131,
Olfr1350
Casp3, Tcf7l2
Casp3, Serpinb1b
Casp3, Tcf7l2
Hcn44, Vipr2
Tcf7l2
Kmo
Casp3, Tcf7l2
Casp3
Tcf7l2
Casp3
Tcf7l2

0.001

0.012
0.03
0.0012
0.011
0.025
0.034
0.041
0.043
0.044
0.047
0.047
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Figure 4.3 Top IPA network for gene expression changes “Free Radical Scavenging,
Gene expression, Dermatological Diseases and Conditions”.
Red nodes represent proteins whose transcripts were increased in ethanol-exposed mice
vs. controls, green nodes represent those that were decreased in ethanol exposed mice.
Score determined in IPA was 31 (right-tailed Fisher’s Exact Test). For legend, see
Appendix B).
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Table 4.4 mRNA abundance from real-time PCR (qPCR) compared to droplet
digital PCR (ddPCR)†.
Microarray
qPCR
ddPCR
Fold
p-value
Fold
p-value
Fold
p-value
change
change
change
Casp3
1.23
0.021
-1.07
0.20
2.52
0.040
Mafg
-1.21
0.036
1.08
0.17
1.03
0.30
Stac
1.22
0.029
-1.04
0.43
-1.15
0.18
Tcf7l2
1.50
0.032
1.99
0.08
2.18
0.045
Vipr2
1.42
0.043
3.94
0.07
2.80
0.023
†Data presented are fold change in ethanol-exposed vs. control groups. Microarray fold
Gene

change and p-values were determined in Partek. qPCR and ddPCR data are presented as
the mean of n=7 biological replicates per group, p-values determined by Paired Samples
t-Test. Shaded cells denote a p-value<0.05.
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Figure 4.4 Droplet digital PCR (ddPCR) confirmations of differential gene
expression.
n=14, 7 ethanol-exposed and 7 control mice. Data are presented as relative quantity
normalized to control expression level, mean ± standard error. *p<0.05 (Paired Samples
t-Test). Not shown is Defb4 which was undetected in the samples.
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The expression patterns of the six confirmed genes in the PND 70 mouse
hippocampus were assessed using data from the Allen Brain Atlas (Sunkin et al., 2013).
Casp3 showed high expression in dentate granule neurons and hippocampal pyramidal
neurons. The other five genes did not show discernable expression patterns in the
hippocampus.

4.4.5

Differentially Expressed MicroRNAs
In addition to the mRNA expression microarray, a microRNA (miRNA)

expression microarray was also performed. It identified 60 differentially expressed
miRNAs at p<0.05, fold cut-off>1.2 (Table 4.5). Most (89%) were increased in
expression in ethanol-exposed mice. There were greater fold-change magnitude values
compared to mRNAs; ranging from 2.59 to -2.01 fold. Next, interactions between
miRNAs and mRNAs were assessed. Using IPA Target Filer™ analysis, miRNAs
predicted to target differentially expressed genes were identified (Table 4.6). Four genes
(Hcn4, Mafg, L3mbtl4, and Tmem79) targeted by five miRNAs were identified with
reciprocal changes in fold-change. (Table 4.6). Other interactions where a miRNA and a
predicted target mRNA had the same direction of change were identified; however, they
were shown due to unlikely functional relevance.

4.4.6

Epigenetic Changes at Differentially Expressed Genes
The differentially expressed genes from Chapter 2 were compared with the

differentially methylated genes from the DNA and histone methylation lists. There was
very little overlap between the lists using the genes generated for pathway analysis (i.e.
p<0.001 for the DNA and histone methylation lists; Figure 4.5). Only one gene
overlapped between the H3K4me3 RDHM list and gene expression list which is
significantly less overlap than expected by chance (X2=55.6, p<0.00001). The gene was
Tcf7l2 which encodes a transcription factor involving in Wnt signaling. It was part of the
top IPA pathway identified in the gene expression analysis and was confirmed with
ddPCR. It is also the top differentially expressed gene in terms of fold-change magnitude.
In order to identify more potentially biologically relevant relationships between gene
expression and epigenetic changes, the expression and methylation datasets were also
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Table 4.5 MicroRNAs and pre-microRNAs identified as differentially expressed
from microarray analysis†.
Probe Set ID
miR-1935
miR-1946a
miR-184
miR-1306
miR-207
miR-130b
miR-1983
miR-669n
miR-1946b
miR-200c
miR-26a-1
miR-695
miR-188-5p
miR-1894-3p
mir-302b
miR-125b
miR-425
miR-105_st
miR-678_st
miR-671-5p
miR-505
miR-452
miR-511
miR-1937
miR-1962
miR-106b
miR-2136
miR-484
miR-18a
miR-105
miR-490
miR-214
miR-2135-4
miR-466b-1
miR-295
miR-698
miR-377
miR-29b-1

p-value
Fold change
0.0315
2.59
0.0160
2.36
0.0185
2.35
0.0496
2.28
0.0294
2.19
0.0180
2.19
0.0284
2.16
0.0327
2.10
0.0174
2.07
0.0221
1.95
0.0127
1.80
0.0146
1.75
0.0487
1.70
0.0343
1.67
0.0174
1.65
0.0281
1.64
0.0034
1.63
0.0177
1.60
0.0264
1.57
0.0133
1.52
0.0127
1.48
0.0058
1.48
0.0002
1.46
0.0036
1.43
0.0026
1.43
0.0489
1.43
0.0265
1.41
0.0468
1.39
0.0283
1.39
0.0069
1.39
0.0368
1.38
0.0477
1.37
0.0241
1.37
0.0238
1.35
0.0481
1.32
0.0403
1.30
0.0185
1.29
0.0292
1.28
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miR-540
0.0455
1.28
miR-700
0.0258
1.26
miR-505
0.0226
1.25
miR-187
0.0366
1.24
miR-704
0.0043
1.24
miR-709
0.0463
1.23
miR-297a-6
0.0428
1.23
miR-3473
0.0157
1.22
miR-1944
0.0319
1.22
miR-466g
0.0300
1.22
miR-450b-3p
0.0165
1.21
miR-876
0.0463
1.20
miR-449c
0.0136
1.20
miR-214
0.0305
-1.21
miR-1956
0.0298
-1.23
miR-882
0.0335
-1.25
miR-290-3p
0.0372
-1.30
miR-1945
0.0125
-1.39
miR-297c
0.0149
-1.95
miR-669
0.0065
-2.01
†n=3 ethanol-exposed and n=3 control microarrays. p-values deterimed using a one-way
ANOVA, fold change in expression vs. control group deterimend using Partek RMA
alorithm. Transcripts presented passed a fold cut off >1.2 and p<0.05.
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Table 4.6 MicroRNA expression changes with corresponding reciprocal changes in
expression of predicted target genes†.
Gene
Symbol
Hcn4
Mafg

p-value

Fold miRNA ID
p-value
Fold Confidence
change
change
0.048
1.23 miR-185-5p
0.026
-1.26
High
0.036
-1.21 miR-130a-3p
0.018
2.19
High
miR-200b-3p
0.022
1.95
High
L3mbtl4
0.040
-1.22 miR-377-3p
0.019
1.29
High
Tmem79
0.027
-1.29 miR-34a-5p
0.046
1.20
Moderate
†Fold changes and p-values determined in Partek using the RMA algorithm.
Relationships were identified using IPA Target Scan™. Fold change and p-values from
microarrays presented. miRNA targets predicted by Ingenuity Target Scan™, only
reciprocal changes in miRNA abundance vs. target mRNA abundance shown. Confidence
is an output of IPA target scan and refers the likelihood of the predicted miRNA-mRNA
interaction occurring in vivo.
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Figure 4.5 Distribution of implicated genes shared between experiments at p<0.001.
Darker shading indicates more genes present at that intersection. Gene expression (GE)
and miRNA list generated using p<0.05, fold-cut off >1.2; H3K4me3 and H3K27me3
lists generated using MAT score cut-off p<0.001; DNA methylation (5mC) list generated
using AMS cut-off p<0.001.
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Figure 4.6 Distribution of implicated genes shared between experiments at p<0.01.
Darker shading indicates more genes present at that intersection. Gene expression (GE)
and miRNA list generated using p<0.05, fold-cut off >1.2; H3K4me3 and H3K27me3
lists generated using MAT score cut-off p<0.01; DNA methylation (5mC) list generated
using AMS cut-off p<0.01.
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Table 4.7 Differentially expressed genes proximal to a change in DNA methylation
or histone methylation†.
Gene expression
Gene Symbol
Tcf7l2

Synpo2
Vipr2
Gm8994
Olfr119
Vmn2r15
Cfhr2
Krt8
Slitrk6
Krt39
Hcn4
Vmn2r109
Dnm3os
Gm4776
Mafg

5mC DMR
pFold
value change
0.032
1.50

0.047
0.043
0.021
0.007
0.049
0.023
0.013
0.023
0.008
0.048
0.022
0.050
0.024
0.036

1.43
1.42
1.32
1.30
1.29
1.29
1.25
1.24
1.23
1.23
1.22
1.21
-1.20
-1.21

H3K4me3
RDHM
AMS pMAT pscore value score value
9.87 0.007 -3.12 0.004
-4.38 0.000
9
11.82 0.004
3.10 0.009
10.32 0.002
3.14 0.008
-2.93 0.008
3.09
3.12
3.24
3.05
-2.95

-2.91

H3K27me3
RDHM
MAT pscore value
1.86 0.003

1.44

0.004

1.14
1.16

0.008
0.007

0.009
0.008
0.006
0.009
0.007

0.008

9.39 0.009
-12.67 0.005
13.42 0.001
†
Differentially 5-methylcytosine (5mC) methylated regions (DMRs) and regions of
differentially histone modification (RDHMs) in gene promoters are also shown (cut-off
p<0.01). Positive AMS indicates increased methylation in ethanol exposed mice, while
positive MAT score indicates reduced methylation in ethanol exposed mice.
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compared with a p-value<0.01 (Figure 4.6). There were 16 differentially expressed genes
proximal to a change in DNA or histone methylation at this significance level (Table
4.7). Gm8994, Olfr119, Cfhr2, Slitrk6, Krt39, Hcn4, Gm4776 and Olfr2 were proximal to
H3K4me3 changes only; Vmn2r15, Vmn2r109, and Dnm3os were proximal to
H3K27me3 changes only; Vipr2 and Mafg were proximal to DNA methylation changes
only; Synpo2 and Krt8 were proximal to H3K4me3 and DNA methylation changes;
Tcf7l2 was proximal to H3K4me3, H3K27me3, and DNA methylation changes. Four of
these genes (Krt8, Mafg, Tcf7l2, and Vipr2) were present in the top IPA pathway
(Chapter 2). No differentially expressed miRNAs were proximal to DNA or histone
methylation changes. There was significantly more overlap between the gene expression
and the H3K4me3 gene lists than expected by chance (X2=31.6, p<0.00001) and
significantly less overlap than expected by between the gene expression and H3K27me3
lists (X2=48.7, p<0.00001) and between the gene expression and DNA methylation lists
(X2=42.6, p<0.00001).
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Discussion
Analysis of the function and interactions of the 59 differentially expressed genes
identified in this experiment revealed that diverse cellular processes are affected by
neonatal ethanol exposure. Most (60%) of the affected genes are co-expressed and many
(22%) are co-localized. None of the gene protein products directly interact, nor transcribe
one another.
GO analysis implicated the differentially expressed genes in various biosynthetic
processes including dicarboxylic acid, kynurenine, and tryptophan metabolism (Table
4.2). The differentially expressed gene Kmo (Kynurenine 3-monooxygenase) is
responsible for identifying these processes. It encodes an enzyme involved in metabolism
of L-tryptophan to the dicarboxylic acid L-3-hydroxykynurenine, part of the synthesis of
quinolinic acid. This is part of the cytokine-mediated inflammation response (Dantzer et
al., 2011). L-3-hydroxykynurenine is also a source of free radicals, and a neurotoxin; it is
an NMDA receptor antagonist, which acts in much the same neurotoxic manner as
ethanol during synaptogenesis (Lugo-Huitrón et al., 2013). Its upregulation may indicate
a residual inflammatory response after ethanol exposure. Fetal ethanol exposure leads to
various neuroimmune changes, including microglia activation and production of proinflammatory molecules, leading to altered neuronal survival (Drew and Kane, 2014).
Several other classes of genes were differentially expressed. Upregulation of
Synpo2 (synaptopodin 2) in ethanol-exposed mice was also confirmed (Figure 4.4).
Synaptopodins are a class of proteins that are highly expressed in telencephalic dendrites.
The precise function of synaptopodins is unknown; they found at dendritic spines and
post-synaptic densities (Deller et al., 2003; Mundel et al., 1997). Synpo2 dysregulation
may underlie some of their characteristic learning and memory impairment in PND 4,7
ethanol-exposed mice (Kleiber et al., 2014a). Olfactory receptors represent 19% (11/59)
of the differentially expressed genes. Olfactory receptors are implicated in several FASD
studies, and may be involved in its etiology.
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4.5.1

Olfactory Receptor Genes
The top Partek Pathway was “Olfactory Transduction” (Table 4.3). There were 11

olfactory receptor (Olfr) genes differentially expressed, five down regulated and 6
upregulated representing 19% of the identified genes (Figure 4.2) Olfactory receptors
(ORs) are G-protein-coupled receptors that function in the main olfactory epithelium
(MOE). They sense external olfactory cues, and through signal transduction pathways,
send this information to the brain. ORs are ectopically expressed in the brain and other
tissues, but their function remains unclear (Kang and Koo, 2012). The ectopically
expressed ORs are evolutionarily constrained between mice, rats and humans, suggesting
they serve conserved functions (De la Cruz et al., 2008). Generation of antibodies to
study these proteins has been difficult, thus very little is known about their cellular
localization (Kang and Koo, 2012). Evidence suggests that they are important for
mediating cell-cell communication; in skin, ORs mediate communication between
keratinocytes and trigeminal neurons (Sondersorg et al., 2014). During mouse
embryogenesis, ORs may act as recognition molecules providing a complex addressing
system facilitating cell-cell recognition, migration, and tissue assembly during
embryogenesis (Dreyer, 1998). ORs may also have a role in repair. In the rat brain, ORs
were upregulated in dorsal root ganglia following nerve injury (Gong et al., 2015).
Induction of oxidative stress in cultured rat Schwann cells induced upregulation of 14
ORs (Gong et al., 2015). Several human neurodegenerative diseases are also associated
with changes in OR expression, including Alzheimer’s disease, Progressive Supranuclear
Palsy, Parkinson’s disease, and Creutzfeldt-Jakob disease (Ansoleaga et al., 2013;
Garcia-Esparcia et al., 2013). These data suggest that ORs may play an important role in
the development of the brain, and its response to external stress.
Dysregulation of Olfr genes is common in FASD studies. In previous work from
our laboratory using the PND 4,7 model, seven Olfr genes were differentially expressed
at P60, though none of the same genes as in this study (Kleiber et al., 2014a). In a study
examining the hippocampus of P28 mice exposed to ethanol from G0.5-8.5, 30% (7/23)
of differentially expressed genes were olfactory receptors (Marjonen et al., 2015). This
study also found reduction in volume of olfactory bulb and hippocampus. Another study
examining the effect of ethanol on whole-embryo culture found changes in DNA
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methylation of several olfactory receptor genes (Liu et al., 2009). Interestingly, impaired
olfaction is an outcome of fetal ethanol exposure (Muralidharan et al., 2013).
Dysregulation of Olfr genes in the brain in response to ethanol may represent a conserved
response. If ORs facilitate cell-cell communication in the brain, their dysregulation may
be related to the known detrimental effect of ethanol on synaptic pruning/development
(Olney et al., 2002). Further, if ORs indeed have a role in response to stresses, their
dysregulation may be a result of ethanol-induced effects such as oxidative stress
(Brocardo et al., 2011).

4.5.2

Implication of Free Radical Scavenging Pathway
Ingenuity pathway analysis (IPA) identified the top affected gene expression

network as “Free Radical Scavenging, Gene Expression, Dermatological Diseases and
Conditions” (Figure 4.3). This gene network is responsible for coordinating the
transcriptional free radical scavenging response. NFE2L2 homodimers and
NFE2L2/MAFG heterodimers control the expression of genes with antioxidant response
elements (ARE) in their promoters (Nguyen et al., 2009). Such genes are involved in
response to inflammation resulting from elevated free radical levels. Other proteins in
this network have roles in oxidative stress such as GPX, KEAP1, and apolipoproteins.
This network also includes many apoptosis-related proteins including BNIP3L, AATF,
and HSD2D as well as proteins important in the brain such as MAOA, CLCN3.
Dysregulation of this pathway could impact these critical processes, all of which are
relevant to FASD etiology.
Microarray analysis identified 13 genes which were differentially regulated in this
top IPA network. Four of these changes were confirmed by ddPCR: Casp3, Krt8, Tcf7l2
and Vipr2 (Figure 4.4); Casp3 (Caspase-3) is a hub of this network. Caspase-3 has a key
role in the execution phase of cellular apoptosis, and is inducible by oxidative stress
(Ueda et al., 1998). It is involved in many response pathways and processes, and is
responsible for implicating many of the pathways in this analysis (Table 4.3). Its
activation by ethanol is part of the apoptotic cascade that happens in the fetal brain during
development (Goodlett et al., 2005). TCF7L2 regulates insulin secretion, acting as a
transcription factor in the Wnt pathway. Wnt signaling is key in brain development and
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synaptogenesis as well as adult functions such as synaptic modeling and neuronal
maintenance (Oliva et al., 2013). It is a key developmental regulator, and as such is
responsible for implicating many of the pathways in this analysis (Table 4.3). VIPR2 is a
G-protein coupled receptor for a small neuropeptide, pituitary adenylate cyclase
activating polypeptide (PACAP). PACAP acts as a hypothalamic hormone, a
neurotransmitter and a neurotrophic factor (Shioda, 2000). Vipr2 showed methylation
differences in a study of children with ADHD (Wilmot et al., 2015). Downregulation of
L3mbtl4 which is a putative polycomb group protein was also confirmed. These proteins
maintain repressive chromatin states by modification of histone modifications.
Other genes in this network have been implicated in FASD-relevant processes.
Defb5 is a defensin, a family of proteins involved in inflammatory response and
antimicrobial defense which are produced by microglia and astrocytes (Hao et al., 2001).
Our laboratory found Defb15, Defb30 upregulated in PND 70 mice given continuous
access to ethanol during pregnancy (Kleiber et al., 2012). A model of gestational ethanol
exposure also affected defensin expression (Muralidharan et al., 2013). Upregulation of
defensins may indicate stressors, such as oxidative stress occurring in hippocampus.
Again, KMO is involved in inflammatory response. The role of keratins in the brain is
unclear; however, several keratin genes and keratin-associated protein (KRTAP) have
been implicated in FASD models. Krtap was downregulated in previous work from our
laboratory (Chater-Diehl et al., 2016) and in P28 mice exposed to ethanol during GD 0.58.5, (Marjonen et al., 2015). The abundance of another keratin protein (KRT72) was
reduced in whole-mouse-embryo culture in ethanol (Mason et al., 2012).
The implication of this pathway, and other evidence presented suggests an altered
free-radical-scavenging response in the hippocampus. Oxidative stress is a well
characterized component of FASD etiology. Ethanol acts directly on mitochondria to
produce superoxide, hydroxide, and nitric oxide radicals (Wu and Cederbaum, 2003).
Metabolism of ethanol by CYP2E1 produces oxidized products and ultimately hydroxide
radical generation (Mansouri et al., 2001). Catalase also produces acetaldehyde from
alcohol in the brain, further increasing the formation of ROS (Shaw, 1989). Oxidative
damage can lead to blood-brain barrier impairment, inflammation, and increased
apoptosis (Haorah et al., 2008). Interestingly, these are also key features of FASD
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etiology. Indeed, oxidative damage is observed in many rodent models of FASD,
including lipid peroxidation, protein oxidation, and DNA damage (Brocardo et al., 2011).
Lipid peroxidation is not often present in young animals, but accumulates over time into
adulthood (Dembele et al., 2006). In a Drosophila model of developmental ethanol
exposure, changes in expression of antioxidant genes contributed to oxidative stress in
adult flies (Logan-Garbisch et al., 2014). Further, this increased oxidative stress was a
primary cause of developmental delay associated with ethanol exposure (Logan-Garbisch
et al., 2014). Oxidative damage to DNA, protein, membranes, and other cellular
components is a key cause of ethanol-induced damage and cell-death in the brain (Guerri,
1998).
Alteration of oxidative stress gene expression has also been reported in FASD
models. Oxidative stress response genes such as c-Fos have been reported to be
differentially expressed in response to ethanol (Incerti et al., 2010; Poggi et al., 2003).
Fetal ethanol exposure reduces the expression of antioxidant enzymes in the brain
(Drever et al., 2012). The direct role of oxidative stress in FASD phenotypes has been
supported by the amelioration of phenotypes with antioxidant treatment (Patten et al.,
2013; Wu and Cederbaum, 2003)

4.5.3

Low Expression Levels of Differentially Expressed Genes
Expression localization data from the Allen Brain Atlas revealed that only one of

the six differentially expressed genes (Casp3) was expressed at high levels in dentate
granule neurons and hippocampal pyramidal neurons. Caspase-3 is a crucial protein in
many neuronal processes. The other five genes show non-neuron-specific expression
patterns, or are expressed at too low a level to be detected. Each of these genes was
upregulated in response to ethanol. The upregulation of a gene normally expressed at
very low levels could have a substantial impact on the hippocampus.
The low levels of expression, and relatively low fold-changes of these genes made
them very difficult to confirm with qPCR. Droplet digital PCR proved to be better able to
quantify these changes (Figure 4.4). The relative expression in each of the confirmed
genes did not differ from the qPCR data; however, the variation was reduced, resulting in
significant differences in expression.
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All of the genes in this study have a relatively low expression fold change, the
maximum magnitude being 1.5 fold. A low fold change does not necessarily imply
irrelevance to phenotype. A small 1.2 fold increase in the expression of many genes in a
pathway can potentially have a greater impact than a 20 fold change in a single gene
(Barabási and Oltvai, 2004; Subramanian et al., 2005). The previous studies from our
laboratory also found low (less than 2 fold) changes in expression in response to PAE
(Kleiber et al., 2014b; Laufer et al., 2013). Examining a specific brain region did not
change this fold change pattern, suggesting that ethanol exerts subtle effects on gene
expression across the brain. Similarly, the number of differentially expressed genes was
similar to our previous work.

4.5.4

Notable Changes in MicroRNA Expression
There were 60 pre- and mature miRNAs differentially expressed in PND 70

hippocampus after ethanol exposure. Five of these were identified in our laboratory
previously: miR-184 and miR-466b were identified in P60 mice exposure to ethanol
during late (G14,16) gestation while miR-184, miR-704, miR-297a, and miR-669 were
identified in PND 7 mice exposed to PND 4,7 ethanol injections (Mantha et al., 2014).
There were no miRNAs in common with the CPD model. Though the functions of many
of the differentially expressed miRNAs remain unknown, several are involved in brain
development and other FASD-relevant processes. MiR-207 and mir449c are involved in
embryonic neurogenesis (Choi et al., 2008; Maiorano and Mallamaci, 2009). Mir-200c
and miR-130b are involved in neural progenitor cell proliferation (Gong et al., 2013;
Peng et al., 2012). MiR-214 and miR-207 are involved in promoting apoptosis (Liao et
al., 2010; Tan et al., 2014). MiR-130b is involved in regulation of peroxisomes (Pan et
al., 2015). Two are also involved in inflammatory response in the brain; miR-125b
promotes microglia activation (Parisi et al., 2016) and miR-200c promotes astrocyte
activation (Mor et al., 2011).
Using IPA Target Scan™, five of the differentially expressed miRNAs were
found to have differentially expressed predicted miRNA targets (Table 4.6).
Confirmation of differential expression of Mafg, L3mbtl4, and Tmem79 was attempted,
only downregulation of L3mbtl4 was confirmed (Figure 4.4). L3mbtl4 encodes a tumour
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suppressor protein has been shown to be mutated often in breast cancers (Addou-Klouche
et al., 2010). Interestingly, its targeting miRNA, miR-377 also functions as a tumour
suppressor renal cell carcinoma by targeting Ets1 (Wang et al., 2015). Tumor suppressors
have complex and unclear roles in the nervous system; however, their downregulation
can trigger apoptosis and abnormal neurodevelopmental trajectories (Baker and
McKinnon, 2004). Altered regulation of L3mbtl4 and its targeting miRNA miR-377 may
be associated with apoptosis present in the PND 4,7 model. Alternatively, they may be a
“footprint” of earlier ethanol exposure remaining into adulthood. Tmem97 encodes a
membrane protein involved in regulating cellular cholesterol levels. It was differentially
methylated in the DNA methylation analysis, and was present in several top IPA
pathways (Chapter 3). Due to its relevance to lipid metabolism, and downregulation of a
putative targeting miRNA, confirmation of Tmem97 upregulation was attempted using
ddPCR; it was not confirmed however.

4.5.5

Few Co-occurring Gene Expression and Methylation
Changes
Identification of genes across experiments was one of the primary goals of this

project during its conception. Genes which are differentially expressed and differentially
methylated are better candidates for participating in FASD etiology. Such genes would be
implicated by multiple independent explements. Further, differential methylation of these
genes would provide an explanation for their differential expression. There were 16
differentially expressed genes that had changes in at least one methylation. Four of these
(Krt8, Mafg, Tcf7l2, and Vipr2) were present in the top IPA pathway and were assessed
using ddPCR. Krt8, Tcf7l2, and Vipr2 were confirmed using this technique. Synpo2 was
also confirmed with ddPCR. Synpo2 and Krt8 were proximal to H3K4me3 and DNA
methylation changes (Table 4.7).
There were very few differentially expressed genes that had changes in any
methylation. A chi-squared analysis was performed to determine if there was more or less
overlap between each of the three methylation gene lists and the gene expression gene list
than expected by chance. Interestingly, there was more overlap than expected between
the H3K4me3 gene list and the gene expression list (X2=31.6, p<0.00001); significantly
fewer between the H3K27me3 list gene and the gene expression list (X2=48.7,
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p<0.00001) and a significantly fewer between the DNA methylation gene list and the
gene expression list (X2=42.6, p<0.00001). This suggests that the differentially expressed
genes are enriched for H3K4me3 changes, and depleted for H3K27me3 and DNA
methylation changes. H3K4me3 may be more relevant to the gene expression changes
observed here. In Chapter 5, the possible origin and implications of methylation changes
without corresponding gene expression changes are discussed.

4.5.6

Tcf7l2 as an FASD Candidate Gene
Tcf7l2 is notable since it was the only differentially expressed gene proximal to an

epigenetic methylation change with p<0.001 (Figure 4.5) and the only differentially
expressed gene proximal to all three assessed epigenetic methylation changes with
p<0.01 (Figure 4.6). The proximal H3K4me3 and H3K27me3 RDHMs and 5mC DMR
were in the predicted direction with respect to increased gene expression (Table 4.7). The
agreement between these changes suggest Tcf7l2 they may play a functional role in its
upregulation. It is also the top differentially expressed gene in terms of fold-change
magnitude (1.5 fold). Together, these findings make it the single most compiling
candidate gene in this thesis.
Tcf7l2 encodes a transcription factor involved in Wnt signaling. Extracelluar Wnt
signalling proteins bind to frizzled receptors, triggering axin to bind to the β-catenin
destruction complex, inhibiting and promoting β-catenin accumulation. β-catenin enters
the nucleus and binds to TCF7L2 which can then bind to target genes promoting their
expression (Araoka et al., 2010). In the liver, these target genes are involved in insulin
secretion. In the brain, Tcf7l2 and Wnt signalling are necessary for oligodendrocyte
differentiation. TCF7L2 promotes the regulation of key oligodendrocyte-specific genes
during their development. It also regulates neuronal lipids, promoting myelination and
cholesterol biosynthesis gene transcription (Zhao et al., 2016). Tcf7l2 is expressed in
oligodendrocytes of the hippocampus during mouse fetal development (Weaver et al.,
2012). TCF7L2 is also negatively responsive to oxidative stress; oxidative stress
signaling diverts β-catenin depleting active TCF7L2 (Gloyn et al., 2009). These
interactions implicate TCF7L2 in the top IPA pathway, and its relation to lipid
metabolism overlap with peroxisome genes.
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Polymorphisms in this gene are the strongest genetic risk factors for type 2
diabetes (Gloyn et al., 2009). Specific polymorphisms are associated with impaired
insulin secretion, glucose production, and glucose tolerance (Lyssenko et al., 2007). The
mechanisms by which these variants influence glucose homeostasis and diabetes are
believed to be through the gene’s role in adipogenesis, myogenesis, glucose and
pancreatic islet development (Takamoto et al., 2014). The link between hypoglycemia
and FASD is not clear, though some studies have found increased incidence in FASD
individuals (Tanaka et al., 1982). Tcf7l2 has not been previously implicated in FASD
prior to this study. The status of this gene in the top gene expression and methylation
pathways, its overlap with epigenetic changes, indicate that it should be considered as a
candidate gene in FASD and investigated further. Given its role in myelination during
development, its alteration may underlie ethanol-induced synaptic changes in the
hippocampus, contributing to learning and memory impairment.

4.5.7

Conclusion
This chapter describes gene and miRNA expression changes in the adult

hippocampus in response to neonatal ethanol exposure. The affected genes were enriched
for olfactory receptors and oxidative stress response genes. Delineating the possible role
of these genes in FASD etiology is challenging. Exposure of mice to ethanol on PND 4 &
7 results in widespread apoptotic cell death. The surviving cells adapt and alter their
developmental trajectories. It is the gene expression changes in these cells that are
detected in this study. These gene expression changes may represent
adaptations/alterations in the surviving cells, or they may simply reflect the differential
cell population created by early apoptotic cell death (Kleiber et al., 2014b). The changes
in gene expression identified here provide insight into the state of the hippocampal
transcriptome long after ethanol exposure. The conditions responsible for establishing
these changes (early ethanol exposure) are well understood. It is unknown what cellular
and gene expression changes occur between ethanol exposure and the transcriptional
timepoint observed here. Other studies can provide insight into these changes, but given
the heterogeneity of ethanol response, it is difficult to make inferences about specific
genes between studies. Tcf7l2 emerged as a strong candidate gene, being upregulated,
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present in the top IPA pathway, proximal to DNA, H3K4me3, and H3K27me3 changes.
Tcf7l2 is critical in the regulation of glucose homeostasis, and may be involved in
metabolic changes in the brain following PAE. Beyond this gene, few examples of
differential gene expression cooccurring with epigenetic methylation changes were
found. In the final chapter the possible mechanistic hypotheses and future experiments
necessary to test them will be explored.
Footnote
A modified version of this chapter has been published (Chater-Diehl et al., 2016).
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Discussion
Overview
The research presented in this thesis describes changes in histone modification
(Chapter 2), DNA methylation (Chapter 3), and gene expression (Chapter 4) in
hippocampus of adult mice exposed to ethanol during development. The results show that
different but related genes show changes in epigenetic marks and expression. These
include changes in apoptotic, synaptic, and oxidative stress genes. In this chapter, the
results from Chapters 2 to 4 are synthesized, revealing important trends. Free radical
scavenging pathways were implicated in each analysis, particularity the gene expression
and combined methylation analyses. The meaning and possible origins of these changes
are explored, generating hypotheses for additional work. Addition caveats and
considerations for future work are considered.

Implications for Biological Processes
A common approach in genetics is to study a perturbation of a system to better
understand its function. Ethanol exposure during synaptogenesis alters hippocampal
developmental trajectory by removing cells via apoptosis (Ikonomidou, 2000), impairing
neurogenesis (Bonthius and West, 1991; Gil-Mohapel et al., 2010) reducing both synaptic
efficacy (Bellinger et al., 1999), and dendritic spine density (Abel et al., 1983). Such
alterations provide insight into neurodevelopmental trajectories, and identify sensitive
timepoints. The results of this thesis support a role for molecular changes in these
processes. GO and pathway analysis from each chapter implicated differential
expression/methylation of synaptic and apoptotic genes. Differential expression of the
synaptic gene Synpo2, and the apoptosis regulator Casp3 highlights the alteration of
neurodevelopmental genes. Similarly, ethanol can be considered an epigenetic disruptor,
and its effects viewed as a challenge to the epigenome during development (Fowler et al.,
2012). The results of this thesis show that epigenetic disruption using ethanol results in
changes in histone and DNA methylation in adulthood. Examining earlier timepoints in
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mice would further the understanding of establishment and maintenance of such
epigenetic changes after environmental perturbation (see section 5.6 below).

Free Radical Scavenging Pathway
The histone modification, DNA methylation, and gene expression analyses
identified free radical scavenging pathways. The top IPA gene expression pathway was
related to the gene expression response to increased free radicals. Peroxisome biogenesis
was the top Partek pathway for the combined methylation analysis and the penultimate
pathway for DNA methylation. Many lipid-related pathways were implicated across
analyses also, further implicating peroxisomes. Few individual ROS genes were
identified by multiple experiments. Nevertheless, the implication of differentially
regulated free-radical scavenging pathways suggests an altered free-radical scavenging
response lasting into adulthood. This thesis reports a novel interface of free-radical
scavenging and epigenetic mechanisms, two key processes in FASD etiology.
There are three main possibilities for the origin of these expression and epigenetic
changes (Figure 5.1). First, these changes were established as a direct response to ethanol
during exposure and are maintained to adulthood. Second, these changes were indirectly
caused by ethanol as a compensation or amelioration response to ethanol-induced
oxidative stress. Third, these changes presented later in life in response to long-term
accumulation of oxidative damage. The second explanation is most likely, or perhaps a
combination of the three. As discussed, ethanol is known to induce ROS as one of its
primary effects on the brain. The genes involved in the response to this stress include
those differentially methylated/expressed in this thesis. Cells may have altered the
epigenetic regulation of these genes to cope with oxidative stress and its effects. The
hypothesis that these changes are established early should be tested with future
experiments to distinguish between these possible explanations.

186

Figure 5.1 Potential origins of observed epigenetic and gene expression hippocampal
profile in response to neonatal ethanol exposure.
It is well established that in the brain, ethanol leads to increased ROS, leading to
oxidative damage, which contributes to altered behaviour (i.e. FASD phenotypes). The
epigenetic and gene expression changes identified here (represented by a Circos plot of
all the changes identified) may have arisen from: a) the direct action of ethanol during the
exposure period, which may then act to perpetuate ethanol-induced oxidative damage; b)
an early response to ethanol-induced oxidative cellular damage, acting to ameliorate or
compensate for this damage; c) a later response to accumulating oxidative damage over
the early life of the mouse, prior to 70 days of age.
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Diagnostic and Therapeutic Potential
Biomarkers can serve several roles; an ideal biomarker should be part of the
causal pathway of the disease. It should also be well understood, and not related to any
unknown factors that are also related to the exposure. If this is the case, it can reduce the
validity of the relation between biomarker and disease (Mayeux, 2004). There are two
main types of biomarkers: biomarkers of exposure which are used to make predictions,
and biomarkers of disease which are used for diagnosis (Mayeux, 2004). Biomarkers of
disease in FASD are very challenging since so little is known about its etiology. One can
imagine a mark that correlates with the severity of neurodevelopmental challenges, but
unless a mechanism is understood, its validity would be suspect. In theory, histone
modifications and DNA methylation should have good utility as biomarkers of fetal
alcohol exposure. Certain marks at certain genes may indicate how much fetal alcohol
exposure has occurred. Importantly, this quantity can be inferred from patient reports and
gauged against the molecular changes. These types of markers would be independent of
the behavioural outcome however, which is known to vary greatly even with the same
exposure.
The data from this thesis implicate Tcf7l2 as a candidate gene for FASD. Tcf7l2
showed differential expression, histone methylation, and DNA methylation. Tcf7l2
encodes a transcription factor in the Wnt signaling pathway. It controls oligodendrocyte
differentiation during development, lipid metabolism gene expression, and is the gene
most associated with type II diabetes (Oliva et al., 2013). Disruption of myelination via
altered Tcf7l2 expression has the potential to affect synaptic function in the hippocampus
and underlie FASD-related learning and memory impairment. Further investigation of
this gene may lead to understanding of FASD etiology, and may serve as a diagnostic
target.
Changes in H3K4me3 and H4K27me3 occurred at numerous Pcdh genes. Pcdh
genes encode protocadherins, cell-cell signaling molecules involved in synaptogenesis
via providing individual neuron identity (Thu et al., 2014). Altered epigenetic regulation
of these genes by ethanol could account for some of the abnormalities in synaptic
structure in FASD (Sadrian et al., 2012). Recent work from our laboratory and others has
implicated differential DNA methylation of Pcdh genes in children with FASD (Laufer et
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al., 2015; Portales-Casamar et al., 2016). Differential histone medication at these genes
may contribute to an epigenetic signature that will better differentiate affected from
unaffected individuals. Employing multiple components makes biomarkers more
discerning (Mayeux, 2004).
The implication of oxidative stress pathways, but few single genes does not
provide many diagnostic targets. It does however raise the possibility of therapeutics
targeting these pathways. Peroxisomes are already the target of therapeutic research in
neurological disorders and FASD. Use of peroxisome proliferator-activated receptor
(PPAR) agonists is being explored as a possible treatment for FASD (Drew et al., 2015;
Kane et al., 2011). Upregulation of peroxisome biogenesis is shown in these studies to
prevent many of the detrimental effects of ethanol. Finding therapeutic interventions that
work after ethanol exposure is challenging, but important as it is far more relevant to
clinical applications. Altered epigenetic methylation of peroxisome genes in this thesis
underscores their importance in FASD etiology.

Limitations and Caveats
Each of the technologies used in this thesis have inherent strengths and
weaknesses. The use of a promoter microarray focused the study on these regions
exclusively, which was more economical and allowed for simplified bioinformatic
analysis. However, by examining only promoters, changes in other relevant regions such
as enhancers could not be examined. In addition, the DNA capture methods used have
inherent biases. For example, MeDIP used in the DNA methylation experiment is most
sensitive in regions with low CpG density (Nair et al., 2011). Use of a different technique
such as MBD-capture or bisulfite sequencing would likely identify completely different
DMRs. ChIP is currently the only viable option to study histone modification changes.
The histone modification experiment was inherently limited by characterizing only two
modifications out of the 100 or more present in mammalian chromatin. The specific
histone modifications assessed in this thesis were chosen for their presence in promoters
and known close association with gene expression levels. Nevertheless, it is possible that
other more salient changes to other modifications occurred in this model. The results of
this this thesis are also affected by the intrinsic limitations of mice as a model. Though
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mice permit studies not feasible in humans, they are also imperfect models of human
disease. In mouse models of FASD specifically, more ethanol per unit body mass must be
administered to reach similar BAC levels to humans, since mice metabolize ethanol much
faster (Patten et al., 2014). In order to target the third trimester equivalent, ethanol must
be injected directly into neonates, bypassing maternal metabolism and the placenta. In
terms of the molecular changes identified, mice and humans have similar but distinct
genomes, transcriptomes, brain architecture etc. Variation at each of these levels may
limit the applicability of specific findings to human FASD. For example, the CpG
identified as differentially methylated in Chapter 3 is not present in the human genome.
Finally, the experiments of this thesis use a relatively low sample size. Minimal
biological replicates were used thesis to reduce microarray costs and allow for multiple
epigenetic marks to be assessed. Low sample size may have limited the power of these
studies, preventing the possible identification of meaning genes. An increased number of
microarrays in each experiment would increase statistical power and potentially identify
more/different genes.

Considerations for Future Experiments
The changes in gene expression and epigenetics identified in this thesis represent
a component of a much larger field. Expansion of these results to other models and
techniques can test their importance in FASD. Several trade-offs were made in this
research. Further, questions were generated which could not be addressed in this thesis.
As such, there are several improvements and extensions of this research to address for the
future. They are as follows:
1. Additional endpoints in younger mice. The hypothesis that changes in
oxidative stress gene modification and expression can be tested. The hippocampus
of younger mice should be assessed for changes in similar free radical pathways,
ideally at multiple timepoints from PND 7 to PND 70. This would test whether
changes persist from early initiation, or accumulate over time.
2. Investigation of candidate genes in other models: Before the candidate genes
identified in this thesis (Tcf7l2, Pcdh) can be explored in a clinical setting, they
must be further verified in human studies and animal models. For instance, the
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functional significance of Tcf7l2 should be assessed by determining if protein
expression level change in response to ethanol. Functional characterization, such
as developmental knock-out studies, would also strengthen the implication of
these genes in FASD etiology.
3. Cell type heterogeneity. The DNA, RNA, and chromatin samples used in this
thesis were extracted from the whole hippocampus. All of the analysis presented
represents a mix of the cell types of the region. Bioinformatics techniques to
address this heterogeneity, or repetition using cell-type specific techniques may
provide further precision and specificity.
4. Histone modification techniques. While two histone modifications were
assessed from the same chromatin sample, determining modification patterns on
individual nucleosomes was not possible. Emerging histone analysis techniques
allow characterization of all modifications to each nucleosome (Shema et al.,
2016).
5. Limitations to oxidative damage assays. Only DNA was available to assess
oxidative damage in the experimental mice. As such, more informative and longlasting markers such as lipid, DNA, and protein peroxidation were not assessed.
Use of these assays in the future in this model may validate the oxidative gene
expression changes identified here.

Conclusions
A number of conclusions are evident from the results of this thesis. The gene
expression, histone modification and DNA methylation analyses provide insight when
analyzed separately and together. They show that:
1. Neonatal ethanol exposure results in long-term changes to gene expression,
histone modification, and DNA methylation in the mouse hippocampus.
2. In the gene expression experiment, expression of free radical scavenging and
olfactory genes were altered.
3. Numerous epigenetic changes occurred across the entire genome; however,
changes were enriched a specific gene types.
a. H3H4me3 & H3K27me3 changes occurred at:
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i. Protocadherins and other synaptic genes &
ii. Imprinted genes
b. DNA methylation changes occurred at:
i. Peroxisome biogenesis genes.
4. The combined analysis of each dataset revealed further enrichment of free-radical
scavenging processes.
The results of this thesis provide a compressive dataset on the epigenomic impact
of early ethanol exposure. The data provide insight into the actions of ethanol at the
molecular level in the hippocampus. The implication of processes observed in other
FASD models suggests that similar mechanisms are at work. Failure to identify any one
gene consistently supports the heterogeneity the response to ethanol exposure. Oxidative
stress pathways are a key component of FASD etiology, and may be a target for
therapeutic interventions. Since the epigenome is mutable and regulates many cellular
processes it may be an ideal target for such interventions. The results presented also
provide insight into basic biologically principles. Chromatin provides both dynamic
transcriptional control, and maintenance of long-term repression. Environmental
perturbation during brain development was associated with long-lasting changes to
chromatin modifications. The fact that a single event during development can have
lasting molecular consequences underscores the importance of the environment in
shaping human health.
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Appendices

Appendix A Animal ethical approval.
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Appendix B Ingenuity Pathway Analysis (IPA) legend.
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Appendix C Linear relationship between number of genes and number of regions of
differential histone medication (RDHMs) per chromosome.
Numbers indicate the chromosome associated with each data point. R2 value calculated in
Microsoft Excel.
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Appendix D Affected genes in pathways identified from each software suite in
proximity to H3K4me3 changes†.
Pathway name
IPA network/pathway
Carbohydrate
Metabolism, Molecular
Transport, Small
Molecule Biochemistry

Hematological System
Development and
Function, Tissue
Morphology, Cell Death
and Survival
Humoral Immune
Response, Protein
Synthesis, Cellular
Function and
Maintenance
Endocrine System
Disorders,
Gastrointestinal Disease,
Immunological Disease
Endocrine System
Development and
Function, Lipid
Metabolism, Small
Molecule Biochemistry
Cellular Development,
Cellular Growth and
Proliferation, Cancer

Cell Morphology,
Connective Tissue
Development and
Function, Cellular
Development

Genes in pathway and list

p-value

Sfrp1, Akt2, Hoxa7, Six3, Tusc2, Socs7, Tspan8, 10E-63
Ctsl, Ddx4, Meis1, Cox4i1, Agt, Mmp2, Brf1,
Actn3, Dbh, Pax6, Sox18, Rho, Lipe, Ddit3,
Nck2, Tcf7l2, Ralgds, Trpv6, Gyk, Fgf1, Slfn4,
Ptprn, Ptprj, Emx2, Rb1, Arntl, Gprc6a, Iigp1,
Flt4, Phox2b, Eef2k, Grk6, Tmem119,
Cyp24a1, Pdcd4, Prl3d2, Col6a2, Fgfr1,
Lamb2
Ptpre, Vamp2, Bst2, Ntrk1, Cd27, Thpo, Flii,
10E-49
Jak3, Tln1, Nedd4, Rnf31, Rbck1, Ebf1,
Cyp3a16, Col15a1, Rnasel, Myd88, Sh3bp2,
Gata3, Arrb1, Sigirr, Ptpn5, Notch4, Drd5,
Snap23, Scfd1, Mapk8ip1, Sct, Smpd3, Mir22,
Efs, Fas
Tbc1d17, Rbp3, Tef, Gng4, Crip1, Chil1, Pbx2, 10E-31
Pcp4, Cryba1, Nlrp4f, Rad21, Ncs1, Zp1,
Muc1, Eci1, Polk, Tia1, Cenpp, Slain1, Senp7,
Rnps1, Tra2a, Crybb3, Id3, Snn, Ifi30
Pou3f3, Pip5k1c, Psd2, Tapbpl, Ecsit, Acat3,
H2-DMa, Rhcg, Gas7, Gja5, Lpin2, Acsl6,
Parp14, Abca8b, Fcgr1, H2-Eb1, Ctsw, Dock5,
Mst1, Trex1, Prpf8, Psme2, Capn5, Arhgef10,
Spdef, Homer2, Gpr146
Hoxd3, Hsd17b3, Gdf10, Abcc4, Rps29, Rgs16,
Glra1, Ttyh1, Ankrd6, Ndufa7, Ccdc74a, Ogfr,
Ttll7, Dnmt3a, Col4a3bp, Krtdap, Atp6v1f,
Sptb, Cox6c, Rps10, Rps15, Mat2a, Ncoa7,
Fgf18, Smarcc1, Taf10, Spen
Gprasp1, Pcdha2, Mid1, Arpc4, Pcdha3,
Pcdha4, Pcdha10, Ryr1, Bai1, Kctd20, Odf3b,
Gpr123, Ap1m1, Jph1, Jakmip1, Mir138-2,
Cfc1, Lpar3, Nuak2, Inf2, Sema4c, Asic1, Stip1,
Cnot6l, Mrgpra3, Faim2, Foxm1, Ltbp4,
Serpina5, Akap1
Ptbp1, Eno1, Naip1, Hes5, Creb3, Syn1, Tnk2,
Noxa1, Slc14a1, Crip2, Urod, Cnn2, Gtf3c2,
Bcr, Fsd1l, Mlh1, Ptp4a3, Ptk7, Mzb1, Pcca,
Scpep1, Dhrs7, Rbm3, Shisa5, Hdlbp, Rgs12,
Idh3g, Slc38a9

10E-25

10E-24

10E-24

10E-23
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Energy Production, Lipid
Metabolism, Small
Molecule Biochemistry

Endocrine System
Development and
Function, Carbohydrate
Metabolism, Molecular
Transport
Cellular Growth and
Proliferation, Cell
Morphology, Cellular
Assembly and
Organization
Embryonic Development,
Organismal
Development, Gene
Expression
Cellular Movement,
Immune Cell Trafficking,
Hematological System
Development and
Function
Lipid Metabolism,
Molecular Transport,
Small Molecule
Biochemistry
IPA canonical
Regulation of cellular
mechanics by calpain
protease
Fatty acid β-oxidation
Amyotrophic lateral
sclerosis signaling
Bladder cancer signaling
Thyroid cancer signaling
Giloma invasiveness
signaling
Non-small cell lung
cancer signalling
Sphingomyelin
metabolism
Estrogen biosynthesis

Ndufa8, Chtf18, Akt1s1, Csnk2b, Rasl10b,
1100001G20Rik, Akr1c21, Slc4a4, Tmem176a,
Tmem176b, Omp, Arpp21, Scd4, C1qtnf5,
Gpr17, Recql4, Tc2n, Rai1, Slc16a1, Macrod1,
Slco2b1, Trrap, Cacng3, Hap1, Ube2v1
Insrr, Mras, Itpr3, Amn, Aars, Irak,1bp1,
Trpm5, Pycr1, Hgfac, Cbx4, Sertad1, Tmod1,
Oog1, Slc38a4, Fgf15, Dmtn, Ssbp2, Ank1,
Ero1lb, Fbxl17, Fermt3, Ctbp2, Rph3al

10E-22

Rassf1, Vmn2r85, Gm11937, Ndst1, Agtpbp1,
Mcf2l, Acaa1a, Hhatl, Nlrp6, Myadml2,
Serpina12, Mtus1, Gprin1, Krtap19-3, Mbp,
Cmip, Paqr7, Zfp106, Pcyox1, Neu2, Cyp2s1,
Cirbp, Pde4c, Gne, Vars, Ip6k2
Plekhf1, Chrd, G530011O06Rik, Gcm2,
Vmn1r44, Serpinf2, Mical2, Shank2, Lrrfip1,
Prrxl1, Isl2, Tsta3, Mmp15, Grik5, Slc22a22,
Sv2b, Cit, Rnase2a, Zfp521, Auts2, Lbx1, Pax9,
Osr2, Btrc
Pde2a, Rnf19a, Hmmr, Rtcb, Tst, Serpinb9e,
Rbfox1, Dsc3, Kctd10, Rab19, Alyref, Neu1,
Slc35d3, Lims2, Snph, Nkx2-3, Cdhr5, H13,
Hnrnpk, Eif1

10E-20

Grik3, Matn1, Cmtm6, Mir7-1, St6galnac4,
Krt31, Apbb1, Gfap, Rbpjl, H2-Ke6, Matn4,
Mknk2, Erv3, Acsl4, Nr2e3, Olfm1, Prl7d1,
Pnoc, Rsl1d1, Chrna9, Pdlim4, Ncor1

10E-14

Ptk2, Capn5, Rb1, Mras, Ln1, Capn9

0.0039

Acaa1, Acsl6, Acsl4, Eci1, Hsd17b8
Capn5, Naip, Grik5, Gdnf, Grik3, Capn9,
Rnf19a, Ssr4
Rb1, Fgf18, Mmp15, Mras, Mmp2, Rassf1,
Fgf1, Fgf19
Gdnf, Ntrk1, Mras, Rxrb, Tcf7l2
Ptk2, Timp1, Hmmr, Mras, Mmp2, Timp2

0.0044
0.0088

Rb1, Akt2, Itpr3, Mras, Rxrb, Rassf1

0.029

Smpd4, Smpd3

0.032

Hsd17b3, Cyp3a5, Hsd17b8, Cyp2s1

0.035

10E-20

10E-18

10E-17

0.013
0.014
0.016
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Spliceosomal cycle
FGF signaling
TREM1 signaling
FAK signaling
Partek Pathway
Pathways in cancer

Fatty acid metabolism
Sphingolipid metabolism
Enrichr KEGG
MAPK Signaling
pathway

U2af2
Akt2, Fgf18, Fgfr1, Creb3, Map2k3, Fgf1,
Fgf19
Sigirr, Nod2, Akt2, Nlrp6, Myd88
Ptk2, Capn5, Akt2, Hmmr, Mras, Tln1, Capn9

0.038
0.040
0.045
0.048

Akt2, Amn, Bcr, Ctbp2, Fas, Fgf1, Fgf15,
0.034
Fgf18, Fgfr1, Flt3, Lamb2, Mlh1, Mmp2, Ntrk1,
Ptk2, Ralgds, Rassf1, Rb1, Rxrb, Tcf7l2
Acaa1a, Acsl4, Acsl6, Fas, Scd4
0.035
Cers1, Neu1, Neu2, Smpd3, Smpd4
0.040

Fas, Map2k3, Ntrk1, Fgf1, Cacng3, Ecsit,
0.041
Mknk2, Fgf18, Ddit3, Arrb1, Fgfr1, Mras,
Ptpn5, Akt2, Mapk8ip1
Sphingolipid metabolism Neu1, Neu2, Smpd3, Smpd4
0.046
†p-values provided for each pathway are shown (right-tailed Fishers exact test).
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Appendix E Genes bearing both H3K4me3 and H3K27me3 changes†.
Gene name

H3K4me3
MAT
score
4.33

H3K4me3
p-value

Distance
from TSS

0.000375

-2489

H3K27me3
MAT
score
3.14

Elfn2

-5.24

0.0000936

41237

Fbrsl1

-4.35

0.000281

-2406

E030025P04Rik

Fbxl16

H3K27me3 pvalue

Distance
from
TSS

Reciprocal

0.000375

-2489

1.90

0.00246

5169

R

1.12

0.00815

23673

R

3.21

0.000375

8911

6620

12.76

0.000753

6620

-4.56

0.0000936

Flii

6.23

0.0000936

-577

4.42

0.000187

577

Gareml

5.05

0.0000936

-2491

3.06

0.000385

-2491

Grik3

-5.15

0.0000936

4162

-13.08

0.000667

4162

H2-DMa

-4.08

0.0002809

13252

-14.26

0.000475

13252

Hoxa7

-6.18

0.0000936

-2823

-19.74

-2823

Mief2

6.22

0.0000936

-579

4.42

0.000093
6
0.000187

Mir5100

6.22

0.0000936

-844

4.42

0.000187

-844

Myadml2

0.998

0.0002809

1056

-13.03

0.000655

1056

Ndor1

-6.04

0.0000936

4744

-12.76

0.000749

4744

Pcdha4-g

-4.11

0.0002809

486398

-12.45

0.001311

540697

-14.11

0.000468

781334

-10.87

0.003558

722971

1.07

0.00899

365221

R

2.02

0.001966

400019

R

-11.29

0.002528

-3178

-579

Pcdhga1

-11.16

0.0000936

72130

-14.11

0.000468

72130

-8.17

0.0000936

13767

-10.87

0.003558

13767

Pcdhga2

-11.16

0.0000936

64970

-14.11

0.000468

64970

-8.17

0.0000936

6607

-10.87

0.003558

6607

11.1605
-8.17

0.0000936

59740

-14.11

0.000468

59740

0.0000936

1377

-10.87

0.003558

1377

Pcdhga4

-11.16

0.0000936

48675

-14.11

0.000468

48675

Pcdhga5

-11.16

0.0000936

39574

-14.11

0.000468

39574

Pcdhga6

-11.16

0.0000936

26846

-14.11

0.000468

26846

Pcdhga7

-11.16

0.0000936

19241

-14.11

0.000468

19241

Pcdhga8

-11.16

0.0000936

8369

-14.11

0.000468

8369

Pcdhga9

-11.16

0.0000936

-2841

-14.11

0.000468

-2841

Pcdhgb1

-11.16

0.0000936

53617

-14.11

0.000468

53617

Pcdhgb2

-11.16

0.0000936

44216

-14.11

0.000468

44216

Pcdhgb4

-11.16

0.0000936

13521

-14.11

0.000468

13521

Pcdhgb5

-11.16

0.0000936

2921

-14.11

0.000468

2921

Pcdhga3

R

R
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Pebp4

4.30

0.0003747

-2474

4.13

0.000187

-2474

Pycr1

-4.16

0.0002809

-3591

-13.03

0.000655

-3591

Rai1

4.28

0.0003745

-2491

1.14

0.007491

10315

3.51

0.000375

76874

Rassf1

-5.00

0.0000936

3765

-13.01

0.000655

3765

Tmem203

-6.04

0.0000936

-4768

-12.76

0.000749

-4768

Tusc2

-5.00

0.0000936

-4887

-13.01

0.000655

-4887

†The

degree of enrichment (MAT score) and p-value for each RDHM is shown for each

gene (two-way ANOVA). The distance from the region of differential histone
methylation (RDHM) to the transcriptional start site (TSS) of the gene in base pairs is
also shown. Negative distance indicates that the RDHM is upstream of the TSS. The
reciprocal column is marked if the two methylations have a reciprocal relationship, i.e.
one is increased and the other decreased indicating the same predicted effect on gene
expression.
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Appendix F Linear relationship between number of genes and number of
differentially methylated regions (DMRs) per chromosome.
Numbers indicate the chromosome associated with each data point. R2 value calculated in
Microsoft Excel.
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Appendix G Affected genes in pathways significantly enriched with genes proximal
to differentially methylated regions (DMRs).
Network name
IPA
Cellular
Movement, Cell
Death and Survival,
Cellular
Development

Affected genes

Acadvl, Adcyap1, Bai1, Banp, Bmp7, Camk2n1,
Cc2d1a, Ccl17, Cd151, Cd1d, Cd38, Cd3e, Cd70,
Cdc25c, Cdh15, Cenpa, Csf1r, Csk, Ctsb, Ctsh,
Cyld, Cyp11b2, Cyp27b1, Ddx5, Dhx58, Dll4,
Dusp4, E2f3, Egr2, Fat1, Fbln2, Fgf1, Flna,
Gas2l1, Gata1, Gins2, Gjb1, Golt1b, Grn, Hdac11,
Hgs, Hipk2, Hist1h2ab, Hspa1a/hspa1b, Id2, Il13,
Il13ra2, Il17rd, Il21r, Itga5, Kat2a, Lsp1, Mcl1,
Mir-135, Mir-143, Mir-146, Mir-26, Myd88,
Ndfip2, Neurog3, Nos2, Nppc, Ntn1, Numbl, P2ry2,
Pcdha5, Pgf, Plcd1, Pole, Polr2a, Ptger4, Rbl2,
Rbp1, Recql, Relb, S100a6, S100a9, Sirpa, Slc9a8,
Snupn, Socs2, Spn, Stra6, Tac1, Tacc2, Tardbp,
Tff1, Thbs4, Thpo, Timp3, Tnfsf4, Tnk2, Tp73,
Trak1, Trib3, Trps1, Tshz3, Uba7, Ung, Vdr, Vegfa,
Vkorc1l1, Wnk2
Cell Cycle, Cellular Antxr1, Atp5b, Bcl2l12, Bclaf1, Bik, Capn3,
Development,
Ccdc33, Cchcr1, Cdc25c, Ctsd, Cul4a, Cxxc1,
Cellular Growth
Ddx5, Egr2, Eif4a2, Elf4, Foxl2, Foxp4, Fzd4,
and Proliferation
Gemin5, Gpa33, Hist4h4, Hopx, Ifitm2, Kctd13,
Lnx2, Lpin1, Lsm2, Mettl1, Mir-135, Mir-150, Mir188, Mir-26, Mir-324, Mir-338, Mir-486, Naca,
Nav2, Ndufb5, Ndufs8, Nos1, Npas1, Numbl, Pax6,
Pla2r1, Poldip2, Ptpru, Rap2b, Rbm3, Sf3a1,
Slc39a3, Snapc1, Tagln2, Tal1, Thpo, Tmem97,
Unc45a

p-value
10E-130

10E-50

Inflammatory
Response, Cellular
Movement,
Immune Cell
Trafficking

Acaa1, Acss2, Ambp, Aoah, Ap1g2, Aplp1, Bcan,
C9orf9, Carhsp1, Cd151, Cd177, Clasp1, Clstn1,
Colq, Csnk2a2, Ctsb, Derl2, Dgkz, Dlec1, Dlg4,
Efnb3, Epha2, Esrrg, Fam53c, Fat1, Fgf1, Fgf4,
Fmn2, Gcc1, Hs6st1, Htr6, Igfbp2, Il17rd, Iscu,
Itga5, Itm2c, Kcnip1, Kcnj12, Lamc1, Mir-146,
Mir-196, Nos2, Nrn1, Pdlim4, Prmt2, Ptger4,
Rab21, Scamp3, Slc1a2, Smtn, Ssh3, Tac1, Timp3,
Tnni3, Tspan4, Usp2, Vamp4,

10E-50

Organismal
Development,
Tissue
Development,

Actc1, Arf5, Atl1, Atl2, Cct6a, Cdo1, Ceacam1,
Chac1, Cnn2, Ddx5, Dlgap5, Dll1, Dpep1, Eif3i,
Enpp4, Exosc6, Gtf2h1, Hsd17b2, Igf2bp2, Il11ra,
Impa2, Iqgap2, Krt80, Lamp2, Lef1, Lrch4,

10E-43
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Embryonic
Development

Lypd6b, Mecr, Mrap, Msl3, Nfx1, Nipal2, Nmb,
Nop2, Nup50, Onecut1, Otx2, Oxtr, Pik3ap1, Pir,
Polr1d, Polr2a, Polr2h, Ptch2, Samm50, Sema3f,
Tmem17, Tmem64, Tmem97, Trpv4, Tspan17,
Umodl1,

Cell Death and
Survival, Cellular
Development,
Cellular Growth
and Proliferation

Aatk, Abcb10, Agrn, Arl16, Bre, C1qtnf4, C4orf19,
Cdc25c, Chpf, Dapk2, Dmrt3, Dpp7, Ebna1bp2,
Emilin2, Fam167a, Fgf1, Fhdc1, Galnt6, Gata5,
Glp2r, Il20rb, L3mbtl3, Lad1, Mfi2, Mis12,
Mybbp1a, Myd88, Nfatc3, Nr1d2, Nr1h4, Nudt11,
Pgam1, Rab17, Rhbdl2, Rpp25, Scn1b, Scx,
Sema5b, Sema7a, Sos2, Stx12, Sytl2, Tjap1, Tmcc3,
Tnfrsf21, Trib3,

10E-35

Cd1d1, Cd3e, Cd38, Csf1r, Gm2002, Gm13305,
Il11ra1, Il11ra2, Itga5, Thpo
Acaa1a, Hao2, Mpv17l, Mvk, Nos2, Peci, Pex26,
Pxmp2, Slc25a17
Gm2002, Gm13305, Il11ra1, Il11ra2, Il12rb1, Il13,
Il13ra2, Il20rb, Il21r, Socs2, Sos2
Abcb9, Ap1g2, Ap1s1, Arsg, Ctsb, Ctsd, Ctsh,
Lamp2, Tcirg1
Cdo1, Ggt6

0.0003

Slc25a17, Mvk, Nos2, Pxmp, Mpv17l, Hao2, Pex26
Ap1g2, Lamp2, Ap1s1, Ctsh, Arsg, Abcb, Tcirg1,
Ctsd, Ctsb

0.024
0.026

Partek pathway
Hematopoietic cell
lineage
Peroxisome
Jak-STAT
signaling pathway
Lysosome
Taurine and
hypotaurine
metabolism
Enrichr KEGG
Peroxisome
Lysosome

0.0006
0.0006
0.003
0.009
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Appendix H Affected genes in pathways significantly enriched with genes proximal
to differentially methylated regions (DMRs) or regions of differential histone
modification (RDHMs).
Pathway name
IPA
Embryonic
Development,
Organismal
Development, Cellular
Development

Genes in list

Apbb1, Aplp1, App, Bmp7, Brf1, Ceacam1,
Cox4I1, Dbh, Ddx4, Ddx5, Derl2, Dis3, E2F3,
Eef2K, Eif5B, Fgf1, Fgf4, Fgfr1, Gnaz,
Gprc6A, Gyk, Hoxb9, Hoxd3, Hoxd9, Hoxd10,
Hs6St1, Htr3A, Id3, Itga5, Itm2B, Itm2C,
Lamb2, Mecr, Meis1, Ncs1, Nr1H4, Nrg1,
Ntn1, Numbl, Otx2, Pax6, Pdcd4, Pgf, Phf1,
Phox2B, Ppargc1B, Rb1, Rbl2, Rbp1, Rho,
S100A6, Six3, Slc14A1, Socs7, Suv420H1,
Tcf7L2, Tusc2
Cardiac Hypertrophy, Acss2, Actc1, Adcyap1, Antxr1, Cc2D1A,
Cardiovascular
Cd53, Cd5L, Cdo1, Cxxc1, Cyp24A1,
Disease,
Cyp27B1, Dleu2, Flt3, Flt4, Foxl2, Gdnf,
Developmental
Hoxa7, Igf1, Inhba, Jph4, Lh, Lingo1, Mb,
Disorder
Nos1, Nos2, Nrgn, Polr2A, Ptger4, Ptpre,
Ptprj, Ptprn, Ralgds, Relb, Retnlb, Serpinh1,
Sfrp1, Sfxn1, Slc39A14, Slc8A1, Socs2, Syn1,
Tkt, Tmem119, Tnk2, Tnni3, Trpv6, Tspan2,
Tspan17, Ttyh1, Vdr, Zbtb20
Humoral Immune
Abcc4, Abcg2, Arhgef10, Bcl3, Bik, Bst2,
Response, Protein
Cabin1, Ccl17, Cd27, Cd38, Cd70, Dhx58,
Synthesis,
Dll4, Dnmt3A, Drd5, Ebf1, Efs, Gas7, Gata3,
Hematological System Glra1, Grn, Ifit3, Il25, Il13Ra2, Il20Rb, Il21R,
Development and
Jak3, Lef1, Mafk, Mapk8Ip1, Mat2A, Myd88,
Function
Nod2, Notch4, Ntrk1, Pou3F1, Rxrb, Smarcc1,
Tardbp, Tcirg1, Tmem97, Tnfrsf21, Trex1,
Uba7, Ung
Cellular Development, Adcy7, Ager, Asap1, Cd3E, Csf1R, Csk, Cyld,
Cellular Growth and
Dgkz, Dmtn, Dok3, Dusp4, Egr2, Epha2,
Proliferation,
Esrrg, Fas, Flii, Il13, Lamc1, Lamp2, Lpin1,
Hematological System Map2K3, Mcf2L, Mcl1, Mif, Pik3Ap1, Plec,
Development and
Prmt2, Ptk2, Rbck1, Rnf31, Scfd1, Sh2B2,
Function
Sh3Bp2, Sigirr, Sirpa, Smpd3, Snap23, Stra6,
Thpo, Tnfsf4, Vegfa
Skeletal and Muscular Abca7, Acot11, Actc1, Actn3, Ankrd6, Arntl,
Disorders,
Atp1B2, Bhmt, Capn3, Cd151, Cd177, Fat1,
Developmental
Flna, Igf2Bp2, Impa2, Inf2, Kcnk3, Ldb3, Lipe,
Disorder, Hereditary
Lpar3, Lrch1, Ncoa7, Nphs1, Nr1D2, P2Ry2,
Disorder
Pnpla2, Rgs19, Slc35D3, Sox18, Srpk3,
Tmem40, Tst, Tsta3

p-value
10E-64

10E-56

10E-49

10E-41

10E-30
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Hematological System
Development and
Function, Tissue
Morphology, Cell-ToCell Signaling and
Interaction
Endocrine System
Development and
Function, Molecular
Transport, Protein
Synthesis

Cell Death and
Survival,
Antimicrobial
Response,
Inflammatory
Response
Cell-To-Cell
Signaling and
Interaction,
Hematological System
Development and
Function, Immune
Cell Trafficking
Embryonic
Development,
Organismal
Development, CellTo-Cell Signaling and
Interaction
Cell-To-Cell
Signaling and
Interaction,
Reproductive System
Development and
Function, Tissue
Development
Cell Death and
Survival, Lipid
Metabolism, Small
Molecule
Biochemistry

Acsl6, Arsg, Ccl17, Cip1, Cryba1, Crybb3,
Dusp4, Ebna1Bp2, Gtf2H4, Homer2, Il12Rb1,
Kat2A, Lad1, Map2K3, Mst1, Mvk, Ndfip2,
Nedd4, Nrn1, Pbx2, Pla2R1, Polr1D, Rasa2,
Rgs16, Rnps1, Ska1, Slain1, Socs2, Tia1,
Usp2, Vdr, Zfhx3
Aatk, Ank1, Atp5B, Cbx4, Ctsd, Ero1Lb,
Fbxl17, Fem1B, Foxp4, Gpr17, Hipk2,
Hsd17B3, Igf1, Insrr, Ip6K1, Itpr3, Kctd10,
Lims2, Lpin1, Mfi2, Mrap, Mrpl47, Mybbp1A,
Ntrk1, Pnpla2, Rbm39, Rnasel, Rph3Al,
Sertad1, Socs2, Sptb, St6, Galnac4, Taf10,
Timp2
Agl, Bcr, Cc2D1A, Ccl17, Cd70, Cd300E,
Ceacam1, Clstn1, Dhx58, Dll1, Dock5, Dsc3,
Ebf1, Glp2R, Hes5, Ifi47, Ifit3, Iigp1,
Irak1Bp1, Lrrfip1, 42801, Mettl1, Mzb1,
Parp14, Sigirr, Slc39A14, Sox1, Spn

10E-26

Ap1S1, Apol6, Bcan, C1Qtnf5, Calb2, Capn5,
Dpp7, Egr2, Emx2, Fermt3, Gata3, Gdnf,
Gins2, Gja5, Gpr146, Hapln2, Il12Rb1,
Kcnk9, Mras, Nfatc3, Nr1H4, Orai1, Pam16,
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